Annotation Detail for NOS2
Basic Information Top
| Gene Symbol: | NOS2 ( HEP-NOS,INOS,NOS,NOS2A ) |
|---|---|
| Gene Full Name: | nitric oxide synthase 2, inducible |
| Band: | 17q11.2 |
| Quick Links | Entrez ID:4843; OMIM: 163730; Uniprot ID:NOS2_HUMAN; ENSEMBL ID: ENSG00000007171; HGNC ID: 7873 |
| Relate to Another Database: | SFARIGene; denovo-db |
| Pathway ID | Pathway Name |
|---|---|
| PWY-4983 | citrulline-nitric oxide cycle |
| PWY-5004 | superpathway of citrulline metabolism |
| Pathway ID | Pathway Name |
|---|---|
| hsa04020 | Calcium signaling pathway |
| hsa05142 | Chagas disease |
| hsa05140 | Leishmaniasis |
| hsa05146 | Amoebiasis |
| hsa05145 | Toxoplasmosis |
| hsa00330 | Arginine and proline metabolism |
| hsa05222 | Small cell lung cancer |
| hsa01100 | Metabolic pathways |
| hsa04146 | Peroxisome |
| hsa05200 | Pathways in cancer |
| Pathway ID | Pathway Name |
|---|---|
| Hemostasis |
| Pathway ID | Pathway Name |
|---|---|
| 200034 | IL12-mediated signaling events |
| 200131 | IL23-mediated signaling events |
| 200154 | Signaling mediated by p38-alpha and p38-beta |
| 200172 | HIF-1-alpha transcription factor network |
| 200116 | ATF-2 transcription factor network |
| No data |
| No data |
| Desease ID | Desease Name |
|---|---|
| Cancers | |
| Cancers of the digestive system | |
| H00017 | Esophageal cancer |
| No data |
| Desease Name |
|---|
| rheumatoid arthritis |
| microalbuminuria, diabetic |
| Parkinson's disease |
| malaria, plasmodium falciparum |
| cirrhosis |
| neuropathy, diabetic |
| atherosclerosis, coronary |
| tuberculosis |
| Type 2 Diabetes (Retinopathy) |
| CARDIOVASCULAR |
| diabetes, type 1 |
| CANCER |
| stomach cancer |
| asthma atopy |
| Asthma |
| bladder cancer |
| nephropathy, diabetic |
| purpura, Henoch-Schonlein |
| RENAL |
| hypertension |
| malaria |
| Essential Hypertension |
| systemic lupus erythematosus |
| IMMUNE |
| NEUROLOGICAL |
| increased nitric oxide production and protection from malaria |
| atopy |
| METABOLIC |
| preterm delivery |
| retinopathy, diabetic |
| REPRODUCTION |
| diabetes, type 2 |
| Dementia |
| INFECTION |
| No data |
| Desease Name |
|---|
| Hypertension, susceptibility to |
| Malaria, resistance to |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| C063609 | 1,2-dimethyl-4-nitrobenzene | 1,2-dimethyl-4-nitrobenzene results in decreased expression of NOS2 mRNA | decreases expression | 19784758 |
| C051360 | 1,3-dipropyl-8-cyclopentylxanthine | 1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [2-chloro-N(6)cyclopentyladenosine results in increased expression of NOS2 protein] | decreases reaction|increases expression | 10952960 |
| C420084 | 1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester | 1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 16818512 |
| C048927 | 1,5-anhydrofructose | 1,5-anhydrofructose inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19559007 |
| C048927 | 1,5-anhydrofructose | 1,5-anhydrofructose inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19559007 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 12847270 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 12847270 |
| C477819 | 15-deoxyprostaglandin J2 | 15-deoxyprostaglandin J2 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 10866999 |
| C477819 | 15-deoxyprostaglandin J2 | 15-deoxyprostaglandin J2 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17891158 |
| C477819 | 15-deoxyprostaglandin J2 | 15-deoxyprostaglandin J2 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17891158 |
| C112765 | 17-(allylamino)-17-demethoxygeldanamycin | 17-(allylamino)-17-demethoxygeldanamycin results in decreased expression of NOS2 mRNA | decreases expression | 11835313 |
| C112765 | 17-(allylamino)-17-demethoxygeldanamycin | Quercetin inhibits the reaction [17-(allylamino)-17-demethoxygeldanamycin results in decreased expression of NOS2 mRNA] | decreases expression|decreases reaction | 11835313 |
| C495109 | 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetra-hydroisoquinoline | 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetra-hydroisoquinoline inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 11961057 |
| C495109 | 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetra-hydroisoquinoline | 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetra-hydroisoquinoline inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11961057 |
| C118559 | 1-bromopropane | 1-bromopropane results in increased expression of NOS2 mRNA | increases expression | 18164123 |
| C118559 | 1-bromopropane | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [1-bromopropane results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18164123 |
| C118559 | 1-bromopropane | PD 98059 inhibits the reaction [1-bromopropane results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18164123 |
| C095284 | 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one | NOS2 protein affects the reaction [[1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one results in decreased activity of GUCA1A protein] which affects the susceptibility to Phenylephrine] | affects reaction|affects response to substance|decreases activity | 15933248 |
| C471009 | 1-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline | 1-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12527339 |
| C471009 | 1-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline | Lipopolysaccharides inhibits the reaction [1-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12527339 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of NOS2 protein | decreases activity | 10527657 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of NOS2 mRNA | decreases expression | 10527657 |
| C007997 | 25-hydroxycholesterol | 25-hydroxycholesterol results in increased expression of NOS2 mRNA | increases expression | 12085989 |
| C007997 | 25-hydroxycholesterol | 25-hydroxycholesterol results in increased expression of NOS2 mRNA | increases expression | 12085989 |
| C076996 | 27-hydroxycholesterol | 27-hydroxycholesterol inhibits the reaction [Estradiol results in increased activity of NOS2 protein] | decreases reaction|increases activity | 17873880 |
| C076996 | 27-hydroxycholesterol | 27-hydroxycholesterol inhibits the reaction [Estradiol results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17873880 |
| C076996 | 27-hydroxycholesterol | 27-hydroxycholesterol results in decreased expression of NOS2 mRNA | decreases expression | 17873880 |
| C076996 | 27-hydroxycholesterol | ESR1 protein affects the reaction [27-hydroxycholesterol results in decreased expression of NOS2 mRNA] | affects reaction|decreases expression | 17873880 |
| C076996 | 27-hydroxycholesterol | ESR2 protein affects the reaction [27-hydroxycholesterol results in decreased expression of NOS2 mRNA] | affects reaction|decreases expression | 17873880 |
| C093124 | 2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine | 2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine binds to and results in decreased activity of NOS2 protein | affects binding|decreases activity | 9421461 |
| C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18570648 17137498 |
| C058394 | 2-chloro-N(6)cyclopentyladenosine | 1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [2-chloro-N(6)cyclopentyladenosine results in increased expression of NOS2 protein] | decreases reaction|increases expression | 10952960 |
| C058394 | 2-chloro-N(6)cyclopentyladenosine | 2-chloro-N(6)cyclopentyladenosine results in increased expression of NOS2 protein | increases expression | 10952960 |
| C116817 | 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid | 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide inhibits the reaction [IFNG protein results in increased expression of NOS2] | decreases reaction|increases expression | 17363558 |
| C433771 | 2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester | 2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester inhibits the reaction [Acetaminophen results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15345658 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11891798 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11891798 |
| C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [1-bromopropane results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18164123 |
| C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Endosulfan results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17261270 |
| C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Methoxychlor results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15979571 |
| C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Triglycerides promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 18710323 |
| C506282 | 3,5-dimethoxy-4'-hydroxystilbene | [3,5-dimethoxy-4'-hydroxystilbene co-treated with Quercetin] results in decreased expression of NOS2 mRNA | affects cotreatment|decreases expression | 17135264 |
| C506282 | 3,5-dimethoxy-4'-hydroxystilbene | 3,5-dimethoxy-4'-hydroxystilbene results in decreased expression of NOS2 mRNA | decreases expression | 17135264 |
| C506282 | 3,5-dimethoxy-4'-hydroxystilbene | [3,5-dimethoxy-4'-hydroxystilbene results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA] | decreases expression|decreases reaction|increases expression | 17135264 |
| C524639 | 3,7-O-dimethylquercetin | 3,7-O-dimethylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18178435 |
| C524639 | 3,7-O-dimethylquercetin | 3,7-O-dimethylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18178435 |
| C106592 | 3,9-bis((ethylthio)methyl)-K-252a | 3,9-bis((ethylthio)methyl)-K-252a results in decreased expression of NOS2 mRNA | decreases expression | 15294995 |
| C041477 | 3-hydroxyflavone | 3-hydroxyflavone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 14563492 |
| C041477 | 3-hydroxyflavone | Hemin promotes the reaction [3-hydroxyflavone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 14563492 |
| C041477 | 3-hydroxyflavone | HMOX1 protein promotes the reaction [3-hydroxyflavone inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases reaction | 14563492 |
| C041477 | 3-hydroxyflavone | tin protoporphyrin IX inhibits the reaction [3-hydroxyflavone inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 14563492 |
| C031136 | 3-methylcatechol | 3-methylcatechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18499097 |
| C031136 | 3-methylcatechol | 3-methylcatechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18499097 |
| C047368 | 3-methylquercetin | 3-methylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18274639 |
| C047368 | 3-methylquercetin | 3-methylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18274639 |
| C092610 | 3-methylsydnone-5-nitrosimine | 3-methylsydnone-5-nitrosimine inhibits the reaction [NOS2 gene mutant form results in decreased susceptibility to Indomethacin] | decreases reaction|decreases response to substance | 10964977 |
| C092610 | 3-methylsydnone-5-nitrosimine | 3-methylsydnone-5-nitrosimine inhibits the reaction [NOS2 gene mutant form results in decreased susceptibility to Zymosan] | decreases reaction|decreases response to substance | 10964977 |
| C452870 | 3-O-methylquercetin | 3-O-methylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16213685 18178435 |
| C452870 | 3-O-methylquercetin | 3-O-methylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18178435 16213685 |
| C031285 | 3-xylene | 3-xylene results in increased expression of NOS2 protein | increases expression | 12717741 |
| C400084 | 4-chlorobenzyltetrahydroberberine | 4-chlorobenzyltetrahydroberberine inhibits the reaction [Monocrotaline results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16225752 |
| C418965 | 4-dimethylamino-3',4'-dimethoxychalcone | 4-dimethylamino-3',4'-dimethoxychalcone inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11134894 |
| C018599 | 4-methylcatechol | 4-methylcatechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18499097 |
| C018599 | 4-methylcatechol | 4-methylcatechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18499097 |
| C478738 | 4-(nitroxy)butanoic acid 4-acetylaminophenyl ester | 4-(nitroxy)butanoic acid 4-acetylaminophenyl ester results in decreased expression of NOS2 mRNA | decreases expression | 16172162 |
| C526423 | 5-aziridinyl-3-hydroxyl-1-methylindole-4,7-dione | NOS2 protein affects the susceptibility to 5-aziridinyl-3-hydroxyl-1-methylindole-4,7-dione | affects response to substance | 17039774 |
| C052853 | 5-hydroxydecanoic acid | 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases expression | 16257489 |
| C052853 | 5-hydroxydecanoic acid | 5-hydroxydecanoic acid inhibits the reaction [N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases expression | 16257489 |
| C052853 | 5-hydroxydecanoic acid | 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Rotenone results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 15927086 15795934 |
| C052853 | 5-hydroxydecanoic acid | 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression | 15927086 15795934 |
| C052853 | 5-hydroxydecanoic acid | 5-hydroxydecanoic acid inhibits the reaction [N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 15795934 15927086 |
| C052853 | 5-hydroxydecanoic acid | 5-hydroxydecanoic acid inhibits the reaction [N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression | 15927086 15795934 |
| C062711 | 5-hydroxyflavone | 5-hydroxyflavone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12512693 |
| C058176 | 5-nitro-2-(3-phenylpropylamino)benzoic acid | 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19446535 |
| C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | [Carmustine co-treated with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid] inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitrites] | affects cotreatment|decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid] | decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| C121465 | 6-methyl-2-(phenylethynyl)pyridine | 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Acetaminophen results in increased activity of NOS2 protein] | decreases reaction|increases activity | 12547406 |
| C121465 | 6-methyl-2-(phenylethynyl)pyridine | 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Acetaminophen results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12547406 |
| C508169 | 7-(2-(4-(4-nitrobenzene)piperazinyl)ethyl)-1,3-dimethylxanthine | 7-(2-(4-(4-nitrobenzene)piperazinyl)ethyl)-1,3-dimethylxanthine inhibits the reaction [TNF protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16754782 |
| C003001 | 7-ketocholesterol | 7-ketocholesterol results in increased expression of NOS2 mRNA | increases expression | 12085989 |
| C003001 | 7-ketocholesterol | 7-ketocholesterol results in increased expression of NOS2 mRNA | increases expression | 12085989 |
| C083763 | 8-bromoguanosino-3',5'-cyclic monophosphorothioate | 8-bromoguanosino-3',5'-cyclic monophosphorothioate inhibits the reaction [TNF protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16754782 |
| C025945 | 8-chlorocarbochromen | 8-chlorocarbochromen inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15322736 |
| D000079 | Acetaldehyde | Acetaldehyde results in increased expression of NOS2 protein | increases expression | 18845238 |
| D000079 | Acetaldehyde | [Acetaldehyde results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | increases abundance|increases expression | 18845238 |
| D000082 | Acetaminophen | 2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester inhibits the reaction [Acetaminophen results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15345658 |
| D000082 | Acetaminophen | 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Acetaminophen results in increased activity of NOS2 protein] | decreases reaction|increases activity | 12547406 |
| D000082 | Acetaminophen | 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Acetaminophen results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12547406 |
| D000082 | Acetaminophen | Acetaminophen inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 12774022 |
| D000082 | Acetaminophen | Acetaminophen inhibits the reaction [TNF protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12774022 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of NOS2 mRNA | decreases expression | 10860828 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of NOS2 protein | decreases expression | 10860828 |
| D000082 | Acetaminophen | [Acetaminophen results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide | decreases chemical synthesis|decreases expression | 10860828 |
| D000082 | Acetaminophen | Acetaminophen results in increased activity of NOS2 protein | increases activity | 12547406 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of NOS2 mRNA | increases expression | 14557383 15345658 16781746 12153990 11826401 16552707 19739265 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of NOS2 protein | increases expression | 12392966 14550746 12547406 19739265 |
| D000082 | Acetaminophen | CXCR2 protein affects the reaction [Acetaminophen results in increased expression of NOS2 mRNA] | affects reaction|increases expression | 16552707 |
| D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 12153990 |
| D000082 | Acetaminophen | IL10 protein inhibits the reaction [Acetaminophen results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11826401 |
| D000082 | Acetaminophen | manumycin inhibits the reaction [Acetaminophen results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19739265 |
| D000082 | Acetaminophen | manumycin inhibits the reaction [Acetaminophen results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19739265 |
| D000082 | Acetaminophen | Methionine inhibits the reaction [Acetaminophen results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19739265 |
| D000082 | Acetaminophen | Methionine inhibits the reaction [Acetaminophen results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19739265 |
| D000082 | Acetaminophen | NOS2 protein inhibits the reaction [Acetaminophen results in increased expression of CTGF mRNA] | decreases reaction|increases expression | 12392966 |
| D000082 | Acetaminophen | NOS2 protein inhibits the reaction [Acetaminophen results in increased expression of TNF mRNA] | decreases reaction|increases expression | 12392966 |
| D000082 | Acetaminophen | NOS2 protein promotes the reaction [Acetaminophen results in increased expression of IL10 mRNA] | increases expression|increases reaction | 12392966 |
| D000082 | Acetaminophen | NOS2 protein results in increased susceptibility to Acetaminophen | increases response to substance | 12392966 11826401 14550746 |
| D000082 | Acetaminophen | pimagedine inhibits the reaction [NOS2 protein results in increased susceptibility to Acetaminophen] | decreases reaction|increases response to substance | 14550746 |
| D000082 | Acetaminophen | S-ethyl glutathione inhibits the reaction [Acetaminophen inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression | 12774022 |
| D000082 | Acetaminophen | SIB 1757 inhibits the reaction [Acetaminophen results in increased activity of NOS2 protein] | decreases reaction|increases activity | 12547406 |
| D000082 | Acetaminophen | SIB 1893 inhibits the reaction [Acetaminophen results in increased activity of NOS2 protein] | decreases reaction|increases activity | 12547406 |
| D000082 | Acetaminophen | TNFRSF1A protein affects the reaction [pimagedine inhibits the reaction [NOS2 protein results in increased susceptibility to Acetaminophen]] | affects reaction|decreases reaction|increases response to substance | 14550746 |
| D000082 | Acetaminophen | TNFRSF1A protein promotes the reaction [Acetaminophen results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 14557383 |
| D000082 | Acetaminophen | TNFRSF1A protein results in decreased susceptibility to [Acetaminophen results in increased expression of NOS2 protein] | decreases response to substance|increases expression | 14550746 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of NOS2 protein | increases expression | 19039654 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of NOS2 mRNA | affects expression | 19784758 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of NOS2 mRNA | decreases expression | 16172162 19784758 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of NOS2 mRNA | increases expression | 19784758 |
| D000109 | Acetylcholine | NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Acetylcholine] | affects cotreatment|affects response to substance | 11498454 |
| D000109 | Acetylcholine | NOS2 protein results in decreased susceptibility to Acetylcholine | decreases response to substance | 15933248 |
| D000109 | Acetylcholine | sepiapterin inhibits the reaction [NOS2 protein results in decreased susceptibility to Acetylcholine] | decreases reaction|decreases response to substance | 15933248 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [TNF protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 7532384 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Triglycerides results in decreased expression of NOS2 mRNA] | decreases expression|decreases reaction | 16140881 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Triglycerides results in decreased expression of NOS2 protein] | decreases expression|decreases reaction | 16140881 |
| D020106 | Acrylamide | Acrylamide results in increased expression of NOS2 protein | increases expression | 15977197 |
| D000244 | Adenosine Diphosphate | NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Adenosine Diphosphate] | affects cotreatment|affects response to substance | 11498454 |
| C000188 | alachlor | alachlor inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15907790 |
| C000188 | alachlor | alachlor inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15907790 |
| C006463 | allyl alcohol | allyl alcohol results in increased expression of NOS2 mRNA | increases expression | 15135310 |
| C523074 | allylpyrocatechol | allylpyrocatechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18602073 |
| C518327 | aloe emodin | aloe emodin inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19352036 |
| D000535 | Aluminum | [Aluminum co-treated with Iron] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 16728372 |
| C010845 | aluminum chloride | [aluminum chloride co-treated with ferric chloride] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 16728372 |
| C011164 | amentoflavone | amentoflavone results in decreased expression of NOS2 protein | decreases expression | 12144868 |
| D000338 | beta-Aminoethyl Isothiourea | beta-Aminoethyl Isothiourea results in decreased expression of NOS2 protein | decreases expression | 9731633 |
| D000338 | beta-Aminoethyl Isothiourea | beta-Aminoethyl Isothiourea results in increased degradation of NOS2 protein | increases degradation | 9731633 |
| D015081 | 2-Naphthylamine | 2-Naphthylamine results in increased expression of NOS2 mRNA | increases expression | 18247414 |
| D000641 | Ammonia | Ammonia results in increased expression of NOS2 mRNA | increases expression | 20217200 |
| D000641 | Ammonia | IL1B protein promotes the reaction [Ammonia results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 20217200 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of NOS2 mRNA | affects expression | 16483693 |
| D000643 | Ammonium Chloride | Ammonium Chloride results in increased expression of NOS2 protein | increases expression | 16483693 |
| D000654 | Amobarbital | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Amobarbital] | decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| D000661 | Amphetamine | Amphetamine results in increased expression of NOS2 mRNA | increases expression | 18524487 |
| D000661 | Amphetamine | Melatonin inhibits the reaction [Amphetamine results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18524487 |
| D000661 | Amphetamine | S-methylisothiopseudouronium inhibits the reaction [Amphetamine results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18524487 |
| D000667 | Ampicillin | Ampicillin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 15610444 11686837 12568917 |
| D000667 | Ampicillin | Ampicillin inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18306037 |
| C078814 | anandamide | anandamide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11891798 |
| C078814 | anandamide | anandamide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11891798 15748152 |
| C028304 | anemonin | anemonin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18281171 |
| C028304 | anemonin | anemonin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18281171 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D000967 | Antimony Sodium Gluconate | [IFNG protein co-treated with Antimony Sodium Gluconate] results in increased expression of NOS2 mRNA | affects cotreatment|increases expression | 9234779 |
| C117813 | apicularen A | apicularen A results in increased expression of NOS2 mRNA | increases expression | 15561798 |
| C117813 | apicularen A | apicularen A results in increased expression of NOS2 protein | increases expression | 15561798 |
| D047310 | Apigenin | Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11343698 |
| D047310 | Apigenin | Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12512693 16934226 |
| D047310 | Apigenin | PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] | affects reaction|decreases reaction|increases expression | 11343698 |
| D047310 | Apigenin | Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18090225 |
| D047310 | Apigenin | Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 18090225 |
| C015001 | arsenite | arsenite results in increased expression of NOS2 mRNA | increases expression | 18296743 |
| C015001 | arsenite | Dietary Fats promotes the reaction [arsenite results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 18296743 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased expression of NOS2 mRNA | increases expression | 12160931 11461780 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased expression of NOS2 protein | increases expression | 12160931 11461780 |
| D017638 | Asbestos, Crocidolite | Iron inhibits the reaction [Asbestos, Crocidolite results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11461780 |
| D017638 | Asbestos, Crocidolite | Iron inhibits the reaction [Asbestos, Crocidolite results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11461780 |
| D017638 | Asbestos, Crocidolite | NOS2 gene mutant form inhibits the reaction [Asbestos, Crocidolite results in increased activity of MPO protein] | decreases reaction|increases activity | 12160931 |
| D017638 | Asbestos, Crocidolite | NOS2 gene mutant form inhibits the reaction [Asbestos, Crocidolite results in increased expression of TNF mRNA] | decreases reaction|increases expression | 12160931 |
| D017638 | Asbestos, Crocidolite | NOS2 gene mutant form inhibits the reaction [Asbestos, Crocidolite results in increased secretion of TNF protein] | decreases reaction|increases secretion | 12160931 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased expression of NOS2 mRNA | increases expression | 12051993 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased expression of NOS2 protein | increases expression | 12051993 |
| D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [endotoxin, Escherichia coli results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| D001241 | Aspirin | Aspirin results in decreased expression of NOS2 protein | decreases expression | 10860828 |
| D001241 | Aspirin | [Aspirin results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide | decreases chemical synthesis|decreases expression | 10860828 |
| D001285 | Atropine | Atropine inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 15610444 |
| D001397 | Azoxymethane | Azoxymethane results in increased expression of NOS2 mRNA | increases expression | 19056647 |
| C006680 | baicalein | baicalein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 14563492 |
| C006680 | baicalein | Hemin promotes the reaction [baicalein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 14563492 |
| C006680 | baicalein | HMOX1 protein promotes the reaction [baicalein inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases reaction | 14563492 |
| C006680 | baicalein | tin protoporphyrin IX inhibits the reaction [baicalein inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 14563492 |
| C038044 | baicalin | baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18187930 |
| C038044 | baicalin | baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18187930 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NOS2 mRNA | affects cotreatment|increases expression | 21295105 |
| D019324 | beta-Naphthoflavone | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 21295105 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of NOS2 mRNA | increases expression | 18247414 |
| C031403 | benzyl isothiocyanate | benzyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 17891158 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12628480 12721113 |
| C095105 | bexarotene | bexarotene results in decreased expression of NOS2 mRNA | decreases expression | 17849452 |
| C518535 | bis(2-hydroxybenzylidene)acetone | bis(2-hydroxybenzylidene)acetone inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| C541028 | bis(3-hydroxyphenyl) diselenide | bis(3-hydroxyphenyl) diselenide results in decreased expression of NOS2 mRNA | decreases expression | 19298695 |
| C541028 | bis(3-hydroxyphenyl) diselenide | bis(3-hydroxyphenyl) diselenide results in decreased expression of NOS2 protein | decreases expression | 19298695 |
| C034786 | bis(4-hydroxycinnamoyl)methane | bis(4-hydroxycinnamoyl)methane inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18449507 19188055 |
| C034786 | bis(4-hydroxycinnamoyl)methane | bis(4-hydroxycinnamoyl)methane inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18481332 19188055 18449507 |
| C034786 | bis(4-hydroxycinnamoyl)methane | bis(4-hydroxycinnamoyl)methane inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18838107 |
| C102120 | bisperoxo(1,10-phenanthroline)oxovanadate(1-) | bisperoxo(1,10-phenanthroline)oxovanadate(1-) results in increased expression of NOS2 protein | increases expression | 11009089 |
| C006780 | bisphenol A | bisphenol A inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 12860292 |
| C006780 | bisphenol A | fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression | 12860292 |
| D001761 | Bleomycin | Bleomycin results in increased expression of NOS2 mRNA | increases expression | 17434272 |
| D001761 | Bleomycin | Bleomycin results in increased expression of NOS2 protein | increases expression | 17434272 |
| D001761 | Bleomycin | Curcumin inhibits the reaction [Bleomycin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17434272 |
| D001761 | Bleomycin | Curcumin inhibits the reaction [Bleomycin results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17434272 |
| D001761 | Bleomycin | Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17434272 |
| D001761 | Bleomycin | Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17434272 |
| C500927 | bolinaquinone | bolinaquinone inhibits the reaction [Zymosan results in increased activity of NOS2 protein] | decreases reaction|increases activity | 12604694 |
| C500927 | bolinaquinone | bolinaquinone affects the expression of NOS2 protein | affects expression | 12604694 |
| C106525 | broussochalcone A | broussochalcone A inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11286985 |
| D019819 | Budesonide | Budesonide results in decreased expression of NOS2 mRNA | decreases expression | 17163412 |
| D019819 | Budesonide | Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15734790 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine promotes the reaction [Trioxsalen analog results in decreased expression of NOS2 mRNA] | decreases expression|increases reaction | 16259964 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 7532384 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine promotes the reaction [Carmustine inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression|increases reaction | 7532384 |
| D019328 | Buthionine Sulfoximine | [Carmustine co-treated with Buthionine Sulfoximine] inhibits the reaction [TNF protein results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 7532384 |
| D019328 | Buthionine Sulfoximine | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Buthionine Sulfoximine] | decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 10231168 |
| C098384 | cacospongionolide B | cacospongionolide B inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12721113 |
| D002104 | Cadmium | Cadmium affects the expression of NOS2 mRNA | affects expression | 16948784 |
| D002104 | Cadmium | Melatonin inhibits the reaction [Cadmium affects the expression of NOS2 mRNA] | affects expression|decreases reaction | 16948784 |
| D002104 | Cadmium | Quercetin inhibits the reaction [Cadmium results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16226777 |
| D019256 | Cadmium Chloride | Cadmium Chloride inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| D019256 | Cadmium Chloride | Cadmium Chloride affects the expression of NOS2 mRNA | affects expression | 16948784 |
| D019256 | Cadmium Chloride | Melatonin inhibits the reaction [Cadmium Chloride affects the expression of NOS2 mRNA] | affects expression|decreases reaction | 16948784 |
| D000001 | Calcimycin | NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Calcimycin] | affects cotreatment|affects response to substance | 11498454 |
| C058076 | calpain inhibitor III | calpain inhibitor III inhibits the reaction [Thioacetamide results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15316131 |
| D002211 | Capsaicin | Capsaicin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 10671773 |
| D002220 | Carbamazepine | Carbamazepine results in increased expression of NOS2 mRNA | increases expression | 12429386 |
| D002220 | Carbamazepine | Carbamazepine results in increased expression of NOS2 protein | increases expression | 14511393 |
| D012721 | Carbaryl | Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15907790 |
| D012721 | Carbaryl | Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15907790 |
| D012721 | Carbaryl | Dithiothreitol inhibits the reaction [Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 15907790 |
| D012721 | Carbaryl | Mercaptoethanol inhibits the reaction [Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 15907790 |
| D002248 | Carbon Monoxide | Carbon Monoxide results in decreased expression of NOS2 protein | decreases expression | 12201358 |
| D002251 | Carbon Tetrachloride | baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18187930 |
| D002251 | Carbon Tetrachloride | baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18187930 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of NOS2 mRNA | increases expression | 18187930 16874658 18429990 17917259 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of NOS2 protein | increases expression | 17917259 18429990 16874658 18187930 |
| D002251 | Carbon Tetrachloride | Glycyrrhizic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17917259 |
| D002251 | Carbon Tetrachloride | Glycyrrhizic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17917259 |
| D002251 | Carbon Tetrachloride | NOS2 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA] | decreases reaction|increases expression | 17105591 |
| D002251 | Carbon Tetrachloride | NOS2 gene mutant form results in decreased susceptibility to Carbon Tetrachloride | decreases response to substance | 17105591 |
| D002251 | Carbon Tetrachloride | S-methylisothiopseudouronium analog inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16874658 |
| D002251 | Carbon Tetrachloride | S-methylisothiopseudouronium analog inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16874658 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of NOS2 mRNA | increases expression | 15963578 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of NOS2 mRNA | decreases expression | 19784758 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of and results in increased activity of NOS2 protein | increases activity|increases expression | 12943827 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of NOS2 | increases expression | 16614485 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of NOS2 mRNA | increases expression | 16964402 17009398 17595544 15135310 16325526 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of NOS2 protein | increases expression | 16325526 12741479 |
| D002251 | Carbon Tetrachloride | IL11 protein inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16964402 |
| D002251 | Carbon Tetrachloride | Quercetin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12741479 |
| D002251 | Carbon Tetrachloride | S-allylcysteine inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2] | decreases reaction|increases expression | 16614485 |
| D002251 | Carbon Tetrachloride | tin mesoporphyrin inhibits the reaction [IL11 protein inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression | 16964402 |
| D002330 | Carmustine | Buthionine Sulfoximine promotes the reaction [Carmustine inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression|increases reaction | 7532384 |
| D002330 | Carmustine | [Carmustine co-treated with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid] inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitrites] | affects cotreatment|decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| D002330 | Carmustine | [Carmustine co-treated with Buthionine Sulfoximine] inhibits the reaction [TNF protein results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 7532384 |
| D002330 | Carmustine | Carmustine inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 7532384 |
| D002330 | Carmustine | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Carmustine] | decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| D002351 | Carrageenan | Carrageenan inhibits the reaction [Raloxifene results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15860553 |
| D002351 | Carrageenan | Carrageenan results in increased expression of NOS2 protein | increases expression | 15860553 |
| C043211 | carvedilol | carvedilol promotes the reaction [wortmannin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 17159805 |
| D002392 | Catechin | Catechin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12512693 |
| C034221 | catechol | catechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18499097 |
| C034221 | catechol | catechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18499097 |
| D017272 | Celiprolol | Celiprolol results in increased expression of and results in increased phosphorylation of and results in increased activity of NOS2 protein | increases activity|increases expression|increases phosphorylation | 15262839 |
| C469298 | CEP-11004 | CEP-11004 results in decreased expression of NOS2 mRNA | decreases expression | 15294995 |
| D002784 | Cholesterol | Cholesterol results in increased expression of NOS2 protein | increases expression | 12020746 |
| D002784 | Cholesterol | [Estradiol co-treated with Cholesterol] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 12020746 |
| D002784 | Cholesterol | [Estriol co-treated with Cholesterol] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 12020746 |
| C043561 | chrysin | chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11343698 |
| C043561 | chrysin | chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17570322 16934226 |
| C043561 | chrysin | PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] | affects reaction|decreases reaction|increases expression | 11343698 |
| C039671 | ciglitazone | ciglitazone inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 12847270 |
| C039671 | ciglitazone | ciglitazone inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 12847270 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde results in decreased expression of NOS2 protein | decreases expression | 17486422 |
| C097256 | CNI 1493 | CNI 1493 results in decreased expression of NOS2 protein | decreases expression | 15947118 |
| C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin results in decreased expression of NOS2 protein | decreases expression | 16309587 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of NOS2 mRNA | increases expression | 17169330 |
| D003300 | Copper | Copper results in increased expression of NOS2 mRNA | increases expression | 16962711 |
| D003300 | Copper | Copper results in increased expression of NOS2 protein | increases expression | 16962711 |
| D003300 | Copper | Plant Extracts inhibits the reaction [Copper results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16962711 |
| D003300 | Copper | Plant Extracts inhibits the reaction [Copper results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16962711 |
| D003300 | Copper | Copper results in increased expression of NOS2 mRNA | increases expression | 16987042 |
| D003300 | Copper | [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in decreased expression of NOS2 mRNA | affects cotreatment|decreases expression | 20302851 |
| D003300 | Copper | tempol inhibits the reaction [Copper results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16987042 |
| C098468 | copper histidine | copper histidine results in increased expression of NOS2 mRNA | increases expression | 16987042 |
| C098468 | copper histidine | tempol inhibits the reaction [copper histidine results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16987042 |
| C030123 | coumarin | coumarin results in increased expression of NOS2 mRNA | increases expression | 15135310 |
| C534043 | CR 3294 | CR 3294 results in decreased expression of NOS2 mRNA | decreases expression | 18927491 |
| D003474 | Curcumin | Curcumin inhibits the reaction [TNF protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17640567 |
| D003474 | Curcumin | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 17640567 |
| D003474 | Curcumin | Curcumin affects the expression of NOS2 mRNA | affects expression | 18752423 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19188055 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19188055 18481332 |
| D003474 | Curcumin | [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 17827730 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Bleomycin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17434272 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Bleomycin results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17434272 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Dinitrochlorobenzene results in decreased expression of NOS2 protein] | decreases expression|decreases reaction | 17373747 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Kainic Acid results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17827730 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18838107 16934299 18368483 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16934299 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Sodium Selenite results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19481068 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Sodium Selenite results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19481068 |
| D003474 | Curcumin | Curcumin results in decreased activity of NOS2 protein | decreases activity | 17461496 |
| D003474 | Curcumin | Curcumin analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19243473 |
| D003474 | Curcumin | Curcumin results in decreased expression of NOS2 | decreases expression | 18462866 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11007951 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of NOS2 mRNA | increases expression | 10607705 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of NOS2 mRNA | increases expression | 18710439 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of NOS2 protein | increases expression | 18710439 |
| D003520 | Cyclophosphamide | Rolipram inhibits the reaction [Cyclophosphamide results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18710439 |
| D003520 | Cyclophosphamide | Rolipram inhibits the reaction [Cyclophosphamide results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18710439 |
| C072247 | cyclo(Trp-Asp-Pro-Val-Leu) | cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [EDN1 protein inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression | 12839867 |
| C072247 | cyclo(Trp-Asp-Pro-Val-Leu) | cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [EDN1 protein inhibits the reaction [TNF protein results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 12839867 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11286988 |
| C004742 | daidzein | daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11308324 18274639 |
| C004742 | daidzein | daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11308324 18274639 |
| C004742 | daidzein | daidzein results in decreased activity of NOS2 protein | decreases activity | 11308324 |
| D003634 | DDT | [DDT co-treated with o,p'-DDT] results in decreased expression of NOS2 mRNA | affects cotreatment|decreases expression | 12007859 |
| D003634 | DDT | DDT metabolite results in decreased expression of NOS2 mRNA | decreases expression | 12007859 |
| D003634 | DDT | DDT results in decreased expression of NOS2 mRNA | decreases expression | 12007859 |
| D003634 | DDT | DDT results in decreased expression of NOS2 mRNA | decreases expression | 11948501 |
| D003634 | DDT | DDT results in increased expression of NOS2 mRNA | increases expression | 11948501 |
| D003676 | Deferoxamine | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Deferoxamine] | decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| C050229 | demethoxycurcumin | demethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18449507 |
| C050229 | demethoxycurcumin | demethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18449507 |
| C050229 | demethoxycurcumin | demethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18838107 |
| C512279 | dendrochrysanene | dendrochrysanene results in decreased expression of NOS2 mRNA | decreases expression | 16431116 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of NOS2 mRNA | decreases expression | 12206003 |
| D003907 | Dexamethasone | [Dexamethasone co-treated with Indomethacin] results in decreased expression of NOS2 protein | affects cotreatment|decreases expression | 18030227 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [IL1 protein promotes the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases reaction | 7540993 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 7540993 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16880258 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Zymosan results in increased activity of NOS2 protein] | decreases reaction|increases activity | 12604694 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12628480 11454666 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of NOS2 protein | decreases expression | 18030227 |
| D003907 | Dexamethasone | Dexamethasone affects the expression of NOS2 protein | affects expression | 12604694 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 12568917 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 10574470 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12694877 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Ozone results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 8666049 |
| D003907 | Dexamethasone | Dexamethasone results in decreased activity of NOS2 protein | decreases activity | 9306416 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of NOS2 mRNA | decreases expression | 9301432 8666049 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of NOS2 mRNA | increases expression | 7529313 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of NOS2 protein | increases expression | 7529313 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of NOS2 mRNA | decreases expression | 10210152 |
| D016264 | Dextran Sulfate | Dextran Sulfate results in increased expression of NOS2 mRNA | increases expression | 15652231 |
| D016264 | Dextran Sulfate | Dextran Sulfate results in increased expression of NOS2 protein | increases expression | 16049979 |
| C493686 | diacetylcurcumin | [diacetylcurcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 17827730 |
| C532887 | diarctigenin | diarctigenin inhibits the reaction [Zymosan results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18694995 |
| C532887 | diarctigenin | diarctigenin inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18694995 |
| D003975 | Diazepam | Diazepam results in increased expression of NOS2 mRNA | increases expression | 12429386 |
| D003981 | Diazoxide | 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases expression | 16257489 |
| D003981 | Diazoxide | Diazoxide inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein] | decreases reaction|increases activity|increases expression | 16257489 |
| D003981 | Diazoxide | 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Rotenone results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 15795934 15927086 |
| D003981 | Diazoxide | 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression | 15795934 15927086 |
| D003981 | Diazoxide | Diazoxide inhibits the reaction [Rotenone results in increased activity of NOS2 protein] | decreases reaction|increases activity | 15927086 15795934 |
| D003981 | Diazoxide | Diazoxide inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15927086 15795934 |
| D003633 | Dichlorodiphenyl Dichloroethylene | Dichlorodiphenyl Dichloroethylene results in decreased expression of NOS2 mRNA | decreases expression | 12007859 |
| D004008 | Diclofenac | Diclofenac results in increased expression of NOS2 mRNA | increases expression | 15135310 |
| D004041 | Dietary Fats | Dietary Fats promotes the reaction [arsenite results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 18296743 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of NOS2 mRNA | increases expression | 18296743 |
| C014476 | diethyl maleate | diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 12774022 |
| C014476 | diethyl maleate | diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12774022 |
| C014476 | diethyl maleate | diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 7532384 |
| C014476 | diethyl maleate | diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 7532384 |
| C014476 | diethyl maleate | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of diethyl maleate] | decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NOS2 mRNA | affects cotreatment|increases expression | 21295105 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of NOS2 protein | increases expression | 20501860 |
| D004052 | Diethylnitrosamine | [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in decreased expression of NOS2 mRNA | affects cotreatment|decreases expression | 20302851 |
| D004052 | Diethylnitrosamine | [Iron co-treated with Diethylnitrosamine] results in decreased expression of NOS2 mRNA | affects cotreatment|decreases expression | 20302851 |
| D004052 | Diethylnitrosamine | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 21295105 |
| D004052 | Diethylnitrosamine | resveratrol inhibits the reaction [Diethylnitrosamine results in increased expression of NOS2 protein] | decreases reaction|increases expression | 20501860 |
| D004061 | Diflunisal | Diflunisal results in increased expression of NOS2 mRNA | increases expression | 15135310 |
| C015144 | dihydrolipoic acid | dihydrolipoic acid inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| D004112 | Dimercaprol | [Dimercaprol co-treated with Mercuric Chloride] inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | affects cotreatment|decreases reaction|increases activity | 18838692 |
| D004112 | Dimercaprol | Dimercaprol inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| C521105 | dimethoxycurcumin | dimethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18481332 |
| D019813 | 1,2-Dimethylhydrazine | 1,2-Dimethylhydrazine results in increased expression of NOS2 mRNA | increases expression | 18155637 |
| D019813 | 1,2-Dimethylhydrazine | Vanadium inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18155637 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of NOS2 mRNA | increases expression | 15135310 17724770 16604421 |
| D004128 | Dimethylnitrosamine | Plant Preparations inhibits the reaction [Dimethylnitrosamine results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17724770 |
| D004128 | Dimethylnitrosamine | Silymarin inhibits the reaction [Dimethylnitrosamine results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17724770 16604421 |
| D004128 | Dimethylnitrosamine | Thalidomide inhibits the reaction [Dimethylnitrosamine results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16604421 |
| D015064 | 16,16-Dimethylprostaglandin E2 | 16,16-Dimethylprostaglandin E2 inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 11855677 11991626 15610444 11686837 |
| D015064 | 16,16-Dimethylprostaglandin E2 | 16,16-Dimethylprostaglandin E2 inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18306037 |
| D004137 | Dinitrochlorobenzene | Curcumin inhibits the reaction [Dinitrochlorobenzene results in decreased expression of NOS2 protein] | decreases expression|decreases reaction | 17373747 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased expression of NOS2 protein | increases expression | 17373747 |
| C039602 | diosmetin | diosmetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16934226 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19005069 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19005069 |
| D004221 | Disulfiram | Disulfiram affects the expression of NOS2 mRNA | affects expression | 17936468 |
| D004229 | Dithiothreitol | Dithiothreitol inhibits the reaction [Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 15907790 |
| D004229 | Dithiothreitol | Dithiothreitol inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 7532384 |
| D004050 | Ditiocarb | Ditiocarb inhibits the reaction [Isoflurane results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18708911 |
| D004280 | Dobutamine | NOS2 protein affects the susceptibility to Dobutamine | affects response to substance | 9396439 |
| D004280 | Dobutamine | NOS2 protein affects the susceptibility to Dobutamine | affects response to substance | 11489778 |
| D004280 | Dobutamine | NOS2 protein affects the susceptibility to Dobutamine | affects response to substance | 20141602 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of NOS2 mRNA | increases expression | 15695394 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of NOS2 protein | increases expression | 18463201 15695394 |
| D004317 | Doxorubicin | Simvastatin promotes the reaction [Doxorubicin results in increased expression of NOS2 protein] | increases expression|increases reaction | 18463201 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of NOS2 mRNA | increases expression | 12490132 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of NOS2 protein | increases expression | 12490132 |
| D004317 | Doxorubicin | ferric nitrilotriacetate inhibits the reaction [Doxorubicin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 12490132 |
| D004317 | Doxorubicin | ferric nitrilotriacetate inhibits the reaction [Doxorubicin results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12490132 |
| D004318 | Doxycycline | Doxycycline results in decreased expression of NOS2 protein | decreases expression | 16365451 |
| D004318 | Doxycycline | Doxycycline results in decreased stability of and results in decreased expression of NOS2 mRNA | decreases expression|decreases stability | 16365451 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17996413 19051357 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19051357 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal inhibits the reaction [Zymosan results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17996413 |
| C042986 | ebselen | ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| C042986 | ebselen | ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| C042986 | ebselen | ebselen results in decreased activity of NOS2 protein | decreases activity | 7590103 |
| D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid analog inhibits the reaction [sym-trinitrobenzene results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15890784 |
| D004642 | Emodin | Emodin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NOS2 protein] | decreases expression|decreases reaction | 18590720 |
| D004726 | Endosulfan | Endosulfan results in increased expression of NOS2 protein | increases expression | 18243363 |
| D004726 | Endosulfan | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Endosulfan results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17261270 |
| D004726 | Endosulfan | [Endosulfan results in increased activity of NFKB1 protein] which results in increased expression of NOS2 mRNA | increases activity|increases expression | 17261270 |
| D004726 | Endosulfan | Endosulfan results in increased expression of NOS2 mRNA | increases expression | 17261270 |
| C044101 | endotoxin, Escherichia coli | Ascorbic Acid inhibits the reaction [endotoxin, Escherichia coli results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| C044101 | endotoxin, Escherichia coli | endotoxin, Escherichia coli results in increased expression of NOS2 mRNA | increases expression | 12770931 |
| C044101 | endotoxin, Escherichia coli | endotoxin, Escherichia coli results in increased expression of NOS2 protein | increases expression | 17637181 |
| C044101 | endotoxin, Escherichia coli | eugenosedin-A inhibits the reaction [endotoxin, Escherichia coli results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| C044101 | endotoxin, Escherichia coli | pimagedine inhibits the reaction [endotoxin, Escherichia coli results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| C044101 | endotoxin, Escherichia coli | Trazodone inhibits the reaction [endotoxin, Escherichia coli results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| C044101 | endotoxin, Escherichia coli | Yohimbine inhibits the reaction [endotoxin, Escherichia coli results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| D004731 | Endotoxins | Endotoxins inhibits the reaction [Ozone results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 8652180 |
| D004731 | Endotoxins | Endotoxins inhibits the reaction [Ozone results in increased expression of NOS2 protein] | decreases reaction|increases expression | 8652180 |
| D004731 | Endotoxins | Endotoxins inhibits the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 8652180 |
| D004731 | Endotoxins | Endotoxins results in increased expression of NOS2 protein | increases expression | 15364003 |
| D004731 | Endotoxins | [Endotoxins results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 15364003 |
| D004731 | Endotoxins | pioglitazone inhibits the reaction [Endotoxins results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15364003 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16206353 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D004837 | Epinephrine | Epinephrine results in increased expression of NOS2 mRNA | increases expression | 16925470 |
| C007628 | esculetin | esculetin promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 16212885 |
| D004958 | Estradiol | 27-hydroxycholesterol inhibits the reaction [Estradiol results in increased activity of NOS2 protein] | decreases reaction|increases activity | 17873880 |
| D004958 | Estradiol | Estradiol results in increased activity of NOS2 protein | increases activity | 17873880 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol results in increased activity of NOS2 protein] | decreases reaction|increases activity | 17873880 |
| D004958 | Estradiol | 27-hydroxycholesterol inhibits the reaction [Estradiol results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17873880 |
| D004958 | Estradiol | Estradiol results in increased expression of NOS2 mRNA | increases expression | 17873880 |
| D004958 | Estradiol | Tamoxifen inhibits the reaction [Estradiol results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17873880 |
| D004958 | Estradiol | [Estradiol co-treated with Cholesterol] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 12020746 |
| D004958 | Estradiol | Estradiol inhibits the reaction [IL1B protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17068060 |
| D004958 | Estradiol | Estradiol affects the expression of NOS2 mRNA | affects expression | 12810170 |
| D004964 | Estriol | [Estriol co-treated with Cholesterol] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 12020746 |
| D004967 | Estrogens | Estrogens results in decreased expression of NOS2 mRNA | decreases expression | 16850686 |
| D000431 | Ethanol | Ethanol results in increased expression of NOS2 protein | increases expression | 18845238 |
| D000431 | Ethanol | [Ethanol results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | increases abundance|increases expression | 18845238 |
| D000431 | Ethanol | Ethanol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18281171 |
| D000431 | Ethanol | Ethanol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 10231168 |
| D000431 | Ethanol | Ethanol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 10231168 |
| D000431 | Ethanol | Ethanol results in decreased expression of and results in decreased activity of NOS2 protein | decreases activity|decreases expression | 11173986 |
| D000431 | Ethanol | [Ethanol results in decreased expression of and results in decreased activity of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide | decreases activity|decreases chemical synthesis|decreases expression | 11173986 |
| D000431 | Ethanol | Ethanol results in increased expression of NOS2 mRNA | increases expression | 19615717 |
| D000431 | Ethanol | Ethanol results in increased expression of NOS2 protein | increases expression | 19615717 18037914 |
| C007687 | etiron | etiron binds to and results in decreased activity of NOS2 protein | affects binding|decreases activity | 9421461 |
| D005047 | Etoposide | Etoposide results in increased expression of NOS2 mRNA | increases expression | 15135310 |
| C496985 | eugenosedin-A | eugenosedin-A inhibits the reaction [endotoxin, Escherichia coli results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| C496985 | eugenosedin-A | eugenosedin-A inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| C505499 | eutigoside C | eutigoside C results in decreased activity of NOS2 protein | decreases activity | 16350850 |
| C024555 | ferric chloride | [aluminum chloride co-treated with ferric chloride] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 16728372 |
| C020326 | ferric nitrilotriacetate | ferric nitrilotriacetate inhibits the reaction [Doxorubicin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 12490132 |
| C020326 | ferric nitrilotriacetate | ferric nitrilotriacetate inhibits the reaction [Doxorubicin results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12490132 |
| C020326 | ferric nitrilotriacetate | ferric nitrilotriacetate inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11461780 |
| C020326 | ferric nitrilotriacetate | ferric nitrilotriacetate promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 11746204 |
| C020326 | ferric nitrilotriacetate | ferric nitrilotriacetate promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 11746204 |
| C020326 | ferric nitrilotriacetate | ferric nitrilotriacetate results in increased expression of NOS2 mRNA | increases expression | 11340304 |
| C020326 | ferric nitrilotriacetate | ferric nitrilotriacetate results in increased expression of NOS2 protein | increases expression | 11340304 |
| C020326 | ferric nitrilotriacetate | pyrrolidine dithiocarbamic acid inhibits the reaction [ferric nitrilotriacetate results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11340304 |
| C020326 | ferric nitrilotriacetate | pyrrolidine dithiocarbamic acid inhibits the reaction [ferric nitrilotriacetate results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11340304 |
| C093230 | fexofenadine | fexofenadine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17910814 |
| C093230 | fexofenadine | fexofenadine results in decreased expression of NOS2 mRNA | decreases expression | 17910814 |
| C017875 | fisetin | fisetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17177504 |
| C043562 | flavone | flavone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18274639 |
| C043562 | flavone | flavone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18274639 |
| D005419 | Flavonoids | Flavonoids results in increased expression of NOS2 mRNA | increases expression | 18035473 |
| D005439 | Flufenamic Acid | Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 10866999 |
| D005439 | Flufenamic Acid | Flufenamic Acid results in increased expression of NOS2 mRNA | increases expression | 15135310 |
| D005472 | Fluorouracil | Fluorouracil inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16724238 |
| D005472 | Fluorouracil | Fluorouracil inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16724238 |
| D005472 | Fluorouracil | Fluorouracil results in increased expression of and results in increased activity of NOS2 protein | increases activity|increases expression | 18069768 |
| D016666 | Fluvoxamine | Fluvoxamine results in increased expression of NOS2 mRNA | increases expression | 12429386 |
| D005632 | Fructose | Fructose results in increased expression of NOS2 protein | increases expression | 10090849 |
| D005632 | Fructose | [Fructose results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 10090849 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol results in increased activity of NOS2 protein] | decreases reaction|increases activity | 17873880 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression | 12860292 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [resveratrol results in increased activity of NOS2 protein] | decreases reaction|increases activity | 17666920 |
| C040029 | gabapentin | gabapentin results in increased expression of NOS2 protein | increases expression | 14511393 |
| C038958 | gadolinium chloride | gadolinium chloride results in increased expression of NOS2 mRNA | increases expression | 15135310 |
| C001277 | geldanamycin | geldanamycin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15583003 |
| C001277 | geldanamycin | geldanamycin results in decreased expression of NOS2 mRNA | decreases expression | 11835313 |
| C001277 | geldanamycin | Quercetin inhibits the reaction [geldanamycin results in decreased expression of NOS2 mRNA] | decreases expression|decreases reaction | 11835313 |
| D019833 | Genistein | Genistein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18274639 11308324 |
| D019833 | Genistein | Genistein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18274639 11308324 |
| D019833 | Genistein | Genistein inhibits the reaction [[TNF protein results in increased expression of NOS2 protein] which results in decreased expression of RETN mRNA] | decreases expression|decreases reaction|increases expression | 18369347 |
| D019833 | Genistein | Genistein results in decreased activity of NOS2 protein | decreases activity | 11308324 |
| D005839 | Gentamicins | Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 17442725 |
| D005839 | Gentamicins | Gentamicins results in increased expression of NOS2 protein | increases expression | 17312373 15936777 |
| D005839 | Gentamicins | [Gentamicins results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | increases abundance|increases expression | 17312373 |
| C478099 | gigantol | gigantol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16924582 |
| C478099 | gigantol | gigantol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16924582 |
| C007845 | gingerol | gingerol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18683823 |
| C007845 | gingerol | gingerol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18683823 |
| C007845 | gingerol | gingerol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18683823 |
| C063170 | Ginkgo biloba extract 761 | Ginkgo biloba extract 761 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11518563 |
| C063170 | Ginkgo biloba extract 761 | Ginkgo biloba extract 761 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11518563 |
| C063170 | Ginkgo biloba extract 761 | Ginkgo biloba extract 761 inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11518563 |
| C112772 | ginsenoside M1 | ginsenoside M1 results in decreased expression of and results in decreased activity of NOS2 protein | decreases activity|decreases expression | 15802804 |
| C097367 | ginsenoside Rg3 | ginsenoside Rg3 results in increased expression of NOS2 mRNA | increases expression | 14534150 |
| C097367 | ginsenoside Rg3 | Staurosporine inhibits the reaction [ginsenoside Rg3 results in increased expression of NOS2 protein] | decreases reaction|increases expression | 14534150 |
| C097367 | ginsenoside Rg3 | Tetradecanoylphorbol Acetate inhibits the reaction [ginsenoside Rg3 results in increased expression of NOS2 protein] | decreases reaction|increases expression | 14534150 |
| D005978 | Glutathione | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 17640567 |
| D005905 | Glyburide | Glyburide inhibits the reaction [Pinacidil inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases expression | 16257489 |
| C086566 | glycitein | glycitein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11308324 |
| C086566 | glycitein | glycitein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11308324 |
| C086566 | glycitein | glycitein results in decreased activity of NOS2 protein | decreases activity | 11308324 |
| D005999 | Glycochenodeoxycholic Acid | Glycochenodeoxycholic Acid results in increased expression of NOS2 mRNA | increases expression | 15767249 |
| C531349 | glycyrol | glycyrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18666753 |
| D019695 | Glycyrrhizic Acid | Glycyrrhizic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17917259 |
| D019695 | Glycyrrhizic Acid | Glycyrrhizic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17917259 |
| C120099 | GW 1929 | GW 1929 inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 12847270 |
| C120099 | GW 1929 | GW 1929 inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 12847270 |
| C409003 | GW 273629 | GW 273629 results in decreased activity of NOS2 protein | decreases activity | 12568917 |
| C453899 | GW 7647 | GW 7647 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17891158 |
| C453899 | GW 7647 | GW 7647 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17891158 |
| C453899 | GW 7647 | lactacystin inhibits the reaction [GW 7647 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 17891158 |
| D006221 | Halothane | Halothane inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11506125 |
| D006221 | Halothane | Halothane inhibits the reaction [IL1B protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11506125 |
| D006427 | Hemin | Hemin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 14563492 |
| D006427 | Hemin | Hemin promotes the reaction [3-hydroxyflavone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 14563492 |
| D006427 | Hemin | Hemin promotes the reaction [baicalein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 14563492 |
| D006427 | Hemin | Hemin promotes the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 14563492 |
| D006427 | Hemin | Hemin promotes the reaction [Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 14563492 |
| C013015 | hesperetin | hesperetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12512693 |
| D006569 | Hesperidin | Hesperidin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12512693 |
| D007975 | Leukotriene B4 | Leukotriene B4 inhibits the reaction [[Zymosan results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitrites] | decreases reaction|increases chemical synthesis|increases expression | 11454666 |
| C005499 | honokiol | honokiol analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19539808 |
| C005499 | honokiol | honokiol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19539808 |
| D006820 | Hyaluronic Acid | Hyaluronic Acid affects the expression of NOS2 mRNA | affects expression | 15597151 |
| D006851 | Hydrochloric Acid | Hydrochloric Acid results in increased activity of NOS2 protein | increases activity | 14621274 |
| D006851 | Hydrochloric Acid | NOS2 protein affects the susceptibility to Hydrochloric Acid | affects response to substance | 12646421 |
| D006851 | Hydrochloric Acid | Hydrochloric Acid results in increased expression of NOS2 protein | increases expression | 11574821 18573544 12771618 |
| D006851 | Hydrochloric Acid | pimagedine inhibits the reaction [Hydrochloric Acid results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11574821 |
| D006851 | Hydrochloric Acid | S-methylisothiopseudouronium inhibits the reaction [Hydrochloric Acid results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18573544 |
| D006854 | Hydrocortisone | Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17434272 |
| D006854 | Hydrocortisone | Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17434272 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of NOS2 mRNA | increases expression | 18255322 |
| C031927 | hydroquinone | hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15831208 |
| C031927 | hydroquinone | hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15831208 |
| C031927 | hydroquinone | hydroquinone results in decreased expression of NOS2 mRNA | decreases expression | 17464197 |
| C031927 | hydroquinone | hydroquinone results in decreased expression of NOS2 protein | decreases expression | 17464197 |
| D016627 | Oxidopamine | N-(4-O-glycerol-3-methoxybenzyl)nonivamide inhibits the reaction [Oxidopamine results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17855475 |
| D016627 | Oxidopamine | Oxidopamine results in increased expression of NOS2 protein | increases expression | 17855475 |
| D019796 | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | NOS2 protein affects the susceptibility to 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | affects response to substance | 11498454 |
| D019796 | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | NOS2 protein results in decreased susceptibility to 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | decreases response to substance | 15933248 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 11080519 |
| D007052 | Ibuprofen | Ibuprofen results in increased activity of NOS2 protein | increases activity | 11837731 |
| D007052 | Ibuprofen | Ibuprofen results in increased expression of NOS2 mRNA | increases expression | 11837731 11545620 |
| C056599 | icariin | icariin results in increased expression of NOS2 mRNA | increases expression | 16281085 15329286 |
| C056599 | icariin | icariin results in increased expression of NOS2 protein | increases expression | 15329286 |
| D007213 | Indomethacin | 3-methylsydnone-5-nitrosimine inhibits the reaction [NOS2 gene mutant form results in decreased susceptibility to Indomethacin] | decreases reaction|decreases response to substance | 10964977 |
| D007213 | Indomethacin | [Dexamethasone co-treated with Indomethacin] results in decreased expression of NOS2 protein | affects cotreatment|decreases expression | 18030227 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 11080519 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of NOS2 protein | decreases expression | 11292070 |
| D007213 | Indomethacin | NOS2 protein affects the susceptibility to Indomethacin | affects response to substance | 10964977 15138204 |
| D007213 | Indomethacin | 1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 16818512 |
| D007213 | Indomethacin | 16,16-Dimethylprostaglandin E2 inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 11686837 11855677 11991626 15610444 |
| D007213 | Indomethacin | 16,16-Dimethylprostaglandin E2 inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18306037 |
| D007213 | Indomethacin | Ampicillin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 15610444 11686837 12568917 |
| D007213 | Indomethacin | Ampicillin inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18306037 |
| D007213 | Indomethacin | Atropine inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 15610444 |
| D007213 | Indomethacin | Capsaicin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 10671773 |
| D007213 | Indomethacin | Dexamethasone inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 12568917 |
| D007213 | Indomethacin | Dexamethasone inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 10574470 |
| D007213 | Indomethacin | Indomethacin results in increased activity of NOS2 protein | increases activity | 16169175 11148446 16818512 12568917 10671773 10192188 15610444 11855677 10210152 11686837 11991626 |
| D007213 | Indomethacin | Indomethacin results in increased expression of NOS2 mRNA | increases expression | 7529313 17202747 18306037 10574470 10210152 |
| D007213 | Indomethacin | Indomethacin results in increased expression of NOS2 protein | increases expression | 7529313 11145282 16133968 17657623 11713966 |
| D007213 | Indomethacin | irsogladine inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18306037 |
| D007213 | Indomethacin | lafutidine inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 10671773 |
| D007213 | Indomethacin | Metronidazole inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 12568917 |
| D007213 | Indomethacin | nitroaspirin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 16818512 |
| D007213 | Indomethacin | ONO-AE1-329 inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 11991626 |
| D007213 | Indomethacin | ONO-NT 012 inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 11991626 |
| D007213 | Indomethacin | Pentoxifylline inhibits the reaction [Indomethacin results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16133968 |
| D007213 | Indomethacin | Polymyxin B inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 12568917 |
| D007213 | Indomethacin | Ranitidine inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 16169175 |
| D007213 | Indomethacin | rebamipide inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 11686837 |
| D007213 | Indomethacin | sulglicotide inhibits the reaction [Indomethacin results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17657623 |
| D007213 | Indomethacin | Tacrolimus inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17202747 |
| D007213 | Indomethacin | Theophylline inhibits the reaction [Indomethacin results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16133968 |
| D007213 | Indomethacin | thiaton inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 11855677 |
| D007213 | Indomethacin | TNF protein affects the reaction [Indomethacin results in increased expression of NOS2 protein] | affects reaction|increases expression | 16133968 |
| D007213 | Indomethacin | usnic acid inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 16169175 |
| D007455 | Iodine | Iodine inhibits the reaction [Mustard Gas results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11305779 |
| D007501 | Iron | Iron inhibits the reaction [Asbestos, Crocidolite results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11461780 |
| D007501 | Iron | Iron inhibits the reaction [Asbestos, Crocidolite results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11461780 |
| D007501 | Iron | [Aluminum co-treated with Iron] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 16728372 |
| D007501 | Iron | [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in decreased expression of NOS2 mRNA | affects cotreatment|decreases expression | 20302851 |
| D007501 | Iron | [Iron co-treated with Diethylnitrosamine] results in decreased expression of NOS2 mRNA | affects cotreatment|decreases expression | 20302851 |
| C041836 | irsogladine | irsogladine inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18306037 |
| D007530 | Isoflurane | Ditiocarb inhibits the reaction [Isoflurane results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18708911 |
| D007530 | Isoflurane | Isoflurane results in increased expression of NOS2 protein | increases expression | 18708911 |
| D007530 | Isoflurane | S-methylisothiopseudouronium inhibits the reaction [Isoflurane results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18708911 |
| D007545 | Isoproterenol | Isoproterenol results in increased expression of NOS2 mRNA | increases expression | 18594475 |
| D007545 | Isoproterenol | pimagedine inhibits the reaction [Isoproterenol results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18594475 |
| C016527 | isoquercitrin | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 21295105 |
| C112524 | JBT-3002 | JBT-3002 results in increased expression of NOS2 mRNA | increases expression | 11404395 |
| C112524 | JBT-3002 | JBT-3002 results in increased expression of NOS2 protein | increases expression | 11404395 |
| C112524 | JBT-3002 | tricyclodecane-9-yl-xanthogenate inhibits the reaction [JBT-3002 results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11404395 |
| C112524 | JBT-3002 | tricyclodecane-9-yl-xanthogenate inhibits the reaction [JBT-3002 results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11404395 |
| C006552 | kaempferol | kaempferol results in decreased expression of NOS2 mRNA | decreases expression | 17184768 |
| C006552 | kaempferol | kaempferol results in decreased expression of NOS2 protein | decreases expression | 17184768 |
| C006552 | kaempferol | Hemin promotes the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 14563492 |
| C006552 | kaempferol | HMOX1 protein promotes the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases reaction | 14563492 |
| C006552 | kaempferol | kaempferol inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19352036 |
| C006552 | kaempferol | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 12512693 18274639 11343698 17177504 |
| C006552 | kaempferol | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12512693 18274639 14563492 16934226 |
| C006552 | kaempferol | PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] | affects reaction|decreases reaction|increases expression | 11343698 |
| C006552 | kaempferol | tin protoporphyrin IX inhibits the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 14563492 |
| D007608 | Kainic Acid | [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 17827730 |
| D007608 | Kainic Acid | Curcumin inhibits the reaction [Kainic Acid results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17827730 |
| D007608 | Kainic Acid | [diacetylcurcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 17827730 |
| D007608 | Kainic Acid | Kainic Acid results in increased expression of NOS2 mRNA | increases expression | 17827730 |
| D015121 | 6-Ketoprostaglandin F1 alpha | NOS2 protein promotes the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of 6-Ketoprostaglandin F1 alpha] | increases abundance|increases expression|increases reaction | 16325209 |
| C439304 | KMUP 1 | KMUP 1 inhibits the reaction [TNF protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16754782 |
| C067713 | lactacystin | lactacystin inhibits the reaction [GW 7647 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 17891158 |
| C067713 | lactacystin | lactacystin inhibits the reaction [pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 17891158 |
| C076948 | lafutidine | lafutidine inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 10671773 |
| C047781 | lamotrigine | lamotrigine results in increased expression of NOS2 protein | increases expression | 14511393 |
| C482199 | lipopolysaccharide, E coli O55-B5 | IFNG protein promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 10868913 |
| C482199 | lipopolysaccharide, E coli O55-B5 | lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA | increases expression | 17630198 10868913 |
| C482199 | lipopolysaccharide, E coli O55-B5 | Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17630198 |
| C482199 | lipopolysaccharide, E coli O55-B5 | [Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]] which results in decreased chemical synthesis of Nitric Oxide | decreases chemical synthesis|decreases reaction|increases expression | 17630198 |
| C482199 | lipopolysaccharide, E coli O55-B5 | SPP1 protein inhibits the reaction [IFNG protein promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression|increases reaction | 10868913 |
| C482199 | lipopolysaccharide, E coli O55-B5 | ferric nitrilotriacetate promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 11746204 |
| C482199 | lipopolysaccharide, E coli O55-B5 | lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA | increases expression | 11746204 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | aloe emodin inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19352036 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | bisphenol A inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 12860292 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression | 12860292 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | kaempferol inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19352036 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA | increases expression | 17656666 12860292 18496239 19352036 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 12860292 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 protein | increases expression | 18496239 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | phenylmethylpyrazolone inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18496239 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | phenylmethylpyrazolone inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18496239 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19352036 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15734790 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Dexamethasone inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12694877 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA | increases expression | 11581148 15734790 12810755 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 protein | increases expression | 12388339 12810755 11581148 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12694877 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 co-treated with TNF protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12694877 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 co-treated with TNF protein] results in increased secretion of NOS2 mRNA] | affects cotreatment|decreases reaction|increases secretion | 12694877 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | mangiferin promotes the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 co-treated with TNFB protein] results in increased expression of NOS2 mRNA] | affects cotreatment|increases expression|increases reaction | 12694877 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA | increases expression | 19607891 19027837 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of NOS2 mRNA | increases expression | 18557954 |
| D008070 | Lipopolysaccharides | Morphine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18760300 |
| D008070 | Lipopolysaccharides | 15-deoxyprostaglandin J2 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 10866999 |
| D008070 | Lipopolysaccharides | Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 10866999 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of NOS2 protein | increases expression | 10866999 16235733 |
| D008070 | Lipopolysaccharides | 1,5-anhydrofructose inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19559007 |
| D008070 | Lipopolysaccharides | 1,5-anhydrofructose inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19559007 |
| D008070 | Lipopolysaccharides | 15-deoxyprostaglandin J2 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17891158 |
| D008070 | Lipopolysaccharides | 15-deoxyprostaglandin J2 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17891158 |
| D008070 | Lipopolysaccharides | 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetra-hydroisoquinoline inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 11961057 |
| D008070 | Lipopolysaccharides | 1-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12527339 |
| D008070 | Lipopolysaccharides | 2-chloroethyl ethyl sulfide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17137498 18570648 |
| D008070 | Lipopolysaccharides | 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| D008070 | Lipopolysaccharides | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11891798 |
| D008070 | Lipopolysaccharides | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11891798 |
| D008070 | Lipopolysaccharides | 3,7-O-dimethylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18178435 |
| D008070 | Lipopolysaccharides | 3,7-O-dimethylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18178435 |
| D008070 | Lipopolysaccharides | 3-hydroxyflavone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 14563492 |
| D008070 | Lipopolysaccharides | 3-methylcatechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18499097 |
| D008070 | Lipopolysaccharides | 3-methylcatechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18499097 |
| D008070 | Lipopolysaccharides | 3-methylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18274639 |
| D008070 | Lipopolysaccharides | 3-methylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18274639 |
| D008070 | Lipopolysaccharides | 3-O-methylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18178435 16213685 |
| D008070 | Lipopolysaccharides | 3-O-methylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16213685 18178435 |
| D008070 | Lipopolysaccharides | 4-methylcatechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18499097 |
| D008070 | Lipopolysaccharides | 4-methylcatechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18499097 |
| D008070 | Lipopolysaccharides | 5-hydroxyflavone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12512693 |
| D008070 | Lipopolysaccharides | alachlor inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15907790 |
| D008070 | Lipopolysaccharides | alachlor inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15907790 |
| D008070 | Lipopolysaccharides | allylpyrocatechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18602073 |
| D008070 | Lipopolysaccharides | anandamide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11891798 |
| D008070 | Lipopolysaccharides | anandamide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15748152 11891798 |
| D008070 | Lipopolysaccharides | anemonin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18281171 |
| D008070 | Lipopolysaccharides | anemonin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18281171 |
| D008070 | Lipopolysaccharides | Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11343698 |
| D008070 | Lipopolysaccharides | Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12512693 16934226 |
| D008070 | Lipopolysaccharides | baicalein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 14563492 |
| D008070 | Lipopolysaccharides | benzyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| D008070 | Lipopolysaccharides | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 17891158 |
| D008070 | Lipopolysaccharides | bis(2-hydroxybenzylidene)acetone inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| D008070 | Lipopolysaccharides | bis(4-hydroxycinnamoyl)methane inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19188055 18449507 |
| D008070 | Lipopolysaccharides | bis(4-hydroxycinnamoyl)methane inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18449507 18481332 19188055 |
| D008070 | Lipopolysaccharides | Cadmium Chloride inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| D008070 | Lipopolysaccharides | Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15907790 |
| D008070 | Lipopolysaccharides | Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15907790 |
| D008070 | Lipopolysaccharides | carvedilol promotes the reaction [wortmannin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 17159805 |
| D008070 | Lipopolysaccharides | Catechin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12512693 |
| D008070 | Lipopolysaccharides | catechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18499097 |
| D008070 | Lipopolysaccharides | catechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18499097 |
| D008070 | Lipopolysaccharides | chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11343698 |
| D008070 | Lipopolysaccharides | chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16934226 17570322 |
| D008070 | Lipopolysaccharides | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19188055 |
| D008070 | Lipopolysaccharides | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18481332 19188055 |
| D008070 | Lipopolysaccharides | daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18274639 11308324 |
| D008070 | Lipopolysaccharides | daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18274639 11308324 |
| D008070 | Lipopolysaccharides | demethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18449507 |
| D008070 | Lipopolysaccharides | demethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18449507 |
| D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [IL1 protein promotes the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases reaction | 7540993 |
| D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 7540993 |
| D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16880258 |
| D008070 | Lipopolysaccharides | dihydrolipoic acid inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| D008070 | Lipopolysaccharides | [Dimercaprol co-treated with Mercuric Chloride] inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | affects cotreatment|decreases reaction|increases activity | 18838692 |
| D008070 | Lipopolysaccharides | Dimercaprol inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| D008070 | Lipopolysaccharides | dimethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18481332 |
| D008070 | Lipopolysaccharides | diosmetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16934226 |
| D008070 | Lipopolysaccharides | diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19005069 |
| D008070 | Lipopolysaccharides | diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19005069 |
| D008070 | Lipopolysaccharides | Dithiothreitol inhibits the reaction [Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 15907790 |
| D008070 | Lipopolysaccharides | Drugs, Chinese Herbal inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17996413 19051357 |
| D008070 | Lipopolysaccharides | Drugs, Chinese Herbal inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19051357 |
| D008070 | Lipopolysaccharides | ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D008070 | Lipopolysaccharides | ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D008070 | Lipopolysaccharides | epigallocatechin gallate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D008070 | Lipopolysaccharides | epigallocatechin gallate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D008070 | Lipopolysaccharides | esculetin promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 16212885 |
| D008070 | Lipopolysaccharides | Ethanol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18281171 |
| D008070 | Lipopolysaccharides | ferric nitrilotriacetate inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11461780 |
| D008070 | Lipopolysaccharides | fexofenadine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17910814 |
| D008070 | Lipopolysaccharides | fisetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17177504 |
| D008070 | Lipopolysaccharides | flavone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18274639 |
| D008070 | Lipopolysaccharides | flavone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18274639 |
| D008070 | Lipopolysaccharides | Fluorouracil inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16724238 |
| D008070 | Lipopolysaccharides | Fluorouracil inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16724238 |
| D008070 | Lipopolysaccharides | Genistein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18274639 11308324 |
| D008070 | Lipopolysaccharides | Genistein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11308324 18274639 |
| D008070 | Lipopolysaccharides | Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 17442725 |
| D008070 | Lipopolysaccharides | gigantol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16924582 |
| D008070 | Lipopolysaccharides | gigantol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16924582 |
| D008070 | Lipopolysaccharides | gingerol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18683823 |
| D008070 | Lipopolysaccharides | gingerol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18683823 |
| D008070 | Lipopolysaccharides | Ginkgo biloba extract 761 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11518563 |
| D008070 | Lipopolysaccharides | Ginkgo biloba extract 761 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11518563 |
| D008070 | Lipopolysaccharides | Ginkgo biloba extract 761 inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11518563 |
| D008070 | Lipopolysaccharides | glycitein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11308324 |
| D008070 | Lipopolysaccharides | glycitein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11308324 |
| D008070 | Lipopolysaccharides | glycyrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18666753 |
| D008070 | Lipopolysaccharides | GW 7647 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17891158 |
| D008070 | Lipopolysaccharides | GW 7647 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17891158 |
| D008070 | Lipopolysaccharides | Hemin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 14563492 |
| D008070 | Lipopolysaccharides | Hemin promotes the reaction [3-hydroxyflavone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 14563492 |
| D008070 | Lipopolysaccharides | Hemin promotes the reaction [baicalein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 14563492 |
| D008070 | Lipopolysaccharides | Hemin promotes the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 14563492 |
| D008070 | Lipopolysaccharides | Hemin promotes the reaction [Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 14563492 |
| D008070 | Lipopolysaccharides | hesperetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12512693 |
| D008070 | Lipopolysaccharides | Hesperidin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12512693 |
| D008070 | Lipopolysaccharides | HMOX1 protein promotes the reaction [3-hydroxyflavone inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases reaction | 14563492 |
| D008070 | Lipopolysaccharides | HMOX1 protein promotes the reaction [baicalein inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases reaction | 14563492 |
| D008070 | Lipopolysaccharides | HMOX1 protein promotes the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases reaction | 14563492 |
| D008070 | Lipopolysaccharides | HMOX1 protein promotes the reaction [Quercetin inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases reaction | 14563492 |
| D008070 | Lipopolysaccharides | honokiol analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19539808 |
| D008070 | Lipopolysaccharides | hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15831208 |
| D008070 | Lipopolysaccharides | hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15831208 |
| D008070 | Lipopolysaccharides | IFNB1 protein affects the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | affects reaction|increases expression | 18323514 |
| D008070 | Lipopolysaccharides | IL1 protein promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 7540993 |
| D008070 | Lipopolysaccharides | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18274639 11343698 12512693 17177504 |
| D008070 | Lipopolysaccharides | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 14563492 16934226 12512693 18274639 |
| D008070 | Lipopolysaccharides | lactacystin inhibits the reaction [GW 7647 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 17891158 |
| D008070 | Lipopolysaccharides | lactacystin inhibits the reaction [pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 17891158 |
| D008070 | Lipopolysaccharides | LCN2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18292240 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein | affects cotreatment|increases activity | 12892526 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA | affects cotreatment|increases expression | 12794164 11054110 15222974 12694877 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 15222974 12794164 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [IFNG protein results in increased expression of NOS2 protein] | increases expression|increases reaction | 7689037 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of NOS2 protein | decreases expression | 16116226 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased activity of NOS2 protein | increases activity | 18838692 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of NOS2 mRNA | increases expression | 17316017 19426678 16212885 18274639 17873880 12619901 11518563 11308324 15907790 16724238 19559007 19188055 18449507 15831208 18666753 11343698 19332304 18323514 16924582 17996413 18841975 7540993 14734799 11461780 15863904 17442725 17910814 18499097 18602073 19005069 18716446 9683428 17321468 15563889 19051357 11891798 18281171 10223745 18292240 12057914 17570322 17891158 15896337 18178435 16880258 12590506 11054110 18683823 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of NOS2 protein | increases expression | 15563889 18716446 18281171 18499097 15863904 14734799 15748152 15831208 11518563 18449507 19051357 16724238 11500931 16924582 18666753 17355946 19332304 11891798 17475668 18683823 12619901 18841975 16880258 19559007 19188055 17137498 17570322 17855475 17158209 18178435 19005069 11461780 18274639 15589480 17321468 15907790 17316017 15896337 18481332 17159805 17891158 19539808 11308324 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 11500931 11518563 |
| D008070 | Lipopolysaccharides | Luteolin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19426678 |
| D008070 | Lipopolysaccharides | Luteolin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16934226 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12694877 |
| D008070 | Lipopolysaccharides | Mercaptoethanol inhibits the reaction [Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 15907790 |
| D008070 | Lipopolysaccharides | Mercuric Chloride inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| D008070 | Lipopolysaccharides | methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| D008070 | Lipopolysaccharides | Methylene Chloride inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15563889 |
| D008070 | Lipopolysaccharides | Methylene Chloride inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15563889 |
| D008070 | Lipopolysaccharides | N1-benzyl-4-methylbenzene-1,2-diamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15863904 |
| D008070 | Lipopolysaccharides | N1-benzyl-4-methylbenzene-1,2-diamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15863904 |
| D008070 | Lipopolysaccharides | N-(4-O-glycerol-3-methoxybenzyl)nonivamide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17855475 |
| D008070 | Lipopolysaccharides | naringenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18274639 |
| D008070 | Lipopolysaccharides | naringenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12512693 18274639 |
| D008070 | Lipopolysaccharides | NFKB1 gene mutant form inhibits the reaction [Ozone promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15064226 |
| D008070 | Lipopolysaccharides | OMDM-1 cpd inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15748152 |
| D008070 | Lipopolysaccharides | Ozone promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein] | affects cotreatment|increases activity|increases reaction | 15064226 |
| D008070 | Lipopolysaccharides | pelargonidin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18274639 |
| D008070 | Lipopolysaccharides | pelargonidin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18274639 |
| D008070 | Lipopolysaccharides | phenyl-N-tert-butylnitrone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D008070 | Lipopolysaccharides | phenyl-N-tert-butylnitrone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D008070 | Lipopolysaccharides | pimagedine inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein] | affects cotreatment|decreases reaction|increases activity | 12892526 |
| D008070 | Lipopolysaccharides | pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17891158 |
| D008070 | Lipopolysaccharides | pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17891158 |
| D008070 | Lipopolysaccharides | pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18323514 |
| D008070 | Lipopolysaccharides | Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2] | decreases reaction|increases expression | 16393471 |
| D008070 | Lipopolysaccharides | Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 12590506 19332304 |
| D008070 | Lipopolysaccharides | Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19332304 |
| D008070 | Lipopolysaccharides | PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] | affects reaction|decreases reaction|increases expression | 11343698 |
| D008070 | Lipopolysaccharides | PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] | affects reaction|decreases reaction|increases expression | 11343698 |
| D008070 | Lipopolysaccharides | PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] | affects reaction|decreases reaction|increases expression | 11343698 |
| D008070 | Lipopolysaccharides | Pravastatin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18323514 |
| D008070 | Lipopolysaccharides | Propanil inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17355946 |
| D008070 | Lipopolysaccharides | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18716446 15896337 |
| D008070 | Lipopolysaccharides | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15896337 18716446 |
| D008070 | Lipopolysaccharides | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 12619901 16171798 11518563 18274639 17177504 |
| D008070 | Lipopolysaccharides | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11500931 18274639 12512693 16171798 14563492 15831208 11518563 |
| D008070 | Lipopolysaccharides | Quercetin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11518563 11500931 |
| D008070 | Lipopolysaccharides | quercetin pentaacetate inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11500931 |
| D008070 | Lipopolysaccharides | quercetin pentaacetate inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11500931 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of NOS2 protein] | decreases expression|decreases reaction | 16116226 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16183991 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15589480 |
| D008070 | Lipopolysaccharides | [rimonabant co-treated with SR 144528] inhibits the reaction [OMDM-1 cpd inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | affects cotreatment|decreases reaction|increases expression | 15748152 |
| D008070 | Lipopolysaccharides | rosiglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11343698 |
| D008070 | Lipopolysaccharides | Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11500931 12512693 |
| D008070 | Lipopolysaccharides | Rutin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11500931 |
| D008070 | Lipopolysaccharides | SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 14734799 |
| D008070 | Lipopolysaccharides | SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11518563 14734799 |
| D008070 | Lipopolysaccharides | SB 203580 inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11518563 |
| D008070 | Lipopolysaccharides | Selenium inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 14734799 |
| D008070 | Lipopolysaccharides | Selenium inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 14734799 |
| D008070 | Lipopolysaccharides | shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18683823 |
| D008070 | Lipopolysaccharides | shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18683823 |
| D008070 | Lipopolysaccharides | sinapinic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18841975 |
| D008070 | Lipopolysaccharides | sinapinic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18841975 |
| D008070 | Lipopolysaccharides | sodium arsenate inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| D008070 | Lipopolysaccharides | sodium arsenite inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| D008070 | Lipopolysaccharides | Sodium Selenite inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18279804 |
| D008070 | Lipopolysaccharides | Sulfasalazine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16934226 |
| D008070 | Lipopolysaccharides | sulforafan inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| D008070 | Lipopolysaccharides | tert-butylcatechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18499097 |
| D008070 | Lipopolysaccharides | tert-butylcatechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18499097 |
| D008070 | Lipopolysaccharides | tin protoporphyrin IX inhibits the reaction [3-hydroxyflavone inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 14563492 |
| D008070 | Lipopolysaccharides | tin protoporphyrin IX inhibits the reaction [baicalein inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 14563492 |
| D008070 | Lipopolysaccharides | tin protoporphyrin IX inhibits the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 14563492 |
| D008070 | Lipopolysaccharides | tin protoporphyrin IX inhibits the reaction [Quercetin inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 14563492 |
| D008070 | Lipopolysaccharides | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18449507 |
| D008070 | Lipopolysaccharides | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18449507 |
| D008070 | Lipopolysaccharides | Vaticanol B inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17475668 |
| D008070 | Lipopolysaccharides | wogonin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17570322 |
| D008070 | Lipopolysaccharides | wogonin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17570322 |
| D008070 | Lipopolysaccharides | wortmannin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17159805 |
| D008070 | Lipopolysaccharides | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetra-hydroisoquinoline inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11961057 |
| D008070 | Lipopolysaccharides | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Triglycerides promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 18710323 |
| D008070 | Lipopolysaccharides | 8-chlorocarbochromen inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15322736 |
| D008070 | Lipopolysaccharides | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | Ascorbic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| D008070 | Lipopolysaccharides | bis(4-hydroxycinnamoyl)methane inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18838107 |
| D008070 | Lipopolysaccharides | broussochalcone A inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11286985 |
| D008070 | Lipopolysaccharides | CD14 protein promotes the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of NOS2 protein] | increases expression|increases reaction|increases secretion | 12133974 |
| D008070 | Lipopolysaccharides | CD14 protein promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 12133974 |
| D008070 | Lipopolysaccharides | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16934299 18838107 18368483 |
| D008070 | Lipopolysaccharides | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16934299 |
| D008070 | Lipopolysaccharides | demethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18838107 |
| D008070 | Lipopolysaccharides | Ethanol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 10231168 |
| D008070 | Lipopolysaccharides | Ethanol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 10231168 |
| D008070 | Lipopolysaccharides | eugenosedin-A inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| D008070 | Lipopolysaccharides | ferric nitrilotriacetate promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 11746204 |
| D008070 | Lipopolysaccharides | geldanamycin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15583003 |
| D008070 | Lipopolysaccharides | [IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 12911628 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 mRNA | affects cotreatment|increases expression | 16366677 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 16366677 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA | affects cotreatment|increases expression | 16488514 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 16488514 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 14700523 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased expression of and results in increased activity of NOS2 protein | affects cotreatment|increases activity|increases expression | 11826407 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides inhibits the reaction [1-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12527339 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of NOS2 mRNA | decreases expression | 15821434 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of and results in increased secretion of NOS2 protein | increases expression|increases secretion | 12133974 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of NOS2 mRNA | increases expression | 15629513 11746204 15205115 15466955 10231168 12022755 17342418 11837731 12133974 10903966 18710323 16698588 15322736 18538761 18368483 7529313 16934299 15135310 16509782 18838107 14534150 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of NOS2 protein | increases expression | 15629513 15583003 17637181 16934299 15542068 16698588 12022755 11286985 7529313 10231168 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 12133974 |
| D008070 | Lipopolysaccharides | Magnesium deficiency promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 15466955 |
| D008070 | Lipopolysaccharides | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | Mifepristone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 10231168 |
| D008070 | Lipopolysaccharides | monorden inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15583003 |
| D008070 | Lipopolysaccharides | NOS3 protein promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | increases expression|increases reaction | 15583003 |
| D008070 | Lipopolysaccharides | Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18538761 |
| D008070 | Lipopolysaccharides | phenylmethylpyrazolone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15629513 |
| D008070 | Lipopolysaccharides | phenylmethylpyrazolone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15629513 |
| D008070 | Lipopolysaccharides | pimagedine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| D008070 | Lipopolysaccharides | polyphenols inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| D008070 | Lipopolysaccharides | polyphenols inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16698588 |
| D008070 | Lipopolysaccharides | polyphenols inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16698588 |
| D008070 | Lipopolysaccharides | pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17342418 |
| D008070 | Lipopolysaccharides | Quercetin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 14700523 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| D008070 | Lipopolysaccharides | Saponins inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| D008070 | Lipopolysaccharides | Saponins inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| D008070 | Lipopolysaccharides | SB 203580 inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12911628 |
| D008070 | Lipopolysaccharides | SB 203580 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | tert-Butyl Alcohol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 10231168 |
| D008070 | Lipopolysaccharides | tert-Butyl Alcohol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 10231168 |
| D008070 | Lipopolysaccharides | tert-Butylhydroperoxide promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 10231168 |
| D008070 | Lipopolysaccharides | Trazodone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| D008070 | Lipopolysaccharides | Triglycerides promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 18710323 |
| D008070 | Lipopolysaccharides | U 0126 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | wogonin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 14700523 |
| D008070 | Lipopolysaccharides | Yohimbine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides affects the expression of NOS2 mRNA | affects expression | 12893242 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides affects the expression of NOS2 protein | affects expression | 12893242 |
| D008070 | Lipopolysaccharides | Curcumin analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19243473 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides binds to and results in increased activity of TLR4 protein] which results in increased expression of NOS2 protein | affects binding|increases activity|increases expression | 17630198 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of NOS2 mRNA | increases expression | 19243473 |
| C009900 | lipoteichoic acid | lipoteichoic acid results in increased expression of NOS2 mRNA | increases expression | 19573522 17570322 |
| C009900 | lipoteichoic acid | lipoteichoic acid results in increased expression of NOS2 protein | increases expression | 17570322 19573522 |
| C009900 | lipoteichoic acid | Propofol inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19573522 |
| C009900 | lipoteichoic acid | Propofol inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19573522 |
| C009900 | lipoteichoic acid | TLR2 protein affects the reaction [lipoteichoic acid results in increased expression of NOS2 mRNA] | affects reaction|increases expression | 19573522 |
| C009900 | lipoteichoic acid | wogonin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17570322 |
| C009900 | lipoteichoic acid | wogonin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17570322 |
| D018021 | Lithium Chloride | Lithium Chloride results in increased expression of NOS2 mRNA | increases expression | 19679347 |
| C059451 | lornoxicam | lornoxicam inhibits the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis | 10450786 |
| D017997 | Leukotriene C4 | Leukotriene C4 inhibits the reaction [[Zymosan results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitrites] | decreases reaction|increases chemical synthesis|increases expression | 11454666 |
| D047311 | Luteolin | Luteolin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19426678 |
| D047311 | Luteolin | Luteolin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16934226 |
| D047311 | Luteolin | Luteolin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18090225 |
| D047311 | Luteolin | Luteolin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 18090225 |
| D008274 | Magnesium | Magnesium deficiency promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 15466955 |
| D008345 | Manganese | Manganese results in increased expression of NOS2 protein | increases expression | 16551646 |
| D008345 | Manganese | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 17827730 |
| D008345 | Manganese | [diacetylcurcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 17827730 |
| D008345 | Manganese | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | Manganese results in decreased activity of NOS2 protein | decreases activity | 16488514 |
| D008345 | Manganese | SB 203580 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | U 0126 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15381052 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12694877 |
| C013592 | mangiferin | mangiferin inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15381052 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12694877 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 co-treated with TNF protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12694877 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 co-treated with TNF protein] results in increased secretion of NOS2 mRNA] | affects cotreatment|decreases reaction|increases secretion | 12694877 |
| C013592 | mangiferin | mangiferin promotes the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 co-treated with TNFB protein] results in increased expression of NOS2 mRNA] | affects cotreatment|increases expression|increases reaction | 12694877 |
| C054474 | manumycin | manumycin inhibits the reaction [Acetaminophen results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19739265 |
| C054474 | manumycin | manumycin inhibits the reaction [Acetaminophen results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19739265 |
| D008376 | Maprotiline | Maprotiline results in increased expression of NOS2 mRNA | increases expression | 12429386 |
| D008550 | Melatonin | Melatonin inhibits the reaction [Amphetamine results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18524487 |
| D008550 | Melatonin | Melatonin inhibits the reaction [Cadmium affects the expression of NOS2 mRNA] | affects expression|decreases reaction | 16948784 |
| D008550 | Melatonin | Melatonin inhibits the reaction [Cadmium Chloride affects the expression of NOS2 mRNA] | affects expression|decreases reaction | 16948784 |
| D008623 | Mercaptoethanol | Mercaptoethanol inhibits the reaction [Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 15907790 |
| D008627 | Mercuric Chloride | [Dimercaprol co-treated with Mercuric Chloride] inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | affects cotreatment|decreases reaction|increases activity | 18838692 |
| D008627 | Mercuric Chloride | Mercuric Chloride inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| D008715 | Methionine | Methionine inhibits the reaction [Acetaminophen results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19739265 |
| D008715 | Methionine | Methionine inhibits the reaction [Acetaminophen results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19739265 |
| C054938 | methoctramine | methoctramine inhibits the reaction [Mevinphos results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17395621 |
| D008727 | Methotrexate | Methotrexate results in decreased activity of NOS2 protein | decreases activity | 17666920 |
| D008731 | Methoxychlor | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Methoxychlor results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15979571 |
| D008731 | Methoxychlor | Methoxychlor results in increased expression of NOS2 mRNA | increases expression | 15979571 |
| D008731 | Methoxychlor | PD 98059 inhibits the reaction [Methoxychlor results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15979571 |
| D008731 | Methoxychlor | SB 203580 inhibits the reaction [Methoxychlor results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15979571 |
| C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate inhibits the reaction [IFNG protein results in increased expression of NOS2] | decreases reaction|increases expression | 17363558 |
| C455529 | methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate | methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| D008752 | Methylene Chloride | Methylene Chloride inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15563889 |
| D008752 | Methylene Chloride | Methylene Chloride inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15563889 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in increased expression of NOS2 protein | increases expression | 16052507 |
| D008795 | Metronidazole | Metronidazole inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 12568917 |
| D008799 | Mevinphos | methoctramine inhibits the reaction [Mevinphos results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17395621 |
| D008799 | Mevinphos | Mevinphos results in increased expression of NOS2 protein | increases expression | 17395621 |
| D008799 | Mevinphos | Tropicamide inhibits the reaction [Mevinphos results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17395621 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 10231168 |
| C015765 | MK 473 | MK 473 inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19446535 |
| D016686 | Monocrotaline | 4-chlorobenzyltetrahydroberberine inhibits the reaction [Monocrotaline results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16225752 |
| D016686 | Monocrotaline | Monocrotaline results in increased expression of NOS2 mRNA | increases expression | 16225752 |
| C035359 | monorden | monorden inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15583003 |
| C093875 | montelukast | montelukast inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11698051 |
| D009020 | Morphine | Morphine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18760300 |
| D009020 | Morphine | Morphine inhibits the reaction [Zymosan results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18760300 |
| D009020 | Morphine | Morphine results in increased expression of NOS2 protein | increases expression | 15220775 |
| D009020 | Morphine | NOS2 protein promotes the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of 6-Ketoprostaglandin F1 alpha] | increases abundance|increases expression|increases reaction | 16325209 |
| D009020 | Morphine | NOS2 protein promotes the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone] | increases abundance|increases expression|increases reaction | 16325209 |
| D009151 | Mustard Gas | Iodine inhibits the reaction [Mustard Gas results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11305779 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of NOS2 protein | increases expression | 11305779 |
| D009151 | Mustard Gas | Mustard Gas results in decreased expression of NOS2 mRNA | decreases expression | 17964119 |
| D009151 | Mustard Gas | Mustard Gas results in decreased expression of NOS2 protein | decreases expression | 17964119 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of NOS2 protein | increases expression | 17524151 |
| D009151 | Mustard Gas | Roxithromycin inhibits the reaction [Mustard Gas results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17524151 |
| C497734 | N1-benzyl-4-methylbenzene-1,2-diamine | N1-benzyl-4-methylbenzene-1,2-diamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15863904 |
| C497734 | N1-benzyl-4-methylbenzene-1,2-diamine | N1-benzyl-4-methylbenzene-1,2-diamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15863904 |
| C502260 | N-(1-methylethyl)-1,1,2-trimethylpropylamine | 5-hydroxydecanoic acid inhibits the reaction [N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases expression | 16257489 |
| C502260 | N-(1-methylethyl)-1,1,2-trimethylpropylamine | N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein] | decreases reaction|increases activity|increases expression | 16257489 |
| C502260 | N-(1-methylethyl)-1,1,2-trimethylpropylamine | 5-hydroxydecanoic acid inhibits the reaction [N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 15795934 15927086 |
| C502260 | N-(1-methylethyl)-1,1,2-trimethylpropylamine | 5-hydroxydecanoic acid inhibits the reaction [N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression | 15927086 15795934 |
| C502260 | N-(1-methylethyl)-1,1,2-trimethylpropylamine | N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased activity of NOS2 protein] | decreases reaction|increases activity | 15927086 15795934 |
| C502260 | N-(1-methylethyl)-1,1,2-trimethylpropylamine | N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15927086 15795934 |
| C104820 | N-(3-(aminomethyl)benzyl)acetamidine | N-(3-(aminomethyl)benzyl)acetamidine results in decreased activity of NOS2 protein | decreases activity | 11134894 |
| C104820 | N-(3-(aminomethyl)benzyl)acetamidine | N-(3-(aminomethyl)benzyl)acetamidine results in decreased activity of NOS2 protein | decreases activity | 15631943 |
| C496401 | N-((3-(aminomethyl)phenyl)methyl)ethanimidamide | N-((3-(aminomethyl)phenyl)methyl)ethanimidamide results in decreased activity of NOS2 protein | decreases activity | 11454666 |
| C496401 | N-((3-(aminomethyl)phenyl)methyl)ethanimidamide | N-((3-(aminomethyl)phenyl)methyl)ethanimidamide results in decreased activity of NOS2 protein | decreases activity | 15846226 |
| C080418 | N-(4-O-glycerol-3-methoxybenzyl)nonivamide | N-(4-O-glycerol-3-methoxybenzyl)nonivamide inhibits the reaction [Oxidopamine results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17855475 |
| C080418 | N-(4-O-glycerol-3-methoxybenzyl)nonivamide | N-(4-O-glycerol-3-methoxybenzyl)nonivamide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17855475 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in decreased expression of NOS2 protein | decreases expression | 18590720 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of NOS2 mRNA | increases expression | 15135310 |
| D015058 | 1-Naphthylisothiocyanate | Emodin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NOS2 protein] | decreases expression|decreases reaction | 18590720 |
| D015058 | 1-Naphthylisothiocyanate | Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NOS2 protein] | decreases expression|decreases reaction | 18590720 |
| C005273 | naringenin | naringenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18274639 |
| C005273 | naringenin | naringenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12512693 18274639 |
| C029938 | nickel sulfate | nickel sulfate results in increased expression of NOS2 mRNA | increases expression | 11114790 |
| D009538 | Nicotine | Nicotine results in increased expression of NOS2 mRNA | increases expression | 18247414 |
| C012655 | nimesulide | nimesulide results in increased expression of NOS2 mRNA | increases expression | 15135310 |
| D009569 | Nitric Oxide | [Acetaldehyde results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | increases abundance|increases expression | 18845238 |
| D009569 | Nitric Oxide | [Ethanol results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | increases abundance|increases expression | 18845238 |
| D009569 | Nitric Oxide | lornoxicam inhibits the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis | 10450786 |
| D009569 | Nitric Oxide | NOS2 protein results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis | 10450786 |
| D009569 | Nitric Oxide | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 12847270 |
| D009569 | Nitric Oxide | [3,5-dimethoxy-4'-hydroxystilbene results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA] | decreases expression|decreases reaction|increases expression | 17135264 |
| D009569 | Nitric Oxide | [Acetaminophen results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide | decreases chemical synthesis|decreases expression | 10860828 |
| D009569 | Nitric Oxide | [Aspirin results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide | decreases chemical synthesis|decreases expression | 10860828 |
| D009569 | Nitric Oxide | bisphenol A inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 12860292 |
| D009569 | Nitric Oxide | ciglitazone inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 12847270 |
| D009569 | Nitric Oxide | Ginkgo biloba extract 761 inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11518563 |
| D009569 | Nitric Oxide | GW 1929 inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 12847270 |
| D009569 | Nitric Oxide | [IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 12847270 |
| D009569 | Nitric Oxide | [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 12860292 |
| D009569 | Nitric Oxide | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 11518563 11500931 |
| D009569 | Nitric Oxide | NFKB1 protein promotes the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | increases chemical synthesis|increases expression|increases reaction | 12162464 |
| D009569 | Nitric Oxide | NOS2 protein results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis | 18481332 |
| D009569 | Nitric Oxide | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 11919077 12162464 |
| D009569 | Nitric Oxide | PPARG protein affects the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | affects reaction|increases chemical synthesis|increases expression | 12847270 |
| D009569 | Nitric Oxide | Quercetin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11518563 11500931 |
| D009569 | Nitric Oxide | quercetin pentaacetate inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11500931 |
| D009569 | Nitric Oxide | [Quercetin results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA] | decreases expression|decreases reaction|increases expression | 17135264 |
| D009569 | Nitric Oxide | Rutin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11500931 |
| D009569 | Nitric Oxide | [S100B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | increases abundance|increases expression | 16376947 |
| D009569 | Nitric Oxide | SB 203580 inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11518563 |
| D009569 | Nitric Oxide | [Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]] which results in decreased chemical synthesis of Nitric Oxide | decreases chemical synthesis|decreases reaction|increases expression | 17630198 |
| D009569 | Nitric Oxide | [Sodium Salicylate results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide | decreases chemical synthesis|decreases expression | 10860828 |
| D009569 | Nitric Oxide | [Thiourea analog results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide | decreases chemical synthesis|decreases expression | 17467989 |
| D009569 | Nitric Oxide | [TNF protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | increases abundance|increases expression | 18369347 |
| D009569 | Nitric Oxide | [[TNF protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide] which results in decreased expression of RETN mRNA | decreases expression|increases abundance|increases expression | 18369347 |
| D009569 | Nitric Oxide | [zoledronic acid results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 19818098 |
| D009569 | Nitric Oxide | Endotoxins inhibits the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 8652180 |
| D009569 | Nitric Oxide | [Endotoxins results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 15364003 |
| D009569 | Nitric Oxide | [Ethanol results in decreased expression of and results in decreased activity of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide | decreases activity|decreases chemical synthesis|decreases expression | 11173986 |
| D009569 | Nitric Oxide | [Fructose results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 10090849 |
| D009569 | Nitric Oxide | [Gentamicins results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | increases abundance|increases expression | 17312373 |
| D009569 | Nitric Oxide | [IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 7519435 |
| D009569 | Nitric Oxide | [IL1B protein results in increased expression of and results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases activity|increases chemical synthesis|increases expression | 11530235 |
| D009569 | Nitric Oxide | [IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 11286988 7519435 18078833 |
| D009569 | Nitric Oxide | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 12133974 |
| D009569 | Nitric Oxide | NOS2 protein results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis | 18838107 |
| D009569 | Nitric Oxide | Ozone promotes the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide] | increases abundance|increases expression|increases reaction | 7519435 |
| D009569 | Nitric Oxide | Ozone promotes the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide] | increases abundance|increases expression|increases reaction | 7519435 |
| D009569 | Nitric Oxide | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 9788894 8652180 10022268 7705308 |
| D009569 | Nitric Oxide | phenylmethylpyrazolone inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 18078833 |
| D009569 | Nitric Oxide | pyrrolidine dithiocarbamic acid inhibits the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 9788894 |
| D009569 | Nitric Oxide | Rotenone inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11530235 |
| D009569 | Nitric Oxide | [S100B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | increases abundance|increases expression | 16376947 |
| D009569 | Nitric Oxide | NOS2 protein results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis | 12568917 18209962 11713966 |
| D009573 | Nitrites | Leukotriene B4 inhibits the reaction [[Zymosan results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitrites] | decreases reaction|increases chemical synthesis|increases expression | 11454666 |
| D009573 | Nitrites | Leukotriene C4 inhibits the reaction [[Zymosan results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitrites] | decreases reaction|increases chemical synthesis|increases expression | 11454666 |
| D009573 | Nitrites | ZM 230487 inhibits the reaction [[Zymosan results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitrites] | decreases reaction|increases chemical synthesis|increases expression | 11454666 |
| D009573 | Nitrites | [Zymosan results in increased expression of NOS2 protein] which results in increased abundance of Nitrites | increases abundance|increases expression | 11454666 |
| D009573 | Nitrites | [Carmustine co-treated with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid] inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitrites] | affects cotreatment|decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| D009573 | Nitrites | IFNG protein promotes the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitrites] | increases activity|increases chemical synthesis|increases reaction | 7532384 |
| D009573 | Nitrites | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid] | decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| D009573 | Nitrites | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Amobarbital] | decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| D009573 | Nitrites | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Buthionine Sulfoximine] | decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| D009573 | Nitrites | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Carmustine] | decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| D009573 | Nitrites | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Deferoxamine] | decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| D009573 | Nitrites | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of diethyl maleate] | decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| D009573 | Nitrites | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Rotenone] | decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| D009573 | Nitrites | [TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitrites | increases activity|increases chemical synthesis | 7532384 |
| C102148 | nitroaspirin | nitroaspirin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 16818512 |
| D009578 | Nitrobenzenes | Nitrobenzenes analog results in decreased expression of NOS2 mRNA | decreases expression | 19784758 |
| D009585 | Nitrogen Dioxide | Nitrogen Dioxide results in increased expression of NOS2 mRNA | increases expression | 10715624 |
| D005996 | Nitroglycerin | Nitroglycerin results in decreased expression of NOS2 mRNA | decreases expression | 12206003 |
| D005996 | Nitroglycerin | Nitroglycerin results in increased expression of NOS2 mRNA | increases expression | 11701602 |
| D005996 | Nitroglycerin | Nitroglycerin results in increased expression of NOS2 protein | increases expression | 11701602 |
| D005996 | Nitroglycerin | NOS2 protein affects the reaction [Nitroglycerin results in increased expression of CALCA mRNA] | affects reaction|increases expression | 14729435 |
| D009599 | Nitroprusside | NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Nitroprusside] | affects cotreatment|affects response to substance | 11498454 |
| C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in increased expression of NOS2 mRNA | increases expression | 15264214 16510608 |
| C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in increased expression of NOS2 protein | increases expression | 16510608 |
| C014707 | nitrosobenzylmethylamine | Plant Preparations inhibits the reaction [nitrosobenzylmethylamine results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16510608 |
| C014707 | nitrosobenzylmethylamine | Plant Preparations inhibits the reaction [nitrosobenzylmethylamine results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16510608 |
| C405615 | NS 1652 | NS 1652 inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19446535 |
| C405615 | NS 1652 | NS 1652 inhibits the reaction [IFNG protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19446535 |
| C517730 | NS3728 | NS3728 inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19446535 |
| C025589 | ochratoxin A | ochratoxin A results in increased expression of NOS2 protein | increases expression | 19414514 |
| C120126 | oil fly ash | oil fly ash results in increased expression of NOS2 mRNA | increases expression | 11114790 |
| C474344 | OMDM-1 cpd | OMDM-1 cpd inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15748152 |
| C474344 | OMDM-1 cpd | [rimonabant co-treated with SR 144528] inhibits the reaction [OMDM-1 cpd inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | affects cotreatment|decreases reaction|increases expression | 15748152 |
| C053238 | onapristone | onapristone results in increased expression of NOS2 mRNA | increases expression | 16399999 |
| C461399 | ONO-AE1-329 | ONO-AE1-329 inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 11991626 |
| C095324 | ONO-NT 012 | ONO-NT 012 inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 11991626 |
| C016340 | o,p'-DDT | [DDT co-treated with o,p'-DDT] results in decreased expression of NOS2 mRNA | affects cotreatment|decreases expression | 12007859 |
| C016340 | o,p'-DDT | o,p'-DDT results in increased expression of NOS2 | increases expression | 15104118 |
| D016566 | Organoselenium Compounds | Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18538761 |
| C036006 | oxcarbazepine | oxcarbazepine results in increased expression of NOS2 protein | increases expression | 14511393 |
| C119540 | oxodiperoxo(pyridine-2-carboxylate)vanadate(V) | oxodiperoxo(pyridine-2-carboxylate)vanadate(V) results in increased expression of NOS2 protein | increases expression | 11009089 |
| D010126 | Ozone | MT1 protein affects the reaction [Ozone affects the expression of NOS2 protein] | affects expression|affects reaction | 18929643 |
| D010126 | Ozone | MT2 protein affects the reaction [Ozone affects the expression of NOS2 protein] | affects expression|affects reaction | 18929643 |
| D010126 | Ozone | NFKB1 gene mutant form inhibits the reaction [Ozone promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15064226 |
| D010126 | Ozone | NFKB1 gene mutant form inhibits the reaction [Ozone results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15064226 |
| D010126 | Ozone | NFKB1 protein promotes the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | increases chemical synthesis|increases expression|increases reaction | 12162464 |
| D010126 | Ozone | NOS2 protein results in increased susceptibility to Ozone | increases response to substance | 11159012 |
| D010126 | Ozone | Ozone promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein] | affects cotreatment|increases activity|increases reaction | 15064226 |
| D010126 | Ozone | Ozone results in increased expression of NOS2 mRNA | increases expression | 10715624 11159012 |
| D010126 | Ozone | Ozone results in increased expression of NOS2 protein | increases expression | 15064226 11919077 12162464 12855403 |
| D010126 | Ozone | [Ozone results in increased expression of NOS2 protein] which results in increased abundance of Dinoprostone | increases abundance|increases expression | 11919077 |
| D010126 | Ozone | [Ozone results in increased expression of NOS2 protein] which results in increased abundance of Superoxides | increases abundance|increases expression | 11919077 |
| D010126 | Ozone | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 12162464 11919077 |
| D010126 | Ozone | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Peroxynitrous Acid | increases chemical synthesis|increases expression | 11919077 |
| D010126 | Ozone | SOD1 protein inhibits the reaction [Ozone results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12855403 |
| D010126 | Ozone | TLR4 protein affects the reaction [Ozone results in increased expression of NOS2 mRNA] | affects reaction|increases expression | 11159012 |
| D010126 | Ozone | Dexamethasone inhibits the reaction [Ozone results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 8666049 |
| D010126 | Ozone | Endotoxins inhibits the reaction [Ozone results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 8652180 |
| D010126 | Ozone | Endotoxins inhibits the reaction [Ozone results in increased expression of NOS2 protein] | decreases reaction|increases expression | 8652180 |
| D010126 | Ozone | Endotoxins inhibits the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 8652180 |
| D010126 | Ozone | Ozone promotes the reaction [IFNG protein results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 7519435 |
| D010126 | Ozone | Ozone promotes the reaction [IFNG protein results in increased expression of NOS2 protein] | increases expression|increases reaction | 7519435 |
| D010126 | Ozone | Ozone promotes the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide] | increases abundance|increases expression|increases reaction | 7519435 |
| D010126 | Ozone | Ozone promotes the reaction [IL1B protein results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 7519435 |
| D010126 | Ozone | Ozone promotes the reaction [IL1B protein results in increased expression of NOS2 protein] | increases expression|increases reaction | 7519435 |
| D010126 | Ozone | Ozone promotes the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide] | increases abundance|increases expression|increases reaction | 7519435 |
| D010126 | Ozone | Ozone results in decreased expression of NOS2 mRNA | decreases expression | 17662977 |
| D010126 | Ozone | Ozone results in increased expression of NOS2 mRNA | increases expression | 8652180 8666049 9788894 16330353 17662977 7705308 10022268 8600936 |
| D010126 | Ozone | Ozone results in increased expression of NOS2 protein | increases expression | 9788894 8652180 10022268 7705308 |
| D010126 | Ozone | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 9788894 7705308 8652180 10022268 |
| D010126 | Ozone | pyrrolidine dithiocarbamic acid inhibits the reaction [Ozone results in increased expression of NOS2 protein] | decreases reaction|increases expression | 9788894 |
| D010126 | Ozone | pyrrolidine dithiocarbamic acid inhibits the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 9788894 |
| D010126 | Ozone | Ozone results in increased expression of NOS2 protein | increases expression | 10593593 |
| D019308 | Palmitic Acid | Palmitic Acid results in increased expression of NOS2 mRNA | increases expression | 18323514 |
| D019308 | Palmitic Acid | pitavastatin inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18323514 |
| D019308 | Palmitic Acid | Pravastatin inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18323514 |
| D010269 | Paraquat | Paraquat results in increased expression of NOS2 mRNA | increases expression | 17215068 |
| D010269 | Paraquat | Paraquat affects the expression of NOS2 mRNA | affects expression | 12935482 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of NOS2 mRNA | increases expression | 19182107 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of NOS2 mRNA | increases expression | 12396869 |
| C113399 | PD 166866 | PD 166866 inhibits the reaction [FGF1 protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16524372 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [1-bromopropane results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18164123 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Methoxychlor results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15979571 |
| C066957 | pelargonidin | pelargonidin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18274639 |
| C066957 | pelargonidin | pelargonidin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18274639 |
| D010431 | Pentoxifylline | Pentoxifylline inhibits the reaction [Indomethacin results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16133968 |
| D030421 | Peroxynitrous Acid | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Peroxynitrous Acid | increases chemical synthesis|increases expression | 11919077 |
| C118309 | petrosaspongiolide m | petrosaspongiolide m inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12628480 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in decreased expression of NOS2 mRNA | decreases expression | 16373530 |
| D010656 | Phenylephrine | NOS2 protein affects the susceptibility to Phenylephrine | affects response to substance | 11498454 |
| D010656 | Phenylephrine | NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Acetylcholine] | affects cotreatment|affects response to substance | 11498454 |
| D010656 | Phenylephrine | NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Adenosine Diphosphate] | affects cotreatment|affects response to substance | 11498454 |
| D010656 | Phenylephrine | NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Calcimycin] | affects cotreatment|affects response to substance | 11498454 |
| D010656 | Phenylephrine | NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Nitroprusside] | affects cotreatment|affects response to substance | 11498454 |
| D010656 | Phenylephrine | NOS2 protein affects the reaction [[1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one results in decreased activity of GUCA1A protein] which affects the susceptibility to Phenylephrine] | affects reaction|affects response to substance|decreases activity | 15933248 |
| D010656 | Phenylephrine | NOS2 protein results in decreased susceptibility to Phenylephrine | decreases response to substance | 15933248 |
| D010656 | Phenylephrine | NOS2 protein results in decreased susceptibility to Phenylephrine | decreases response to substance | 15902277 |
| D010656 | Phenylephrine | Phenylephrine results in increased activity of NOS2 protein | increases activity | 15753950 |
| D010656 | Phenylephrine | Prazosin inhibits the reaction [Phenylephrine results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15753950 |
| D010656 | Phenylephrine | Prazosin inhibits the reaction [Phenylephrine results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15753950 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18496239 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18496239 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18078833 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 18078833 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15629513 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15629513 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone results in decreased expression of NOS2 protein | decreases expression | 18078833 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone results in increased degradation of NOS2 mRNA | increases degradation | 18078833 |
| C029217 | phenyl-N-tert-butylnitrone | phenyl-N-tert-butylnitrone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| C029217 | phenyl-N-tert-butylnitrone | phenyl-N-tert-butylnitrone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| C029217 | phenyl-N-tert-butylnitrone | phenyl-N-tert-butylnitrone results in decreased expression of NOS2 | decreases expression | 15631943 |
| C004479 | pimagedine | pimagedine inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein] | affects cotreatment|decreases reaction|increases activity | 12892526 |
| C004479 | pimagedine | pimagedine inhibits the reaction [NOS2 protein results in increased susceptibility to Acetaminophen] | decreases reaction|increases response to substance | 14550746 |
| C004479 | pimagedine | pimagedine results in decreased activity of NOS2 protein | decreases activity | 12054156 |
| C004479 | pimagedine | [pimagedine results in decreased activity of NOS2 protein] which results in decreased expression of BCL2 mRNA | decreases activity|decreases expression | 17135264 |
| C004479 | pimagedine | TNFRSF1A protein affects the reaction [pimagedine inhibits the reaction [NOS2 protein results in increased susceptibility to Acetaminophen]] | affects reaction|decreases reaction|increases response to substance | 14550746 |
| C004479 | pimagedine | pimagedine binds to and results in decreased activity of NOS2 protein | affects binding|decreases activity | 9421461 |
| C004479 | pimagedine | pimagedine affects the expression of NOS2 mRNA | affects expression | 17936468 |
| C004479 | pimagedine | pimagedine inhibits the reaction [endotoxin, Escherichia coli results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| C004479 | pimagedine | pimagedine inhibits the reaction [Hydrochloric Acid results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11574821 |
| C004479 | pimagedine | pimagedine inhibits the reaction [Isoproterenol results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18594475 |
| C004479 | pimagedine | pimagedine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| C004479 | pimagedine | pimagedine inhibits the reaction [Sodium Selenite results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19481068 |
| C004479 | pimagedine | pimagedine inhibits the reaction [Sodium Selenite results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19481068 |
| C004479 | pimagedine | pimagedine results in decreased activity of NOS2 protein | decreases activity | 14729435 9306416 |
| C004479 | pimagedine | pimagedine results in decreased expression of NOS2 mRNA | decreases expression | 12473873 |
| C004479 | pimagedine | pimagedine results in decreased expression of NOS2 protein | decreases expression | 12473873 |
| C004479 | pimagedine | pimagedine results in decreased activity of NOS2 protein | decreases activity | 12911628 15976188 18380797 11535926 10574470 10210152 18209962 |
| D020110 | Pinacidil | Glyburide inhibits the reaction [Pinacidil inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases expression | 16257489 |
| D020110 | Pinacidil | Pinacidil inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein] | decreases reaction|increases activity|increases expression | 16257489 |
| C060836 | pioglitazone | pioglitazone results in decreased expression of NOS2 mRNA | decreases expression | 15817521 |
| C060836 | pioglitazone | pioglitazone inhibits the reaction [Endotoxins results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15364003 |
| C006253 | pirinixic acid | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 17891158 |
| C006253 | pirinixic acid | lactacystin inhibits the reaction [pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 17891158 |
| C006253 | pirinixic acid | pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17891158 |
| C006253 | pirinixic acid | pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17891158 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of NOS2 mRNA | decreases expression | 17426115 |
| C006253 | pirinixic acid | pirinixic acid affects the expression of NOS2 mRNA | affects expression | 16912651 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of NOS2 mRNA | decreases expression | 16940010 |
| C108475 | pitavastatin | pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18323514 |
| C108475 | pitavastatin | pitavastatin inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18323514 |
| C108475 | pitavastatin | pitavastatin inhibits the reaction [Poly I-C results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18323514 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Copper results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16962711 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Copper results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16962711 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 20559769 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [TNF protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18841906 |
| D010936 | Plant Extracts | Plant Extracts promotes the reaction [Tamoxifen inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression|increases reaction | 20559769 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of NOS2 mRNA | decreases expression | 16962711 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of NOS2 protein | decreases expression | 16962711 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2] | decreases reaction|increases expression | 16393471 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 12590506 19332304 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19332304 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of NOS2 protein | decreases expression | 16133999 |
| D028321 | Plant Preparations | Plant Preparations results in decreased expression of NOS2 mRNA | decreases expression | 16373530 |
| D028321 | Plant Preparations | Plant Preparations inhibits the reaction [Dimethylnitrosamine results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17724770 |
| D028321 | Plant Preparations | Plant Preparations inhibits the reaction [nitrosobenzylmethylamine results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16510608 |
| D028321 | Plant Preparations | Plant Preparations inhibits the reaction [nitrosobenzylmethylamine results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16510608 |
| D028321 | Plant Preparations | Plant Preparations results in decreased expression of NOS2 mRNA | decreases expression | 16777990 |
| D011070 | Poly I-C | pitavastatin inhibits the reaction [Poly I-C results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18323514 |
| D011070 | Poly I-C | Poly I-C results in increased expression of NOS2 mRNA | increases expression | 17321468 21195166 18323514 |
| D011070 | Poly I-C | Poly I-C results in increased expression of NOS2 protein | increases expression | 17321468 |
| D011070 | Poly I-C | Pravastatin inhibits the reaction [Poly I-C results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18323514 |
| D011070 | Poly I-C | Sodium Selenite inhibits the reaction [Poly I-C results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18279804 |
| D011112 | Polymyxin B | Polymyxin B inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 12568917 |
| C025299 | polyphenols | polyphenols inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| C025299 | polyphenols | polyphenols inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16698588 |
| C025299 | polyphenols | polyphenols inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16698588 |
| D011189 | Potassium Chloride | NOS2 protein affects the susceptibility to Potassium Chloride | affects response to substance | 11498454 |
| D017035 | Pravastatin | Pravastatin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18323514 |
| D017035 | Pravastatin | Pravastatin inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18323514 |
| D017035 | Pravastatin | Pravastatin inhibits the reaction [Poly I-C results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18323514 |
| D011224 | Prazosin | Prazosin inhibits the reaction [Phenylephrine results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15753950 |
| D011224 | Prazosin | Prazosin inhibits the reaction [Phenylephrine results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15753950 |
| C009042 | pristane | pristane results in increased expression of NOS2 mRNA | increases expression | 15075356 |
| D011374 | Progesterone | NOS2 protein affects the susceptibility to Progesterone | affects response to substance | 15869954 |
| D011374 | Progesterone | Progesterone results in decreased expression of NOS2 mRNA | decreases expression | 16399999 |
| D011411 | Propanil | Propanil inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17355946 |
| D015742 | Propofol | Propofol inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19573522 |
| D015742 | Propofol | Propofol inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19573522 |
| D015232 | Dinoprostone | NOS2 protein promotes the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone] | increases abundance|increases expression|increases reaction | 16325209 |
| D015232 | Dinoprostone | [Ozone results in increased expression of NOS2 protein] which results in increased abundance of Dinoprostone | increases abundance|increases expression | 11919077 |
| D011509 | Proteoglycans | NOS2 protein affects the reaction [Zymosan inhibits the reaction [IGF1 protein results in increased metabolism of Proteoglycans]] | affects reaction|decreases reaction|increases metabolic processing | 16646036 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12879239 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 8662662 11530235 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17342418 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Ozone results in increased expression of NOS2 protein] | decreases reaction|increases expression | 9788894 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 9788894 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid results in decreased expression of NOS2 mRNA | decreases expression | 17416599 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [ferric nitrilotriacetate results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11340304 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [ferric nitrilotriacetate results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11340304 |
| D011794 | Quercetin | Quercetin results in decreased expression of NOS2 mRNA | decreases expression | 17184768 |
| D011794 | Quercetin | Quercetin results in decreased expression of NOS2 protein | decreases expression | 12144868 17184768 |
| D011794 | Quercetin | [3,5-dimethoxy-4'-hydroxystilbene co-treated with Quercetin] results in decreased expression of NOS2 mRNA | affects cotreatment|decreases expression | 17135264 |
| D011794 | Quercetin | Hemin promotes the reaction [Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 14563492 |
| D011794 | Quercetin | HMOX1 protein promotes the reaction [Quercetin inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases reaction | 14563492 |
| D011794 | Quercetin | Quercetin inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16171798 |
| D011794 | Quercetin | Quercetin inhibits the reaction [IFNG protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16171798 |
| D011794 | Quercetin | Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19352036 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 12619901 16171798 18274639 17177504 11518563 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12512693 11500931 14563492 15831208 11518563 18274639 16171798 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11518563 11500931 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Zymosan results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17651994 |
| D011794 | Quercetin | Quercetin results in decreased expression of NOS2 mRNA | decreases expression | 17135264 |
| D011794 | Quercetin | [Quercetin results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA] | decreases expression|decreases reaction|increases expression | 17135264 |
| D011794 | Quercetin | tin protoporphyrin IX inhibits the reaction [Quercetin inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 14563492 |
| D011794 | Quercetin | Quercetin results in decreased expression of NOS2 mRNA | decreases expression | 19207477 |
| D011794 | Quercetin | Quercetin results in decreased expression of NOS2 protein | decreases expression | 19207477 |
| D011794 | Quercetin | Quercetin affects the expression of NOS2 protein | affects expression | 15476665 |
| D011794 | Quercetin | Quercetin inhibits the reaction [17-(allylamino)-17-demethoxygeldanamycin results in decreased expression of NOS2 mRNA] | decreases expression|decreases reaction | 11835313 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Cadmium results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16226777 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12741479 |
| D011794 | Quercetin | Quercetin inhibits the reaction [geldanamycin results in decreased expression of NOS2 mRNA] | decreases expression|decreases reaction | 11835313 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18090225 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 18090225 |
| D011794 | Quercetin | Quercetin inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15930438 |
| D011794 | Quercetin | Quercetin inhibits the reaction [IL1B protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15930438 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 14700523 |
| C523166 | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18716446 15896337 |
| C523166 | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18716446 15896337 |
| C435940 | quercetin pentaacetate | quercetin pentaacetate inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11500931 |
| C435940 | quercetin pentaacetate | quercetin pentaacetate inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11500931 |
| D020849 | Raloxifene | Carrageenan inhibits the reaction [Raloxifene results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15860553 |
| D011899 | Ranitidine | Ranitidine inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 16169175 |
| D017382 | Reactive Oxygen Species | [TNF protein results in increased abundance of Reactive Oxygen Species] which results in increased activity of NOS2 protein | increases abundance|increases activity | 7532384 |
| D017382 | Reactive Oxygen Species | [TNF protein results in increased abundance of Reactive Oxygen Species] which results in increased expression of NOS2 mRNA | increases abundance|increases expression | 7532384 |
| C052785 | rebamipide | rebamipide inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 11686837 |
| C052785 | rebamipide | rebamipide results in increased expression of NOS2 mRNA | increases expression | 15104358 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of NOS2 protein] | decreases expression|decreases reaction | 16116226 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16183991 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15589480 |
| C059514 | resveratrol | fulvestrant inhibits the reaction [resveratrol results in increased activity of NOS2 protein] | decreases reaction|increases activity | 17666920 |
| C059514 | resveratrol | resveratrol affects the activity of NOS2 protein | affects activity | 17923197 |
| C059514 | resveratrol | resveratrol inhibits the reaction [APP protein results in increased expression of and results in increased activity of NOS2 protein] | decreases reaction|increases activity|increases expression | 16685418 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Diethylnitrosamine results in increased expression of NOS2 protein] | decreases reaction|increases expression | 20501860 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| C059514 | resveratrol | resveratrol inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16178859 |
| C059514 | resveratrol | resveratrol results in decreased expression of NOS2 mRNA | decreases expression | 17600658 17416599 |
| C059514 | resveratrol | resveratrol results in decreased expression of NOS2 protein | decreases expression | 17600658 |
| C059514 | resveratrol | resveratrol results in increased activity of NOS2 protein | increases activity | 17666920 |
| C059514 | resveratrol | resveratrol results in increased expression of NOS2 protein | increases expression | 15905131 16456233 |
| C089032 | rimonabant | [rimonabant co-treated with SR 144528] inhibits the reaction [OMDM-1 cpd inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | affects cotreatment|decreases reaction|increases expression | 15748152 |
| D020889 | Rolipram | Rolipram inhibits the reaction [Cyclophosphamide results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18710439 |
| D020889 | Rolipram | Rolipram inhibits the reaction [Cyclophosphamide results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18710439 |
| C089730 | rosiglitazone | rosiglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11343698 |
| D012402 | Rotenone | 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases expression | 16257489 |
| D012402 | Rotenone | 5-hydroxydecanoic acid inhibits the reaction [N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases expression | 16257489 |
| D012402 | Rotenone | Diazoxide inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein] | decreases reaction|increases activity|increases expression | 16257489 |
| D012402 | Rotenone | Glyburide inhibits the reaction [Pinacidil inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein]] | decreases reaction|increases activity|increases expression | 16257489 |
| D012402 | Rotenone | N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein] | decreases reaction|increases activity|increases expression | 16257489 |
| D012402 | Rotenone | Pinacidil inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein] | decreases reaction|increases activity|increases expression | 16257489 |
| D012402 | Rotenone | Rotenone results in increased expression of and results in increased activity of NOS2 protein | increases activity|increases expression | 16257489 |
| D012402 | Rotenone | 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Rotenone results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 15795934 15927086 |
| D012402 | Rotenone | 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression | 15795934 15927086 |
| D012402 | Rotenone | 5-hydroxydecanoic acid inhibits the reaction [N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 15927086 15795934 |
| D012402 | Rotenone | 5-hydroxydecanoic acid inhibits the reaction [N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression | 15927086 15795934 |
| D012402 | Rotenone | Diazoxide inhibits the reaction [Rotenone results in increased activity of NOS2 protein] | decreases reaction|increases activity | 15927086 15795934 |
| D012402 | Rotenone | Diazoxide inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15927086 15795934 |
| D012402 | Rotenone | N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased activity of NOS2 protein] | decreases reaction|increases activity | 15927086 15795934 |
| D012402 | Rotenone | N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15795934 15927086 |
| D012402 | Rotenone | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Rotenone] | decreases reaction|increases activity|increases chemical synthesis | 7532384 |
| D012402 | Rotenone | Rotenone inhibits the reaction [IL1B protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 8662662 |
| D012402 | Rotenone | Rotenone inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11530235 |
| D012402 | Rotenone | Rotenone inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 7532384 |
| D012402 | Rotenone | Rotenone inhibits the reaction [TNF protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 7532384 |
| D012402 | Rotenone | Rotenone results in increased activity of NOS2 protein | increases activity | 15927086 |
| D012402 | Rotenone | Rotenone results in increased expression of NOS2 mRNA | increases expression | 15795934 15927086 15135310 |
| D012402 | Rotenone | Rotenone results in increased expression of NOS2 protein | increases expression | 15795934 |
| D015575 | Roxithromycin | Roxithromycin inhibits the reaction [Mustard Gas results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17524151 |
| D012431 | Rutin | Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11500931 12512693 |
| D012431 | Rutin | Rutin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11500931 |
| C065299 | S-allylcysteine | S-allylcysteine inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2] | decreases reaction|increases expression | 16614485 |
| D012503 | Saponins | Saponins inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| D012503 | Saponins | Saponins inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 14734799 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11518563 14734799 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 11518563 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Methoxychlor results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15979571 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [S100B protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16376947 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [S100B protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16376947 |
| C093642 | SB 203580 | SB 203580 results in increased degradation of NOS2 mRNA | increases degradation | 11518563 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12911628 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| C093642 | SB 203580 | SB 203580 results in decreased expression of NOS2 mRNA | decreases expression | 17368305 |
| C093642 | SB 203580 | SB 203580 results in decreased expression of NOS2 protein | decreases expression | 17368305 |
| C484876 | scutellarin | scutellarin results in decreased expression of NOS2 protein | decreases expression | 16297343 |
| D012643 | Selenium | Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17630198 |
| D012643 | Selenium | [Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]] which results in decreased chemical synthesis of Nitric Oxide | decreases chemical synthesis|decreases reaction|increases expression | 17630198 |
| D012643 | Selenium | Selenium inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 14734799 |
| D012643 | Selenium | Selenium inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 14734799 |
| C016727 | sepiapterin | sepiapterin inhibits the reaction [NOS2 protein results in decreased susceptibility to Acetylcholine] | decreases reaction|decreases response to substance | 15933248 |
| C042431 | S-ethyl glutathione | S-ethyl glutathione inhibits the reaction [Acetaminophen inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression | 12774022 |
| C040115 | shogaol | shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18683823 |
| C040115 | shogaol | shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18683823 |
| C040115 | shogaol | shogaol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18683823 |
| C120147 | SIB 1757 | SIB 1757 inhibits the reaction [Acetaminophen results in increased activity of NOS2 protein] | decreases reaction|increases activity | 12547406 |
| C120148 | SIB 1893 | SIB 1893 inhibits the reaction [Acetaminophen results in increased activity of NOS2 protein] | decreases reaction|increases activity | 12547406 |
| C440975 | silybin | silybin results in decreased expression of NOS2 protein | decreases expression | 16788158 |
| D012838 | Silymarin | Silymarin inhibits the reaction [Dimethylnitrosamine results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16604421 17724770 |
| D019821 | Simvastatin | Simvastatin promotes the reaction [Doxorubicin results in increased expression of NOS2 protein] | increases expression|increases reaction | 18463201 |
| D019821 | Simvastatin | Simvastatin results in increased expression of NOS2 protein | increases expression | 18463201 |
| C073734 | sinapinic acid | sinapinic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18841975 |
| C073734 | sinapinic acid | sinapinic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18841975 |
| C027744 | S-methylisothiopseudouronium | S-methylisothiopseudouronium analog inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16874658 |
| C027744 | S-methylisothiopseudouronium | S-methylisothiopseudouronium analog inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16874658 |
| C027744 | S-methylisothiopseudouronium | S-methylisothiopseudouronium inhibits the reaction [NOS2 protein results in increased phosphorylation of and results in increased activity of PEPD protein] | decreases reaction|increases activity|increases phosphorylation | 16167338 |
| C027744 | S-methylisothiopseudouronium | S-methylisothiopseudouronium affects the expression of NOS2 mRNA | affects expression | 15772520 |
| C027744 | S-methylisothiopseudouronium | S-methylisothiopseudouronium inhibits the reaction [Amphetamine results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18524487 |
| C027744 | S-methylisothiopseudouronium | S-methylisothiopseudouronium inhibits the reaction [Hydrochloric Acid results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18573544 |
| C027744 | S-methylisothiopseudouronium | S-methylisothiopseudouronium inhibits the reaction [Isoflurane results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18708911 |
| C027744 | S-methylisothiopseudouronium | S-methylisothiopseudouronium inhibits the reaction [Sucralfate results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18573544 |
| C027744 | S-methylisothiopseudouronium | S-methylisothiopseudouronium results in decreased activity of NOS2 protein | decreases activity | 10554365 |
| C027744 | S-methylisothiopseudouronium | S-methylisothiopseudouronium results in decreased expression of NOS2 mRNA | decreases expression | 15363445 |
| C009277 | sodium arsenate | sodium arsenate inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| C017947 | sodium arsenite | sodium arsenite affects the expression of NOS2 mRNA | affects expression | 20339924 |
| C017947 | sodium arsenite | sodium arsenite inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| D012980 | Sodium Salicylate | Sodium Salicylate results in decreased expression of NOS2 protein | decreases expression | 10860828 |
| D012980 | Sodium Salicylate | [Sodium Salicylate results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide | decreases chemical synthesis|decreases expression | 10860828 |
| D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18279804 |
| D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [Poly I-C results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18279804 |
| D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [Streptozocin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18789669 |
| D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [Streptozocin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18789669 |
| D018038 | Sodium Selenite | Curcumin inhibits the reaction [Sodium Selenite results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19481068 |
| D018038 | Sodium Selenite | Curcumin inhibits the reaction [Sodium Selenite results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19481068 |
| D018038 | Sodium Selenite | pimagedine inhibits the reaction [Sodium Selenite results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19481068 |
| D018038 | Sodium Selenite | pimagedine inhibits the reaction [Sodium Selenite results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19481068 |
| D018038 | Sodium Selenite | Sodium Selenite results in increased expression of NOS2 mRNA | increases expression | 19481068 |
| D018038 | Sodium Selenite | Sodium Selenite results in increased expression of NOS2 protein | increases expression | 19481068 |
| C110630 | SR 144528 | [rimonabant co-treated with SR 144528] inhibits the reaction [OMDM-1 cpd inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | affects cotreatment|decreases reaction|increases expression | 15748152 |
| C530804 | S,S'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea | S,S'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea results in increased expression of and results in increased activity of NOS2 protein | increases activity|increases expression | 19497413 |
| C118852 | S,S'-1,4-phenylene-bis(1,2-ethanediyl)bis-isothiourea | S,S'-1,4-phenylene-bis(1,2-ethanediyl)bis-isothiourea results in increased expression of and results in increased activity of NOS2 protein | increases activity|increases expression | 19497413 |
| D019311 | Staurosporine | Staurosporine inhibits the reaction [ginsenoside Rg3 results in increased expression of NOS2 protein] | decreases reaction|increases expression | 14534150 |
| D013311 | Streptozocin | Sodium Selenite inhibits the reaction [Streptozocin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18789669 |
| D013311 | Streptozocin | Sodium Selenite inhibits the reaction [Streptozocin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18789669 |
| D013311 | Streptozocin | Streptozocin results in increased activity of NOS2 protein | increases activity | 18789669 |
| D013311 | Streptozocin | Streptozocin results in increased expression of NOS2 mRNA | increases expression | 18789669 |
| D013311 | Streptozocin | Streptozocin results in increased expression of NOS2 protein | increases expression | 16309587 |
| C116890 | SU 5416 | SU 5416 results in increased expression of NOS2 protein | increases expression | 15331199 |
| D013392 | Sucralfate | S-methylisothiopseudouronium inhibits the reaction [Sucralfate results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18573544 |
| D013392 | Sucralfate | Sucralfate results in increased expression of NOS2 protein | increases expression | 18573544 |
| D012460 | Sulfasalazine | Sulfasalazine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16934226 |
| C016766 | sulforafan | sulforafan inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | decreases reaction|increases activity | 18838692 |
| C009354 | sulglicotide | sulglicotide inhibits the reaction [Indomethacin results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17657623 |
| D013481 | Superoxides | [Ozone results in increased expression of NOS2 protein] which results in increased abundance of Superoxides | increases abundance|increases expression | 11919077 |
| C029222 | sym-trinitrobenzene | Eicosapentaenoic Acid analog inhibits the reaction [sym-trinitrobenzene results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15890784 |
| C029222 | sym-trinitrobenzene | sym-trinitrobenzene results in increased expression of NOS2 mRNA | increases expression | 15890784 |
| D016559 | Tacrolimus | Tacrolimus inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17202747 |
| D013629 | Tamoxifen | Plant Extracts promotes the reaction [Tamoxifen inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression|increases reaction | 20559769 |
| D013629 | Tamoxifen | Tamoxifen inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 20559769 |
| D013629 | Tamoxifen | Tamoxifen inhibits the reaction [Estradiol results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17873880 |
| C001803 | tempol | tempol inhibits the reaction [copper histidine results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16987042 |
| C001803 | tempol | tempol inhibits the reaction [Copper results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16987042 |
| C480848 | tephrosin | tephrosin inhibits the reaction [TNF protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18841906 |
| D020002 | tert-Butyl Alcohol | tert-Butyl Alcohol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 10231168 |
| D020002 | tert-Butyl Alcohol | tert-Butyl Alcohol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 10231168 |
| C038096 | tert-butylcatechol | tert-butylcatechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18499097 |
| C038096 | tert-butylcatechol | tert-butylcatechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18499097 |
| D013749 | Tetrachlorodibenzodioxin | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11007951 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NOS2 mRNA | increases expression | 11007951 |
| D013755 | Tetradecanoylphorbol Acetate | Plant Extracts inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 20559769 |
| D013755 | Tetradecanoylphorbol Acetate | Plant Extracts promotes the reaction [Tamoxifen inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression|increases reaction | 20559769 |
| D013755 | Tetradecanoylphorbol Acetate | Tamoxifen inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 20559769 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA | increases expression | 20559769 |
| D013755 | Tetradecanoylphorbol Acetate | gingerol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18683823 |
| D013755 | Tetradecanoylphorbol Acetate | honokiol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19539808 |
| D013755 | Tetradecanoylphorbol Acetate | shogaol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18683823 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein | increases expression | 19539808 18683823 |
| D013755 | Tetradecanoylphorbol Acetate | [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 14700523 |
| D013755 | Tetradecanoylphorbol Acetate | Quercetin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 14700523 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate inhibits the reaction [ginsenoside Rg3 results in increased expression of NOS2 protein] | decreases reaction|increases expression | 14534150 |
| D013755 | Tetradecanoylphorbol Acetate | wogonin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 14700523 |
| D013792 | Thalidomide | Thalidomide inhibits the reaction [Dimethylnitrosamine results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16604421 |
| D013806 | Theophylline | Theophylline inhibits the reaction [Indomethacin results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16133968 |
| C030950 | thiaton | thiaton inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 11855677 |
| D013853 | Thioacetamide | calpain inhibitor III inhibits the reaction [Thioacetamide results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15316131 |
| D013853 | Thioacetamide | CYP2E1 protein affects the reaction [Thioacetamide results in increased expression of NOS2 protein] | affects reaction|increases expression | 18374380 |
| D013853 | Thioacetamide | POMC protein alternative form inhibits the reaction [Thioacetamide results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 15313186 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of NOS2 mRNA | increases expression | 15316131 15313186 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of NOS2 protein | increases expression | 15158337 18374380 |
| D013853 | Thioacetamide | Thioacetamide results in decreased expression of NOS2 mRNA | decreases expression | 19784758 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of NOS2 mRNA | increases expression | 15135310 |
| D013874 | Thiopental | Thiopental promotes the reaction [IL1B protein results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 9436821 |
| D013874 | Thiopental | Thiopental promotes the reaction [IL1B protein results in increased expression of NOS2 protein] | increases expression|increases reaction | 9436821 |
| D013890 | Thiourea | Thiourea analog results in decreased expression of NOS2 mRNA | decreases expression | 17467989 |
| D013890 | Thiourea | Thiourea analog results in decreased expression of NOS2 protein | decreases expression | 17467989 |
| D013890 | Thiourea | [Thiourea analog results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide | decreases chemical synthesis|decreases expression | 17467989 |
| C055421 | tin mesoporphyrin | tin mesoporphyrin inhibits the reaction [IL11 protein inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression | 16964402 |
| C032628 | tin protoporphyrin IX | tin protoporphyrin IX inhibits the reaction [3-hydroxyflavone inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 14563492 |
| C032628 | tin protoporphyrin IX | tin protoporphyrin IX inhibits the reaction [baicalein inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 14563492 |
| C032628 | tin protoporphyrin IX | tin protoporphyrin IX inhibits the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 14563492 |
| C032628 | tin protoporphyrin IX | tin protoporphyrin IX inhibits the reaction [Quercetin inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] | decreases reaction|increases activity | 14563492 |
| D008625 | Tiopronin | Tiopronin affects the expression of NOS2 mRNA | affects expression | 15834306 |
| D014051 | Toluene 2,4-Diisocyanate | Toluene 2,4-Diisocyanate results in increased expression of NOS2 protein | increases expression | 12974195 |
| C052342 | topiramate | topiramate results in increased expression of NOS2 protein | increases expression | 14511393 |
| D014107 | Tosyllysine Chloromethyl Ketone | Tosyllysine Chloromethyl Ketone inhibits the reaction [S100B protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16376947 |
| D014107 | Tosyllysine Chloromethyl Ketone | Tosyllysine Chloromethyl Ketone inhibits the reaction [S100B protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16376947 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18449507 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18449507 |
| D014196 | Trazodone | Trazodone inhibits the reaction [endotoxin, Escherichia coli results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| D014196 | Trazodone | Trazodone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| C046498 | tricyclodecane-9-yl-xanthogenate | tricyclodecane-9-yl-xanthogenate inhibits the reaction [JBT-3002 results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 11404395 |
| C046498 | tricyclodecane-9-yl-xanthogenate | tricyclodecane-9-yl-xanthogenate inhibits the reaction [JBT-3002 results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11404395 |
| D014280 | Triglycerides | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Triglycerides promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 18710323 |
| D014280 | Triglycerides | Acetylcysteine inhibits the reaction [Triglycerides results in decreased expression of NOS2 mRNA] | decreases expression|decreases reaction | 16140881 |
| D014280 | Triglycerides | Acetylcysteine inhibits the reaction [Triglycerides results in decreased expression of NOS2 protein] | decreases expression|decreases reaction | 16140881 |
| D014280 | Triglycerides | Triglycerides promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 18710323 |
| D014280 | Triglycerides | Triglycerides results in decreased expression of NOS2 mRNA | decreases expression | 16140881 |
| D014280 | Triglycerides | Triglycerides results in decreased expression of NOS2 protein | decreases expression | 16140881 |
| D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA | increases expression | 17982090 |
| D014302 | Trinitrobenzenesulfonic Acid | montelukast inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11698051 |
| D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein | increases expression | 17276891 11698051 |
| D014307 | Trioxsalen | Buthionine Sulfoximine promotes the reaction [Trioxsalen analog results in decreased expression of NOS2 mRNA] | decreases expression|increases reaction | 16259964 |
| D014307 | Trioxsalen | Trioxsalen analog inhibits the reaction [IFNG protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16259964 |
| D014307 | Trioxsalen | Trioxsalen analog results in decreased expression of NOS2 mRNA | decreases expression | 16259964 |
| D014331 | Tropicamide | Tropicamide inhibits the reaction [Mevinphos results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17395621 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D014520 | Urethane | Urethane results in decreased expression of NOS2 mRNA | decreases expression | 11211925 |
| D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NOS2 protein] | decreases expression|decreases reaction | 18590720 |
| C073339 | usnic acid | usnic acid inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | decreases reaction|increases activity | 16169175 |
| D014639 | Vanadium | Vanadium inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18155637 |
| D017968 | Vanadium Compounds | Vanadium Compounds results in increased expression of NOS2 mRNA | increases expression | 11114790 |
| C522219 | Vaticanol B | Vaticanol B inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17475668 |
| C025643 | vinclozolin | vinclozolin results in increased expression of NOS2 mRNA | increases expression | 18629315 |
| C085514 | wogonin | wogonin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17570322 |
| C085514 | wogonin | wogonin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17570322 |
| C085514 | wogonin | wogonin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17570322 |
| C085514 | wogonin | wogonin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17570322 |
| C085514 | wogonin | wogonin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 14700523 |
| C009687 | wortmannin | carvedilol promotes the reaction [wortmannin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | decreases reaction|increases expression|increases reaction | 17159805 |
| C009687 | wortmannin | wortmannin inhibits the reaction [EDN1 protein inhibits the reaction [TNF protein results in increased expression of NOS2 protein]] | decreases reaction|increases expression | 12839867 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17159805 |
| D015016 | Yohimbine | Yohimbine inhibits the reaction [endotoxin, Escherichia coli results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| D015016 | Yohimbine | Yohimbine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17637181 |
| C011145 | zaprinast | zaprinast inhibits the reaction [TNF protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16754782 |
| C088450 | ZM 230487 | ZM 230487 inhibits the reaction [[Zymosan results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitrites] | decreases reaction|increases chemical synthesis|increases expression | 11454666 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of NOS2 protein | increases expression | 19818098 |
| C088658 | zoledronic acid | [zoledronic acid results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 19818098 |
| C022189 | zonisamide | zonisamide results in increased expression of NOS2 mRNA | increases expression | 12429386 |
| D015054 | Zymosan | Morphine inhibits the reaction [Zymosan results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18760300 |
| D015054 | Zymosan | Zymosan results in increased expression of NOS2 mRNA | increases expression | 18760300 17988736 |
| D015054 | Zymosan | 3-methylsydnone-5-nitrosimine inhibits the reaction [NOS2 gene mutant form results in decreased susceptibility to Zymosan] | decreases reaction|decreases response to substance | 10964977 |
| D015054 | Zymosan | 4-dimethylamino-3',4'-dimethoxychalcone inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases reaction|increases expression | 11134894 |
| D015054 | Zymosan | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12628480 12721113 |
| D015054 | Zymosan | bolinaquinone inhibits the reaction [Zymosan results in increased activity of NOS2 protein] | decreases reaction|increases activity | 12604694 |
| D015054 | Zymosan | cacospongionolide B inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12721113 |
| D015054 | Zymosan | Dexamethasone inhibits the reaction [Zymosan results in increased activity of NOS2 protein] | decreases reaction|increases activity | 12604694 |
| D015054 | Zymosan | Dexamethasone inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12628480 11454666 |
| D015054 | Zymosan | diarctigenin inhibits the reaction [Zymosan results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 18694995 |
| D015054 | Zymosan | diarctigenin inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases reaction|increases expression | 18694995 |
| D015054 | Zymosan | Drugs, Chinese Herbal inhibits the reaction [Zymosan results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17996413 |
| D015054 | Zymosan | Leukotriene B4 inhibits the reaction [[Zymosan results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitrites] | decreases reaction|increases chemical synthesis|increases expression | 11454666 |
| D015054 | Zymosan | Leukotriene C4 inhibits the reaction [[Zymosan results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitrites] | decreases reaction|increases chemical synthesis|increases expression | 11454666 |
| D015054 | Zymosan | NOS2 protein affects the reaction [Zymosan inhibits the reaction [IGF1 protein results in increased metabolism of Proteoglycans]] | affects reaction|decreases reaction|increases metabolic processing | 16646036 |
| D015054 | Zymosan | NOS2 protein affects the susceptibility to Zymosan | affects response to substance | 10964977 |
| D015054 | Zymosan | petrosaspongiolide m inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12628480 |
| D015054 | Zymosan | pyrrolidine dithiocarbamic acid inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases reaction|increases expression | 12879239 |
| D015054 | Zymosan | Quercetin inhibits the reaction [Zymosan results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 17651994 |
| D015054 | Zymosan | SPP1 gene alternative form affects the reaction [Zymosan results in increased expression of NOS2 mRNA] | affects reaction|increases expression | 14742262 |
| D015054 | Zymosan | TNFRSF1A gene mutant form inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | decreases reaction|increases expression | 17724436 |
| D015054 | Zymosan | ZM 230487 inhibits the reaction [[Zymosan results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitrites] | decreases reaction|increases chemical synthesis|increases expression | 11454666 |
| D015054 | Zymosan | Zymosan results in increased activity of NOS2 protein | increases activity | 12604694 |
| D015054 | Zymosan | Zymosan results in increased expression of NOS2 mRNA | increases expression | 17651994 18323514 10964977 12794164 17321468 17996413 12130978 18694995 |
| D015054 | Zymosan | Zymosan results in increased expression of NOS2 protein | increases expression | 17321468 12879239 17724436 18694995 12130978 12628480 11134894 12721113 |
| D015054 | Zymosan | [Zymosan results in increased expression of NOS2 protein] which results in increased abundance of Nitrites | increases abundance|increases expression | 11454666 |
| D015054 | Zymosan | Zymosan results in increased expression of NOS2 mRNA | increases expression | 15135310 11289658 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 2.95 | 14745880 | |
| MESH:D015746 | Abdominal Pain | SU 5416 | 5.60 | 12673719 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Capsaicin | 16.85 | 18926900 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Carbamazepine | 16.85 | 8986270 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Disulfiram | 16.85 | 17676605 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Ethanol | 16.85 | 17676605 18926900 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Methotrexate | 16.85 | 12039119 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 16.85 | 14514962 11752688 15322242 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Thalidomide | 16.85 | 8333272 | |
| MESH:D000038 | Abscess | Drugs, Chinese Herbal | 4.70 | 15043669 | |
| MESH:D000138 | Acidosis | Ammonium Chloride | 8.92 | 18287403 | |
| MESH:D000138 | Acidosis | Ethanol | 8.92 | 11192467 | |
| MESH:D000138 | Acidosis | Hydrochloric Acid | 8.92 | 12771618 20872349 16144966 11574821 15920416 19262391 | |
| MESH:D000141 | Acidosis, Renal Tubular | Hydrochloric Acid | 4.21 | 17183249 | |
| MESH:D000142 | Acidosis, Respiratory | Hydrochloric Acid | 4.21 | 20597076 | |
| MESH:D000163 | Acquired Immunodeficiency Syndrome | Disulfiram | 4.02 | 9207937 | |
| MESH:D000168 | Acrocephalosyndactylia | U 0126 | 3.93 | 17694057 | |
| MESH:D058186 | Acute Kidney Injury | Capsaicin | 21.98 | 18460982 | |
| MESH:D058186 | Acute Kidney Injury | Diclofenac | 21.98 | 7897758 | |
| MESH:D058186 | Acute Kidney Injury | Gentamicins | 21.98 | 11274264 | |
| MESH:D058186 | Acute Kidney Injury | Ibuprofen | 21.98 | 6375363 | |
| MESH:D058186 | Acute Kidney Injury | Mercuric Chloride | 21.98 | 11274264 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 21.98 | 16538975 | |
| MESH:D058186 | Acute Kidney Injury | Superoxides | 21.98 | 18460982 | |
| MESH:D058186 | Acute Kidney Injury | zoledronic acid | 21.98 | 19715164 | |
| MESH:D055371 | Acute Lung Injury | 3-xylene | 20.44 | 15204773 | |
| MESH:D055371 | Acute Lung Injury | Bleomycin | 20.44 | 17118201 | |
| MESH:D055371 | Acute Lung Injury | Hydrochloric Acid | 20.44 | 16759491 19760209 19060228 11953099 19094174 15970105 11850527 | |
| MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 20.44 | 11850527 18653653 | |
| MESH:D055371 | Acute Lung Injury | nickel sulfate | 20.44 | 19131640 16100012 11954676 12718980 | |
| MESH:D055371 | Acute Lung Injury | Particulate Matter | 20.44 | 12396868 | |
| MESH:D055371 | Acute Lung Injury | pirinixic acid | 20.44 | 18653653 | |
| MESH:D000210 | Acute-Phase Reaction | zoledronic acid | 3.91 | 20200999 | |
| MESH:D000230 | Adenocarcinoma | 1,2-Dimethylhydrazine | 22.28 | 1933837 1113308 | |
| MESH:D000230 | Adenocarcinoma | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | 22.28 | 17363558 | |
| MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 22.28 | 20127859 20464547 | |
| MESH:D000230 | Adenocarcinoma | daidzein | 22.28 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Dimethylnitrosamine | 22.28 | 16033868 | |
| MESH:D000230 | Adenocarcinoma | Doxorubicin | 22.28 | 17418594 | |
| MESH:D000230 | Adenocarcinoma | Estradiol | 22.28 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Fluorouracil | 22.28 | 17638652 | |
| MESH:D000230 | Adenocarcinoma | Genistein | 22.28 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ibuprofen | 22.28 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Indomethacin | 22.28 | 16537180 | |
| MESH:D000230 | Adenocarcinoma | Methylnitrosourea | 22.28 | 15688392 15113128 | |
| MESH:D000230 | Adenocarcinoma | Urethane | 22.28 | 18316556 | |
| MESH:D002282 | Adenocarcinoma, Bronchiolo-Alveolar | Urethane | 4.11 | 15814487 | |
| MESH:D000236 | Adenoma | Benzo(a)pyrene | 19.66 | 6695378 | |
| MESH:D000236 | Adenoma | beta-Naphthoflavone | 19.66 | 19389873 | |
| MESH:D000236 | Adenoma | Diethylnitrosamine | 19.66 | 10737359 6695378 | |
| MESH:D000236 | Adenoma | Dimethylnitrosamine | 19.66 | 19555203 | |
| MESH:D000236 | Adenoma | Indomethacin | 19.66 | 11497255 | |
| MESH:D000236 | Adenoma | Magnesium | 19.66 | 17823441 | |
| MESH:D000236 | Adenoma | Melatonin | 19.66 | 17195641 | |
| MESH:D000236 | Adenoma | resveratrol | 19.66 | 15688382 | |
| MESH:D000236 | Adenoma | Urethane | 19.66 | 16926031 6695378 11497255 17093202 10822126 17195641 10530776 | |
| MESH:D018248 | Adenoma, Liver Cell | DDT | 12.28 | 12597452 | |
| MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 12.28 | 19052882 18056438 19061943 17162532 16434500 17620307 | |
| MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 12.28 | 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 12.28 | 16835633 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Dinoprostone | 8.34 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Leukotriene B4 | 8.34 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | sulforafan | 8.34 | 17942926 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 3.10 | 15276417 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 3.30 | 17306315 16712894 | |
| MESH:D000382 | Agricultural Workers' Diseases | alachlor | 8.13 | 14769641 11874814 | |
| MESH:D000382 | Agricultural Workers' Diseases | DDT | 8.13 | 16487989 12584743 | |
| MESH:D000382 | Agricultural Workers' Diseases | Dichlorodiphenyl Dichloroethylene | 8.13 | 16487989 | |
| MESH:D000382 | Agricultural Workers' Diseases | Paraquat | 8.13 | 11874814 | |
| MESH:D000419 | Albuminuria | Doxorubicin | 6.40 | 21441931 | |
| MESH:D000419 | Albuminuria | Raloxifene | 6.40 | 17308373 17451421 | |
| MESH:D020268 | Alcohol-Induced Disorders, Nervous System | Ethanol | 3.71 | 15451039 15451040 | |
| MESH:D000437 | Alcoholism | Disulfiram | 5.55 | 10841824 18968458 17079463 | |
| MESH:D000437 | Alcoholism | topiramate | 5.55 | 18552399 19331489 17925516 | |
| MESH:D019973 | Alcohol-Related Disorders | Curcumin | 3.48 | 17887948 | |
| OMIM:607154 | ALLERGIC RHINITIS | fexofenadine | 4.29 | 16037679 | |
| MESH:D000505 | Alopecia | Capsaicin | 3.38 | 17569567 | |
| MESH:D019896 | alpha 1-Antitrypsin Deficiency | Iron | 4.07 | 16640825 | |
| MESH:D016301 | Alveolar Bone Loss | Indomethacin | 3.77 | 17225004 | |
| MESH:D000544 | Alzheimer Disease | 27-hydroxycholesterol | 33.46 | 14523054 20157255 | |
| MESH:D000544 | Alzheimer Disease | Aluminum | 33.46 | 10721010 17662457 | |
| MESH:D000544 | Alzheimer Disease | bis(4-hydroxycinnamoyl)methane | 33.46 | 19090986 | |
| MESH:D000544 | Alzheimer Disease | Copper | 33.46 | 16886094 17119284 16325427 16962711 16866297 16410023 | |
| MESH:D000544 | Alzheimer Disease | Curcumin | 33.46 | 15590663 | |
| MESH:D000544 | Alzheimer Disease | Ibuprofen | 33.46 | 18351690 | |
| MESH:D000544 | Alzheimer Disease | icariin | 33.46 | 19858766 19782061 | |
| MESH:D000544 | Alzheimer Disease | Indomethacin | 33.46 | 15579461 17627676 | |
| MESH:D000544 | Alzheimer Disease | Iron | 33.46 | 16640825 16563566 | |
| MESH:D000544 | Alzheimer Disease | Nicotine | 33.46 | 16627626 | |
| MESH:D000544 | Alzheimer Disease | Nitric Oxide | 33.46 | 17556102 | |
| MESH:D000544 | Alzheimer Disease | Ozone | 33.46 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Particulate Matter | 33.46 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Plant Extracts | 33.46 | 16962711 | |
| MESH:D000544 | Alzheimer Disease | Raloxifene | 33.46 | 15800139 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 33.46 | 16162502 16183991 | |
| MESH:D000544 | Alzheimer Disease | rosiglitazone | 33.46 | 19621015 | |
| MESH:D000544 | Alzheimer Disease | Trazodone | 33.46 | 17897735 16856516 | |
| MESH:D019969 | Amphetamine-Related Disorders | Amphetamine | 4.47 | 16916582 16459022 18475255 15010207 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Copper | 4.58 | 10694572 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Thalidomide | 4.58 | 16510725 | |
| MESH:D000707 | Anaphylaxis | Ibuprofen | 10.94 | 9532969 | |
| MESH:D000707 | Anaphylaxis | Mangifera indica extract | 10.94 | 16536907 14669257 | |
| MESH:D000707 | Anaphylaxis | mangiferin | 10.94 | 14669257 16536907 | |
| MESH:D000740 | Anemia | Drugs, Chinese Herbal | 12.80 | 15504547 17963324 | |
| MESH:D000740 | Anemia | Fluorouracil | 12.80 | 17963324 16511603 15504547 | |
| MESH:D000740 | Anemia | Iron | 12.80 | 16434484 16566752 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 12.80 | 11748828 | |
| MESH:D000740 | Anemia | Zymosan | 12.80 | 18664788 | |
| MESH:D000743 | Anemia, Hemolytic | Quercetin | 2.79 | 17084956 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Copper | 5.68 | 16614410 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Iron | 5.68 | 17163184 16569441 17375513 17162259 17147795 | |
| MESH:D000756 | Anemia, Sideroblastic | Iron | 9.51 | 16910769 | |
| MESH:D000756 | Anemia, Sideroblastic | Manganese | 9.51 | 16910769 | |
| MESH:D000756 | Anemia, Sideroblastic | Superoxides | 9.51 | 16910769 | |
| MESH:D000787 | Angina Pectoris | Drugs, Chinese Herbal | 3.83 | 11477813 | |
| MESH:D000799 | Angioedema | Acetaminophen | 6.90 | 10982225 | |
| MESH:D000799 | Angioedema | montelukast | 6.90 | 10982225 | |
| MESH:D000853 | Anophthalmos | Ethanol | 3.27 | 15513904 | |
| MESH:D000855 | Anorexia | Amphetamine | 3.59 | 16101753 16084549 12183048 12005258 | |
| MESH:D000860 | Anoxia | Bleomycin | 6.57 | 15782499 | |
| MESH:D000860 | Anoxia | Hydrochloric Acid | 6.57 | 15090967 | |
| MESH:D001004 | Anus Diseases | Drugs, Chinese Herbal | 4.36 | 15043669 | |
| MESH:D001008 | Anxiety Disorders | Diazepam | 7.16 | 16284244 18313124 | |
| MESH:D001008 | Anxiety Disorders | Ethanol | 7.16 | 11141031 | |
| MESH:D001008 | Anxiety Disorders | vinclozolin | 7.16 | 19015723 | |
| MESH:D001014 | Aortic Aneurysm | Dinoprostone | 7.14 | 10231640 | |
| MESH:D001014 | Aortic Aneurysm | Indomethacin | 7.14 | 10231640 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 11.22 | 19183758 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Dinoprostone | 11.22 | 10388637 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Indomethacin | 11.22 | 10388637 | |
| MESH:D001145 | Arrhythmias, Cardiac | Iron | 4.64 | 16604332 | |
| MESH:D001145 | Arrhythmias, Cardiac | Phenylephrine | 4.64 | 17460149 | |
| MESH:D001161 | Arteriosclerosis | Cyclophosphamide | 5.25 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Dietary Fats | 5.25 | 15238619 | |
| MESH:D018771 | Arthralgia | Indomethacin | 3.57 | 2160914 | |
| MESH:D001168 | Arthritis | Leukotriene B4 | 4.60 | 11006272 | |
| MESH:D001169 | Arthritis, Experimental | Carrageenan | 16.16 | 17392412 | |
| MESH:D001169 | Arthritis, Experimental | Dexamethasone | 16.16 | 17659584 | |
| MESH:D001169 | Arthritis, Experimental | Plant Extracts | 16.16 | 14686799 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 16.16 | 17115116 | |
| MESH:D001169 | Arthritis, Experimental | Thalidomide | 16.16 | 9598899 | |
| MESH:D001169 | Arthritis, Experimental | Tosylphenylalanyl Chloromethyl Ketone | 16.16 | 18706406 | |
| MESH:D001169 | Arthritis, Experimental | Zymosan | 16.16 | 15944321 16872482 15188379 15142272 17659584 | |
| MESH:D015210 | Arthritis, Gouty | Drugs, Chinese Herbal | 4.16 | 19655406 | |
| MESH:D015535 | Arthritis, Psoriatic | marker/mechanism | 20953189 | ||
| MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 7.64 | 16807698 | |
| MESH:D001172 | Arthritis, Rheumatoid | Indomethacin | 7.64 | 11248219 | |
| MESH:D001172 | Arthritis, Rheumatoid | Methotrexate | 7.64 | 17286800 | |
| MESH:D001172 | Arthritis, Rheumatoid | Ozone | 7.64 | 15570426 | |
| MESH:D001172 | Arthritis, Rheumatoid | phenylmethylpyrazolone | 7.64 | 16390820 | |
| MESH:D001172 | Arthritis, Rheumatoid | Sulfasalazine | 7.64 | 9133974 | |
| MESH:D001195 | Asbestosis | marker/mechanism | 12160931 | ||
| MESH:D053627 | Asthenozoospermia | Sulfasalazine | 4.70 | 10689203 | |
| MESH:D001249 | Asthma | Acetaldehyde | 13.87 | 9600491 | |
| MESH:D001249 | Asthma | Budesonide | 13.87 | 15136378 10893010 20004779 15572850 18489783 12113382 12604023 | |
| MESH:D001249 | Asthma | epigallocatechin gallate | 13.87 | 16516891 | |
| MESH:D001249 | Asthma | Leukotriene B4 | 13.87 | 19667530 11006272 | |
| MESH:D001249 | Asthma | montelukast | 13.87 | 10852428 17895592 16293801 20332717 19667530 19681236 | |
| MESH:D001249 | Asthma | Mustard Gas | 13.87 | 10378619 | |
| MESH:D001249 | Asthma | Ozone | 13.87 | 16373670 17854713 | |
| MESH:D001249 | Asthma | Theophylline | 13.87 | 12113382 9701106 | |
| MESH:D001249 | Asthma | Toluene 2,4-Diisocyanate | 13.87 | 170078 12684321 19187332 11467998 17015710 6091946 18394133 6091945 8156442 3040596 10934080 12762349 15590890 11742282 16210060 15855793 7684630 15590891 10797510 12585506 11077013 16792590 20032816 | |
| MESH:D055963 | Asthma, Aspirin-Induced | Aspirin | 5.93 | 20485159 12372130 | |
| MESH:D055963 | Asthma, Aspirin-Induced | montelukast | 5.93 | 19667532 | |
| MESH:D001250 | Asthma, Exercise-Induced | Leukotriene B4 | 7.14 | 19667531 | |
| MESH:D001250 | Asthma, Exercise-Induced | montelukast | 7.14 | 19667531 10984370 | |
| MESH:D001260 | Ataxia Telangiectasia | Iron | 7.88 | 15336622 | |
| MESH:D001260 | Ataxia Telangiectasia | Quercetin | 7.88 | 15336622 | |
| MESH:D050197 | Atherosclerosis | 27-hydroxycholesterol | 21.57 | 11166758 9059518 | |
| MESH:D050197 | Atherosclerosis | 7-ketocholesterol | 21.57 | 16632123 | |
| MESH:D050197 | Atherosclerosis | Cadmium | 21.57 | 15687053 | |
| MESH:D050197 | Atherosclerosis | Cholesterol | 21.57 | 16632123 | |
| MESH:D050197 | Atherosclerosis | Curcumin | 21.57 | 18704882 | |
| MESH:D050197 | Atherosclerosis | Iron | 21.57 | 16632123 16640825 | |
| MESH:D050197 | Atherosclerosis | Mangifera indica extract | 21.57 | 18450471 | |
| MESH:D050197 | Atherosclerosis | mangiferin | 21.57 | 18450471 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 21.57 | 16873680 17967414 | |
| MESH:D050197 | Atherosclerosis | Saponins | 21.57 | 18637019 | |
| MESH:D001284 | Atrophy | fulvestrant | 3.34 | 11514358 | |
| MESH:D001289 | Attention Deficit Disorder with Hyperactivity | Oxidopamine | 3.44 | 14699433 | |
| MESH:D001321 | Autistic Disorder | marker/mechanism | 18563708 | ||
| MESH:D001321 | Autistic Disorder | Acetaminophen | 2.67 | 18445737 | |
| MESH:D001321 | Autistic Disorder | Fluvoxamine | 2.67 | 18775368 19232924 12607287 | |
| MESH:D001321 | Autistic Disorder | Glutathione | 2.67 | 19056591 16917939 18929414 19267885 | |
| MESH:D001321 | Autistic Disorder | Iron | 2.67 | 17352947 | |
| MESH:D001321 | Autistic Disorder | Magnesium | 2.67 | 16846101 | |
| MESH:D001321 | Autistic Disorder | Melatonin | 2.67 | 16897403 16919138 | |
| MESH:D001321 | Autistic Disorder | Methionine | 2.67 | 19056591 19267885 16917939 | |
| MESH:D001321 | Autistic Disorder | pioglitazone | 2.67 | 17207275 | |
| MESH:D001327 | Autoimmune Diseases | Curcumin | 13.35 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | epigallocatechin gallate | 13.35 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | Quercetin | 13.35 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | sulforafan | 13.35 | 19761891 | |
| MESH:D001424 | Bacterial Infections | Iron | 3.62 | 16640825 | |
| MESH:D001477 | Bartter Syndrome | Dinoprostone | 7.55 | 15976003 | |
| MESH:D001477 | Bartter Syndrome | Indomethacin | 7.55 | 10684365 | |
| MESH:D001528 | Behcet Syndrome | Sulfasalazine | 4.70 | 15870978 | |
| MESH:D001714 | Bipolar Disorder | Carbamazepine | 4.50 | 17594078 20046352 | |
| MESH:D001714 | Bipolar Disorder | zonisamide | 4.50 | 15383137 16855456 | |
| MESH:D001768 | Blister | Mustard Gas | 3.57 | 19167455 | |
| MESH:D001778 | Blood Coagulation Disorders | Hydrochloric Acid | 10.17 | 15920416 | |
| MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 10.17 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 10.17 | 12125929 | |
| MESH:D001778 | Blood Coagulation Disorders | Thioacetamide | 10.17 | 19483382 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.20 | 15340226 | |
| MESH:D001847 | Bone Diseases | icariin | 4.82 | 18295595 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 1.56 | 15746008 | |
| MESH:D001851 | Bone Diseases, Metabolic | Ginkgo biloba extract 761 | 4.76 | 19356626 | |
| MESH:D019046 | Bone Marrow Neoplasms | Dactinomycin | 11.33 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 11.33 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Etoposide | 11.33 | 14601052 | |
| MESH:D001859 | Bone Neoplasms | zoledronic acid | 3.48 | 17312309 16778634 11697798 15867366 19442620 16121404 | |
| MESH:D001862 | Bone Resorption | bisphenol A | 10.80 | 11985600 | |
| MESH:D001862 | Bone Resorption | Drugs, Chinese Herbal | 10.80 | 9881647 | |
| MESH:D001862 | Bone Resorption | mangiferin | 10.80 | 9881647 | |
| MESH:D001862 | Bone Resorption | zoledronic acid | 10.80 | 18496637 11869084 18404659 15845617 16769263 8053405 | |
| MESH:D001919 | Bradycardia | Capsaicin | 8.86 | 18207255 | |
| MESH:D001919 | Bradycardia | Isoproterenol | 8.86 | 6740701 | |
| MESH:D001919 | Bradycardia | Phenylephrine | 8.86 | 15306635 | |
| MESH:D001929 | Brain Edema | Ammonia | 7.74 | 11481608 19393034 20217200 | |
| MESH:D001929 | Brain Edema | Indomethacin | 7.74 | 11481608 | |
| MESH:D020201 | Brain Hemorrhage, Traumatic | Progesterone | 3.73 | 17868700 | |
| MESH:D001930 | Brain Injuries | Nitroprusside | 9.72 | 14637104 | |
| MESH:D001930 | Brain Injuries | Progesterone | 9.72 | 15845082 15665606 15380490 | |
| MESH:D001930 | Brain Injuries | Raloxifene | 9.72 | 16580743 | |
| MESH:D002545 | Brain Ischemia | Capsaicin | 34.11 | 19211983 | |
| MESH:D002545 | Brain Ischemia | Curcumin | 34.11 | 16770732 | |
| MESH:D002545 | Brain Ischemia | Ibuprofen | 34.11 | 15837124 | |
| MESH:D002545 | Brain Ischemia | icariin | 34.11 | 19303870 | |
| MESH:D002545 | Brain Ischemia | Indomethacin | 34.11 | 12524144 | |
| MESH:D002545 | Brain Ischemia | Morphine | 34.11 | 19211983 | |
| MESH:D002545 | Brain Ischemia | Plant Extracts | 34.11 | 16041641 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 34.11 | 17600658 | |
| MESH:D002545 | Brain Ischemia | scutellarin | 34.11 | 16297343 | |
| MESH:D001932 | Brain Neoplasms | Aspirin | 12.35 | 15481559 | |
| MESH:D001932 | Brain Neoplasms | Carmustine | 12.35 | 16187019 | |
| MESH:D001932 | Brain Neoplasms | Copper | 12.35 | 17079463 | |
| MESH:D001932 | Brain Neoplasms | Curcumin | 12.35 | 17596214 | |
| MESH:D001932 | Brain Neoplasms | Doxorubicin | 12.35 | 17150277 | |
| MESH:D001943 | Breast Neoplasms | marker/mechanism | 15631943 | ||
| MESH:D001943 | Breast Neoplasms | Acrylamide | 43.62 | 16253758 18183576 | |
| MESH:D001943 | Breast Neoplasms | Apigenin | 43.62 | 16541309 17132221 | |
| MESH:D001943 | Breast Neoplasms | Ascorbic Acid | 43.62 | 16443354 | |
| MESH:D001943 | Breast Neoplasms | Aspirin | 43.62 | 15161893 | |
| MESH:D001943 | Breast Neoplasms | Atropine | 43.62 | 12762645 | |
| MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 43.62 | 17474063 20146248 | |
| MESH:D001943 | Breast Neoplasms | bexarotene | 43.62 | 16818667 16344269 | |
| MESH:D001943 | Breast Neoplasms | bisphenol A | 43.62 | 17123778 | |
| MESH:D001943 | Breast Neoplasms | Copper | 43.62 | 17079463 15986119 | |
| MESH:D001943 | Breast Neoplasms | Curcumin | 43.62 | 19250217 16243823 18593918 18462866 | |
| MESH:D001943 | Breast Neoplasms | Cyclophosphamide | 43.62 | 18234424 18323546 11325840 15093573 17388661 17020986 15136595 12006526 16978400 | |
| MESH:D001943 | Breast Neoplasms | DDT | 43.62 | 16792888 12709520 | |
| MESH:D001943 | Breast Neoplasms | Deferoxamine | 43.62 | 15993339 | |
| MESH:D001943 | Breast Neoplasms | Dichlorodiphenyl Dichloroethylene | 43.62 | 15061365 | |
| MESH:D001943 | Breast Neoplasms | Dietary Fats | 43.62 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 43.62 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Disulfiram | 43.62 | 17026967 | |
| MESH:D001943 | Breast Neoplasms | Doxorubicin | 43.62 | 18628466 18234424 19526202 17983394 15939500 15994142 15668708 15634643 16096432 15692762 15136595 18695136 11325840 16264153 16115903 16826403 17369602 16935488 18382427 16322301 16595493 15567936 15993339 17426702 | |
| MESH:D001943 | Breast Neoplasms | Estradiol | 43.62 | 17289903 17261762 14630087 16675129 12948864 19861407 17018787 18497071 | |
| MESH:D001943 | Breast Neoplasms | Etoposide | 43.62 | 16322251 | |
| MESH:D001943 | Breast Neoplasms | Fluorouracil | 43.62 | 15136595 16110121 18357371 16595493 19217205 16557594 18608205 | |
| MESH:D001943 | Breast Neoplasms | fulvestrant | 43.62 | 18984771 | |
| MESH:D001943 | Breast Neoplasms | Genistein | 43.62 | 17200150 16873071 16541309 | |
| MESH:D001943 | Breast Neoplasms | gingerol | 43.62 | 17683926 | |
| MESH:D001943 | Breast Neoplasms | Indomethacin | 43.62 | 17401462 | |
| MESH:D001943 | Breast Neoplasms | kaempferol | 43.62 | 16756079 | |
| MESH:D001943 | Breast Neoplasms | Methotrexate | 43.62 | 16978400 | |
| MESH:D001943 | Breast Neoplasms | Methylene Chloride | 43.62 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Methylnitrosourea | 43.62 | 11306469 14633655 16253758 | |
| MESH:D001943 | Breast Neoplasms | Nitric Oxide | 43.62 | 15631943 | |
| MESH:D001943 | Breast Neoplasms | ochratoxin A | 43.62 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | Organoselenium Compounds | 43.62 | 15833885 16155795 | |
| MESH:D001943 | Breast Neoplasms | Plant Preparations | 43.62 | 17398067 | |
| MESH:D001943 | Breast Neoplasms | Progesterone | 43.62 | 17614352 16175315 15562024 | |
| MESH:D001943 | Breast Neoplasms | Quercetin | 43.62 | 18628248 | |
| MESH:D001943 | Breast Neoplasms | Raloxifene | 43.62 | 17242785 15758505 17261762 16912660 17049068 15775269 16837676 15572757 17595753 17893378 17952589 17440819 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 43.62 | 17651959 17534123 16393696 | |
| MESH:D001943 | Breast Neoplasms | Sulfasalazine | 43.62 | 17356269 | |
| MESH:D001943 | Breast Neoplasms | Tamoxifen | 43.62 | 18821012 19115204 18997820 19155303 21152245 18629630 20005174 20135344 19200415 18351453 18815881 19084267 19011961 16273361 17893378 16202921 17049068 19103187 18984771 15668708 20065188 11161223 19221464 19189212 17242785 15565566 19487384 19059307 19189210 20544844 19066611 18855134 19288272 19142967 19244106 16818667 17440819 18425577 20390343 16873071 20859285 17261762 19410462 19289846 21138602 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 43.62 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Toluene 2,4-Diisocyanate | 43.62 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | Vanadium | 43.62 | 15565634 | |
| MESH:D001943 | Breast Neoplasms | zoledronic acid | 43.62 | 18695136 16096432 | |
| MESH:D016535 | Bronchial Hyperreactivity | Hydrochloric Acid | 12.14 | 12378975 | |
| MESH:D016535 | Bronchial Hyperreactivity | Leukotriene B4 | 12.14 | 12794006 12654629 | |
| MESH:D016535 | Bronchial Hyperreactivity | Leukotriene C4 | 12.14 | 12654629 | |
| MESH:D016535 | Bronchial Hyperreactivity | Ozone | 12.14 | 17626835 16777450 14754758 18417511 19059883 18315731 15516495 | |
| MESH:D016535 | Bronchial Hyperreactivity | Toluene 2,4-Diisocyanate | 12.14 | 15590891 8156442 12507178 | |
| MESH:D001986 | Bronchial Spasm | Hydrochloric Acid | 3.88 | 15578804 | |
| MESH:D001989 | Bronchiolitis Obliterans | Mustard Gas | 3.57 | 15286001 | |
| MESH:D029481 | Bronchitis, Chronic | Mustard Gas | 3.38 | 17687719 10378619 | |
| MESH:D002056 | Burns | Ethanol | 6.26 | 16374292 | |
| MESH:D002056 | Burns | Indomethacin | 6.26 | 10459503 | |
| MESH:D002057 | Burns, Chemical | Plant Extracts | 3.74 | 9625245 | |
| MESH:D002100 | Cachexia | Ibuprofen | 12.11 | 15141370 | |
| MESH:D002100 | Cachexia | Indomethacin | 12.11 | 11239499 16537180 15141370 15625704 | |
| MESH:D002100 | Cachexia | Ozone | 12.11 | 16183385 | |
| MESH:D002105 | Cadmium Poisoning | Quercetin | 3.94 | 16962696 | |
| MESH:D002177 | Candidiasis | Disulfiram | 4.28 | 15325261 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 2.88 | 16111702 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | 16,16-Dimethylprostaglandin E2 | 11.80 | 3786805 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 11.80 | 16124888 16097048 16227642 18705752 15700767 15721981 3786805 16011737 10355542 16050911 16192424 15673190 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Melatonin | 11.80 | 15700767 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Pentoxifylline | 11.80 | 16227642 | |
| MESH:D002276 | Carcinoid Tumor | Doxorubicin | 12.09 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Fluorouracil | 12.09 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Streptozocin | 12.09 | 16051944 | |
| MESH:D002277 | Carcinoma | Curcumin | 11.85 | 18593918 | |
| MESH:D002277 | Carcinoma | Dimethylnitrosamine | 11.85 | 19555203 | |
| MESH:D002277 | Carcinoma | Disulfiram | 11.85 | 17026967 | |
| MESH:D002277 | Carcinoma | Fluorouracil | 11.85 | 17121937 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 11.85 | 16835633 | |
| MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 2.95 | 19066611 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 33.61 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | anthra(1,9-cd)pyrazol-6(2H)-one | 33.61 | 19418558 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 33.61 | 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cyclophosphamide | 33.61 | 19701751 | |
| MESH:D006528 | Carcinoma, Hepatocellular | DDT | 33.61 | 12597452 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 33.61 | 19171122 16681979 17138121 19394651 17055752 10737359 16502159 20432363 19539802 18056438 20214788 18665156 17761372 3084413 16830150 20524982 17978847 11831363 16569478 17162532 20727157 18691550 10672840 18494052 16328049 20512989 16288022 20007298 20514400 20084675 17173139 19335982 16935385 17428255 18788625 18971187 16698587 19107877 19919837 18785209 16878318 19701751 18506893 19519916 19208518 20935162 16540662 21159647 16779866 19052882 16807293 19822196 18210153 18393292 19383236 18978308 19418558 3581430 20101231 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 33.61 | 18059187 16023760 16234567 17876044 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 33.61 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estrogens | 33.61 | 15341023 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Ethanol | 33.61 | 15289165 15763234 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fluorouracil | 33.61 | 17045692 17088986 16332177 18930000 17971768 16799960 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 33.61 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Indomethacin | 33.61 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | nimesulide | 33.61 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Plant Extracts | 33.61 | 18834353 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 33.61 | 12508355 19519916 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 33.61 | 19321006 16227395 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 33.61 | 15276417 17306315 16507464 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 33.61 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Thalidomide | 33.61 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Thioacetamide | 33.61 | 17997003 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Vanadium | 33.61 | 16830150 16878318 | |
| MESH:D002278 | Carcinoma in Situ | bisphenol A | 3.40 | 17123778 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Cyclophosphamide | 14.62 | 16152834 | |
| MESH:D018827 | Carcinoma, Lewis Lung | ginsenoside Rg3 | 14.62 | 16152834 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Indomethacin | 14.62 | 11053908 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 14.62 | 16675471 | |
| MESH:D018276 | Carcinoma, Medullary | Indomethacin | 3.77 | 14736730 11352223 18791128 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | bexarotene | 7.06 | 16247446 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 7.06 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Disulfiram | 7.06 | 17026967 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | S,S'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea | 7.06 | 19497413 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | zoledronic acid | 7.06 | 19233551 | |
| MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 3.40 | 17234771 | |
| MESH:D002292 | Carcinoma, Renal Cell | Cyclophosphamide | 11.42 | 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 11.42 | 16201981 1485588 | |
| MESH:D002292 | Carcinoma, Renal Cell | ferric nitrilotriacetate | 11.42 | 8340253 | |
| MESH:D002292 | Carcinoma, Renal Cell | Fluorouracil | 11.42 | 18695887 | |
| MESH:D002292 | Carcinoma, Renal Cell | Indomethacin | 11.42 | 17341418 | |
| MESH:D002292 | Carcinoma, Renal Cell | zoledronic acid | 11.42 | 18507039 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Acetylcysteine | 25.59 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 25.59 | 20419170 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Bleomycin | 25.59 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 25.59 | 18462866 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Dimethylnitrosamine | 25.59 | 16033868 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 25.59 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fluorouracil | 25.59 | 17066447 18986760 16757204 16280240 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Glutathione | 25.59 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Indomethacin | 25.59 | 12636206 15482327 | |
| MESH:D002294 | Carcinoma, Squamous Cell | nimesulide | 25.59 | 15482327 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Plant Preparations | 25.59 | 17418620 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 25.59 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 25.59 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 25.59 | 18922899 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Raloxifene | 4.73 | 17572228 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 4.73 | 17572228 | |
| MESH:D006332 | Cardiomegaly | Copper | 14.74 | 17327471 | |
| MESH:D006332 | Cardiomegaly | Ethanol | 14.74 | 19332462 | |
| MESH:D006332 | Cardiomegaly | Isoproterenol | 14.74 | 11179087 7544033 | |
| MESH:D006332 | Cardiomegaly | Phenylephrine | 14.74 | 11754973 16170337 15728586 17287366 17124262 11179087 | |
| MESH:D006332 | Cardiomegaly | Plant Extracts | 14.74 | 17645561 | |
| MESH:D006332 | Cardiomegaly | Quercetin | 14.74 | 19794523 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 14.74 | 16120746 18850075 18670907 | |
| MESH:D009202 | Cardiomyopathies | carvedilol | 8.41 | 15476868 | |
| MESH:D009202 | Cardiomyopathies | Doxorubicin | 8.41 | 17928571 17131338 16952015 17007740 16455267 15476868 15792986 17519947 17924179 16651473 16242529 18627295 16278810 16364871 17382496 17308081 15811867 15505089 17974986 17329180 16731534 16269455 17351982 16612575 16109756 | |
| MESH:D009202 | Cardiomyopathies | Iron | 8.41 | 16640825 | |
| MESH:D009202 | Cardiomyopathies | pimagedine | 8.41 | 16612575 | |
| MESH:D002310 | Cardiomyopathy, Alcoholic | Acetaldehyde | 4.87 | 10525098 | |
| MESH:D002311 | Cardiomyopathy, Dilated | carvedilol | 4.56 | 19477965 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 4.56 | 17334414 16243910 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Iron | 4.56 | 16604332 | |
| MESH:D002318 | Cardiovascular Diseases | daidzein | 21.07 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Genistein | 21.07 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 21.07 | 16936243 | |
| MESH:D002318 | Cardiovascular Diseases | kaempferol | 21.07 | 16756079 | |
| MESH:D002318 | Cardiovascular Diseases | Particulate Matter | 21.07 | 12396868 | |
| MESH:D002318 | Cardiovascular Diseases | Plant Preparations | 21.07 | 16862667 | |
| MESH:D002318 | Cardiovascular Diseases | Raloxifene | 21.07 | 15775269 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 21.07 | 15458977 | |
| MESH:D002318 | Cardiovascular Diseases | Tacrolimus | 21.07 | 17703430 | |
| MESH:D016893 | Carotid Stenosis | Plant Preparations | 4.55 | 15158307 | |
| MESH:D002386 | Cataract | Acetaminophen | 10.71 | 10977129 | |
| MESH:D002386 | Cataract | Disulfiram | 10.71 | 15003327 17936468 | |
| MESH:D002386 | Cataract | Methylnitrosourea | 10.71 | 12484553 | |
| MESH:D002386 | Cataract | pimagedine | 10.71 | 15003327 17936468 | |
| MESH:D002386 | Cataract | Simvastatin | 10.71 | 12518039 | |
| MESH:D002418 | Cattle Diseases | Acrylamide | 3.88 | 12510666 | |
| MESH:D002471 | Cell Transformation, Neoplastic | marker/mechanism | 14700523 | ||
| MESH:D002471 | Cell Transformation, Neoplastic | Acetylcysteine | 21.11 | 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Azoxymethane | 21.11 | 18075178 15705887 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cadmium | 21.11 | 17332340 | |
| MESH:D002471 | Cell Transformation, Neoplastic | cinnamic aldehyde | 21.11 | 8243401 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 21.11 | 17174075 21159647 2727394 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Dinoprostone | 21.11 | 16192471 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 21.11 | 18566989 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Methylnitrosourea | 21.11 | 2727394 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 21.11 | 20056578 19524636 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Vanadium | 21.11 | 17174075 | |
| MESH:D002524 | Cerebellar Ataxia | Antimony Sodium Gluconate | 5.01 | 16432602 | |
| MESH:D002543 | Cerebral Hemorrhage | phenylmethylpyrazolone | 4.29 | 19095969 | |
| MESH:D002637 | Chest Pain | Theophylline | 7.63 | 15238202 | |
| MESH:D002637 | Chest Pain | Trazodone | 7.63 | 15238202 | |
| MESH:D002659 | Child Development Disorders, Pervasive | Methionine | 3.99 | 19267885 | |
| MESH:D002659 | Child Development Disorders, Pervasive | topiramate | 3.99 | 15650499 | |
| MESH:D018281 | Cholangiocarcinoma | marker/mechanism | 16818635 | ||
| MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 11.54 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 11.54 | 16835633 | |
| MESH:D018281 | Cholangiocarcinoma | Thalidomide | 11.54 | 18291259 | |
| MESH:D018281 | Cholangiocarcinoma | Thioacetamide | 11.54 | 18291259 | |
| MESH:D002761 | Cholangitis | 1-Naphthylisothiocyanate | 4.59 | 12912871 | |
| MESH:D002764 | Cholecystitis | Indomethacin | 3.57 | 11181007 | |
| MESH:D002779 | Cholestasis | 1-Naphthylisothiocyanate | 8.66 | 19486331 16629650 18164287 18590720 15500046 12927374 15913567 7624871 | |
| MESH:D002779 | Cholestasis | Nitric Oxide | 8.66 | 16919318 | |
| MESH:D002779 | Cholestasis | pirinixic acid | 8.66 | 19176532 | |
| MESH:D002779 | Cholestasis | Ursodeoxycholic Acid | 8.66 | 16487557 | |
| MESH:D002780 | Cholestasis, Intrahepatic | 1-Naphthylisothiocyanate | 9.36 | 10220858 19407337 | |
| MESH:D002780 | Cholestasis, Intrahepatic | Ursodeoxycholic Acid | 9.36 | 14728856 | |
| MESH:D019457 | Chromosome Breakage | Sodium Selenite | 3.19 | 15894690 | |
| MESH:D002971 | Cleft Lip | Ethanol | 2.52 | 15513904 | |
| MESH:D002972 | Cleft Palate | Diazepam | 7.93 | 3629520 | |
| MESH:D002972 | Cleft Palate | Ethanol | 7.93 | 15513904 | |
| MESH:D002972 | Cleft Palate | Hydrocortisone | 7.93 | 15826874 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 7.93 | 12621046 8697196 16354765 15340226 15668235 | |
| MESH:D002972 | Cleft Palate | Urethane | 7.93 | 12810352 | |
| MESH:D019970 | Cocaine-Related Disorders | Disulfiram | 4.17 | 19462300 | |
| MESH:D003072 | Cognition Disorders | Raloxifene | 3.07 | 15800139 | |
| MESH:D003092 | Colitis | Carbon Monoxide | 26.10 | 16365149 | |
| MESH:D003092 | Colitis | Curcumin | 26.10 | 16804969 18200517 16782535 | |
| MESH:D003092 | Colitis | Dextran Sulfate | 26.10 | 16375993 18023891 12065299 15652231 | |
| MESH:D003092 | Colitis | resveratrol | 26.10 | 16474422 | |
| MESH:D003092 | Colitis | Rutin | 26.10 | 15652231 | |
| MESH:D003092 | Colitis | Selenium | 26.10 | 17936198 | |
| MESH:D003092 | Colitis | Thalidomide | 26.10 | 16680017 | |
| MESH:D003092 | Colitis | Trinitrobenzenesulfonic Acid | 26.10 | 18200517 17991707 16474422 17936198 16804969 11698051 16782535 16867261 18023891 | |
| MESH:D003093 | Colitis, Ulcerative | Dinitrochlorobenzene | 6.22 | 17373747 19159591 | |
| MESH:D003093 | Colitis, Ulcerative | phenethyl isothiocyanate | 6.22 | 20423518 | |
| MESH:D003093 | Colitis, Ulcerative | Sulfasalazine | 6.22 | 17339853 15955209 | |
| MESH:D003093 | Colitis, Ulcerative | Trinitrobenzenesulfonic Acid | 6.22 | 17276891 | |
| MESH:D003103 | Coloboma | Curcumin | 3.08 | 18809619 | |
| MESH:D003110 | Colonic Neoplasms | 1,2-Dimethylhydrazine | 30.48 | 16293270 18155637 1113308 16338953 1933837 | |
| MESH:D003110 | Colonic Neoplasms | 1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester | 30.48 | 16818512 | |
| MESH:D003110 | Colonic Neoplasms | 17-(allylamino)-17-demethoxygeldanamycin | 30.48 | 15993848 | |
| MESH:D003110 | Colonic Neoplasms | arsenite | 30.48 | 15037631 | |
| MESH:D003110 | Colonic Neoplasms | Aspirin | 30.48 | 12411196 | |
| MESH:D003110 | Colonic Neoplasms | Azoxymethane | 30.48 | 16293270 14668109 16818512 15824018 12189186 19056647 15705887 | |
| MESH:D003110 | Colonic Neoplasms | cinnamic aldehyde | 30.48 | 17510524 16343908 | |
| MESH:D003110 | Colonic Neoplasms | Curcumin | 30.48 | 16340194 19359593 | |
| MESH:D003110 | Colonic Neoplasms | Dexamethasone | 30.48 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Fluorouracil | 30.48 | 18772588 16510598 17169374 17725105 17016597 15001691 17018589 17287894 17172411 16340194 | |
| MESH:D003110 | Colonic Neoplasms | Genistein | 30.48 | 17182828 | |
| MESH:D003110 | Colonic Neoplasms | Indomethacin | 30.48 | 15637740 15936596 11260862 15963497 15625704 15786552 | |
| MESH:D003110 | Colonic Neoplasms | Iron | 30.48 | 16640825 | |
| MESH:D003110 | Colonic Neoplasms | nitroaspirin | 30.48 | 16818512 | |
| MESH:D003110 | Colonic Neoplasms | polyphenols | 30.48 | 16293270 | |
| MESH:D003110 | Colonic Neoplasms | Quercetin | 30.48 | 15741050 11134977 17191121 19056647 19440933 16640504 17148506 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 30.48 | 16338953 | |
| MESH:D003110 | Colonic Neoplasms | Vanadium | 30.48 | 18155637 | |
| MESH:D003111 | Colonic Polyps | Magnesium | 4.52 | 17823441 | |
| MESH:D015179 | Colorectal Neoplasms | Aspirin | 6.09 | 17047198 | |
| MESH:D015179 | Colorectal Neoplasms | Azoxymethane | 6.09 | 11076880 10416599 | |
| MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 6.09 | 18802399 18259882 | |
| MESH:D015179 | Colorectal Neoplasms | Fluorouracil | 6.09 | 18802399 17594712 17695437 15289873 16331619 18448328 18383874 18949393 20501625 18288408 17401013 17255274 18509181 16391804 15148649 17094418 16282729 17016601 16303861 14970324 16524972 17454858 | |
| MESH:D015179 | Colorectal Neoplasms | Indomethacin | 6.09 | 12606626 18059344 17054584 11197048 | |
| MESH:D015179 | Colorectal Neoplasms | Magnesium | 6.09 | 17823441 | |
| MESH:D015179 | Colorectal Neoplasms | nimesulide | 6.09 | 18349538 | |
| MESH:D015179 | Colorectal Neoplasms | Quercetin | 6.09 | 18852136 18095365 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 6.09 | 16550006 | |
| MESH:D003128 | Coma | Ginkgo biloba extract 761 | 8.13 | 10836866 | |
| MESH:D003128 | Coma | Trazodone | 8.13 | 10836866 | |
| MESH:D003139 | Common Cold | Ascorbic Acid | 3.88 | 17323712 | |
| MESH:D000013 | Congenital Abnormalities | DDT | 4.77 | 15095906 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 4.77 | 14669216 17141729 | |
| MESH:D016510 | Corneal Neovascularization | Curcumin | 7.46 | 18497527 | |
| MESH:D016510 | Corneal Neovascularization | Thalidomide | 7.46 | 9301478 | |
| MESH:D003324 | Coronary Artery Disease | Plant Preparations | 3.20 | 15158307 | |
| MESH:D003327 | Coronary Disease | Fructose | 4.64 | 18504504 | |
| MESH:D003327 | Coronary Disease | resveratrol | 4.64 | 16507316 | |
| MESH:D018352 | Coronavirus Infections | Indomethacin | 4.11 | 17302372 | |
| MESH:D003371 | Cough | Capsaicin | 3.61 | 10350223 | |
| MESH:D003389 | Cranial Nerve Diseases | Thalidomide | 4.70 | 9200351 | |
| MESH:D019465 | Craniofacial Abnormalities | 6-methyl-2-(phenylethynyl)pyridine | 9.83 | 17065172 | |
| MESH:D019465 | Craniofacial Abnormalities | Carbamazepine | 9.83 | 9014606 | |
| MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 9.83 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Ethanol | 9.83 | 11198716 19302082 15513904 11873399 15451040 15451039 10194807 | |
| MESH:D019465 | Craniofacial Abnormalities | Hydrocortisone | 9.83 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Methotrexate | 9.83 | 12039119 9562676 | |
| MESH:D019465 | Craniofacial Abnormalities | ochratoxin A | 9.83 | 20036863 | |
| MESH:D019465 | Craniofacial Abnormalities | Reactive Oxygen Species | 9.83 | 15736158 | |
| MESH:D019465 | Craniofacial Abnormalities | sodium arsenate | 9.83 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 9.83 | 10048152 20055451 15322242 | |
| MESH:D019465 | Craniofacial Abnormalities | Thalidomide | 9.83 | 9200351 | |
| MESH:D016638 | Critical Illness | Estrogens | 4.36 | 16670151 | |
| MESH:D003424 | Crohn Disease | Thalidomide | 3.15 | 16078585 | |
| MESH:D003456 | Cryptorchidism | vinclozolin | 2.82 | 14966744 | |
| MESH:D003457 | Cryptosporidiosis | mangiferin | 8.74 | 16547730 | |
| MESH:D003457 | Cryptosporidiosis | Roxithromycin | 8.74 | 11362904 | |
| MESH:D003490 | Cyanosis | Endosulfan | 7.19 | 7900959 | |
| MESH:D003490 | Cyanosis | Propanil | 7.19 | 4714336 | |
| MESH:D003550 | Cystic Fibrosis | Acetylcysteine | 11.76 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Glutathione | 11.76 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Methotrexate | 11.76 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | pioglitazone | 11.76 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Simvastatin | 11.76 | 19747007 | |
| MESH:D003556 | Cystitis | Cyclophosphamide | 10.90 | 10498854 18433785 10700343 18295254 11948286 15643279 16614059 12913760 18710439 12388444 17979934 18483878 17010015 15276878 16989017 12161096 18093676 18372110 16651033 16413132 | |
| MESH:D003556 | Cystitis | Hydrochloric Acid | 10.90 | 19279288 12853844 20719367 12599022 | |
| MESH:D003556 | Cystitis | Rolipram | 10.90 | 18710439 | |
| MESH:D018856 | Cystitis, Interstitial | Hydrochloric Acid | 4.21 | 17714534 | |
| MESH:D007644 | Darier Disease | Fluorouracil | 3.21 | 16733453 | |
| MESH:D003704 | Dementia | Trazodone | 3.99 | 11575062 12587811 | |
| MESH:D015140 | Dementia, Vascular | Nitric Oxide | 4.37 | 17556102 | |
| MESH:D003711 | Demyelinating Diseases | Tamoxifen | 2.81 | 19031437 | |
| MESH:D003715 | Dengue | 27-hydroxycholesterol | 6.95 | 19427377 | |
| MESH:D003715 | Dengue | Doxycycline | 6.95 | 17502914 | |
| MESH:D003866 | Depressive Disorder | Fluvoxamine | 6.12 | 19571598 | |
| MESH:D003866 | Depressive Disorder | Trazodone | 6.12 | 19623435 3690436 20305041 3378227 4066620 15014590 18083778 | |
| MESH:D003866 | Depressive Disorder | zonisamide | 6.12 | 16855456 | |
| MESH:D003865 | Depressive Disorder, Major | Fluvoxamine | 8.74 | 17474826 | |
| MESH:D003865 | Depressive Disorder, Major | Raloxifene | 8.74 | 17474826 | |
| MESH:D003865 | Depressive Disorder, Major | Trazodone | 8.74 | 16968574 | |
| MESH:D003872 | Dermatitis | 3-xylene | 7.22 | 12717741 15902427 | |
| MESH:D003872 | Dermatitis | Rolipram | 7.22 | 16442096 | |
| MESH:D017449 | Dermatitis, Allergic Contact | alachlor | 12.80 | 8428444 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Ammonia | 12.80 | 16823706 | |
| MESH:D017449 | Dermatitis, Allergic Contact | cinnamic aldehyde | 12.80 | 11042091 | |
| MESH:D017449 | Dermatitis, Allergic Contact | cobaltous chloride | 12.80 | 11298694 15059100 16823706 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 12.80 | 12438553 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dinitrochlorobenzene | 12.80 | 15491423 | |
| MESH:D017449 | Dermatitis, Allergic Contact | nickel sulfate | 12.80 | 16823706 16780908 11298694 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Toluene 2,4-Diisocyanate | 12.80 | 15491423 12956900 18759878 | |
| MESH:D003876 | Dermatitis, Atopic | fexofenadine | 3.76 | 17133778 | |
| MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 3.76 | 18249437 | |
| MESH:D003877 | Dermatitis, Contact | Toluene 2,4-Diisocyanate | 3.35 | 17010967 | |
| MESH:D003882 | Dermatomyositis | Methotrexate | 3.60 | 20191521 | |
| MESH:D002658 | Developmental Disabilities | Magnesium | 3.70 | 16846101 | |
| MESH:D018500 | Diabetes Insipidus, Nephrogenic | 17-(allylamino)-17-demethoxygeldanamycin | 4.69 | 18854434 | |
| MESH:D003920 | Diabetes Mellitus | Iron | 10.50 | 16640825 16604332 | |
| MESH:D003920 | Diabetes Mellitus | rosiglitazone | 10.50 | 17446233 | |
| MESH:D003920 | Diabetes Mellitus | Sodium Selenite | 10.50 | 16285004 | |
| MESH:D003920 | Diabetes Mellitus | Streptozocin | 10.50 | 16285004 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Cyclophosphamide | 14.65 | 15331540 11751995 10990075 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Fructose | 14.65 | 18603373 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | mangiferin | 14.65 | 19028559 12093613 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 14.65 | 19496084 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 14.65 | 16873680 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Streptozocin | 14.65 | 7637645 18603373 19960420 15862027 16286809 6379147 2177838 19298542 17442507 1374869 16684804 19496084 15298345 11260395 12446591 8740154 12093613 12644472 17874149 15831366 19586609 18715473 11055810 12083368 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Cyclophosphamide | 4.19 | 18772604 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Iron | 4.19 | 16506275 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Streptozocin | 4.19 | 18603373 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Ascorbic Acid | 28.19 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | coumarin | 28.19 | 19647726 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 28.19 | 18403477 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | daidzein | 28.19 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 28.19 | 20387270 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | epigallocatechin gallate | 28.19 | 16988119 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Fructose | 28.19 | 18603373 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 28.19 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Iron | 28.19 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | mangiferin | 28.19 | 11315760 9881663 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | pioglitazone | 28.19 | 16023994 12642470 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | rosiglitazone | 28.19 | 12642470 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Streptozocin | 28.19 | 19586609 19647726 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 28.19 | 17107852 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | topiramate | 28.19 | 16979414 | |
| MESH:D058065 | Diabetic Cardiomyopathies | Streptozocin | 4.14 | 16025228 | |
| MESH:D003928 | Diabetic Nephropathies | Curcumin | 24.89 | 18204486 | |
| MESH:D003928 | Diabetic Nephropathies | Estradiol | 24.89 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | mangiferin | 24.89 | 19960420 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | Plant Extracts | 24.89 | 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | Raloxifene | 24.89 | 17451421 15920148 17308373 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 24.89 | 16286809 | |
| MESH:D003928 | Diabetic Nephropathies | Streptozocin | 24.89 | 19682444 19960420 | |
| MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 24.89 | 19279558 | |
| MESH:D003929 | Diabetic Neuropathies | Progesterone | 2.94 | 17187935 | |
| MESH:D003930 | Diabetic Retinopathy | Streptozocin | 3.90 | 17662242 | |
| MESH:D003967 | Diarrhea | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 24.36 | 10611417 | |
| MESH:D003967 | Diarrhea | Atropine | 24.36 | 10867622 | |
| MESH:D003967 | Diarrhea | Dexamethasone | 24.36 | 7237001 | |
| MESH:D003967 | Diarrhea | Dinoprostone | 24.36 | 10446763 7237001 11488427 | |
| MESH:D003967 | Diarrhea | Endotoxins | 24.36 | 7907874 7237001 | |
| MESH:D003967 | Diarrhea | Hydrocortisone | 24.36 | 7237001 | |
| MESH:D003967 | Diarrhea | Indomethacin | 24.36 | 7907874 7237001 | |
| MESH:D003967 | Diarrhea | Morphine | 24.36 | 2540324 | |
| MESH:D003967 | Diarrhea | Pinacidil | 24.36 | 8749038 | |
| MESH:D003967 | Diarrhea | SU 5416 | 24.36 | 12673719 | |
| OMIM:607208 | DRAVET SYNDROME | Carbamazepine | 7.51 | 11748493 | |
| OMIM:607208 | DRAVET SYNDROME | zonisamide | 7.51 | 11748493 | |
| MESH:D004342 | Drug Hypersensitivity | Carbamazepine | 3.24 | 16538175 20216337 15057820 16538176 | |
| MESH:D056486 | Drug-Induced Liver Injury | 16,16-Dimethylprostaglandin E2 | 46.16 | 3786805 | |
| MESH:D056486 | Drug-Induced Liver Injury | 1-Naphthylisothiocyanate | 46.16 | 20133375 17522070 18289764 7624871 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 46.16 | 16081117 12594235 17562736 10774834 19085960 11529661 14986274 12392966 16227642 19164858 16109766 12153990 16485898 18713872 12705907 14550746 14725611 11739529 16393943 19420014 19370779 10663392 19739265 12540782 11421492 15619225 15968718 17906064 11834606 11743745 16781746 11287661 19923254 18071297 16177239 12958197 17522070 2444490 19416960 10915739 11461765 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetylcysteine | 46.16 | 11287661 | |
| MESH:D056486 | Drug-Induced Liver Injury | allyl alcohol | 46.16 | 7440962 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbamazepine | 46.16 | 17465707 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 46.16 | 15968718 11566570 2869522 3786805 21278145 19336974 7440962 3732212 16177239 15027814 6884620 7179309 16227642 7120509 19085960 10092053 10915739 17522070 9327722 6623471 4309450 15998439 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 46.16 | 19107877 | |
| MESH:D056486 | Drug-Induced Liver Injury | Dimethylnitrosamine | 46.16 | 8172417 | |
| MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 46.16 | 17416283 | |
| MESH:D056486 | Drug-Induced Liver Injury | Drugs, Chinese Herbal | 46.16 | 15027814 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ethanol | 46.16 | 11566570 | |
| MESH:D056486 | Drug-Induced Liver Injury | gadolinium chloride | 46.16 | 12963478 | |
| MESH:D056486 | Drug-Induced Liver Injury | Halothane | 46.16 | 12919722 | |
| MESH:D056486 | Drug-Induced Liver Injury | manumycin | 46.16 | 19739265 | |
| MESH:D056486 | Drug-Induced Liver Injury | Pentoxifylline | 46.16 | 16227642 | |
| MESH:D056486 | Drug-Induced Liver Injury | polyphenols | 46.16 | 19370779 | |
| MESH:D056486 | Drug-Induced Liver Injury | Prazosin | 46.16 | 18071297 | |
| MESH:D056486 | Drug-Induced Liver Injury | scutellarin | 46.16 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Selenium | 46.16 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Silymarin | 46.16 | 14998559 | |
| MESH:D056486 | Drug-Induced Liver Injury | sodium arsenate | 46.16 | 18186108 | |
| MESH:D056486 | Drug-Induced Liver Injury | Sodium Selenite | 46.16 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 46.16 | 20420201 | |
| MESH:D056486 | Drug-Induced Liver Injury | Thioacetamide | 46.16 | 12963478 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 8.04 | 19426721 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Glycyrrhizic Acid | 8.04 | 19426721 | |
| MESH:D004362 | Drug Toxicity | Carbamazepine | 15.10 | 20216337 | |
| MESH:D004362 | Drug Toxicity | Doxorubicin | 15.10 | 18602426 | |
| MESH:D004362 | Drug Toxicity | Gentamicins | 15.10 | 11033412 15033597 | |
| MESH:D004362 | Drug Toxicity | phenylmethylpyrazolone | 15.10 | 12231392 12649298 | |
| MESH:D004362 | Drug Toxicity | Plant Preparations | 15.10 | 11033412 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 15.10 | 11462148 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Ibuprofen | 8.00 | 18446180 16133044 18450898 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Indomethacin | 8.00 | 18446180 16133044 17190690 12774134 18043480 16326151 | |
| MESH:D004381 | Duodenal Ulcer | marker/mechanism | 12481160 17045617 | ||
| MESH:D004381 | Duodenal Ulcer | 16,16-Dimethylprostaglandin E2 | 32.47 | 11595431 11991626 10671773 16699067 | |
| MESH:D004381 | Duodenal Ulcer | Ampicillin | 32.47 | 10671773 | |
| MESH:D004381 | Duodenal Ulcer | Atropine | 32.47 | 11595415 | |
| MESH:D004381 | Duodenal Ulcer | Capsaicin | 32.47 | 10671773 11535926 | |
| MESH:D004381 | Duodenal Ulcer | Curcumin | 32.47 | 17351913 | |
| MESH:D004381 | Duodenal Ulcer | Indomethacin | 32.47 | 11595415 10671773 17151854 11991626 17045617 11595431 17329845 16699067 11535926 17202747 17351913 | |
| MESH:D004381 | Duodenal Ulcer | lafutidine | 32.47 | 10671773 11535926 | |
| MESH:D004381 | Duodenal Ulcer | ONO-AE1-329 | 32.47 | 11595431 11991626 | |
| MESH:D004381 | Duodenal Ulcer | ONO-NT 012 | 32.47 | 11991626 11595431 | |
| MESH:D004381 | Duodenal Ulcer | Tacrolimus | 32.47 | 17202747 | |
| MESH:D004409 | Dyskinesia, Drug-Induced | Trazodone | 4.34 | 3690436 | |
| MESH:D050171 | Dyslipidemias | Dietary Fats | 2.18 | 18367378 | |
| MESH:D004417 | Dyspnea | Budesonide | 15.61 | 20016425 | |
| MESH:D004417 | Dyspnea | DDT | 15.61 | 16487989 | |
| MESH:D004417 | Dyspnea | Dichlorodiphenyl Dichloroethylene | 15.61 | 16487989 | |
| MESH:D004417 | Dyspnea | Endosulfan | 15.61 | 3388749 7900959 | |
| MESH:D004417 | Dyspnea | SU 5416 | 15.61 | 12673719 12649163 | |
| MESH:D004421 | Dystonia | Diazepam | 6.67 | 1851702 | |
| MESH:D004421 | Dystonia | Trazodone | 6.67 | 3700695 | |
| MESH:D020821 | Dystonic Disorders | Nicotine | 4.34 | 17881519 | |
| MESH:C538011 | Eales disease | Ascorbic Acid | 3.88 | 9068938 | |
| MESH:D004485 | Eczema | Dexamethasone | 6.50 | 12438553 | |
| MESH:D004485 | Eczema | Trioxsalen | 6.50 | 16259964 | |
| MESH:D004487 | Edema | Aspirin | 62.49 | 17259670 | |
| MESH:D004487 | Edema | bis(4-hydroxycinnamoyl)methane | 62.49 | 18449507 | |
| MESH:D004487 | Edema | Bleomycin | 62.49 | 17118201 | |
| MESH:D004487 | Edema | Carrageenan | 62.49 | 18841975 10653021 12787963 17259670 12083418 8985016 16100529 12798668 18621150 18449507 15860553 | |
| MESH:D004487 | Edema | demethoxycurcumin | 62.49 | 18449507 | |
| MESH:D004487 | Edema | Dexamethasone | 62.49 | 19703484 | |
| MESH:D004487 | Edema | Diclofenac | 62.49 | 16273134 | |
| MESH:D004487 | Edema | glycyrol | 62.49 | 18621150 | |
| MESH:D004487 | Edema | Indomethacin | 62.49 | 7907874 19703484 16100529 8985016 7990266 8273558 10653021 | |
| MESH:D004487 | Edema | Mangifera indica extract | 62.49 | 15177302 16273134 16716910 | |
| MESH:D004487 | Edema | Mustard Gas | 62.49 | 11428647 11402378 9260866 11428631 | |
| MESH:D004487 | Edema | pirinixic acid | 62.49 | 12083418 | |
| MESH:D004487 | Edema | Plant Extracts | 62.49 | 12787963 | |
| MESH:D004487 | Edema | Raloxifene | 62.49 | 15860553 | |
| MESH:D004487 | Edema | resveratrol | 62.49 | 8985016 | |
| MESH:D004487 | Edema | rosiglitazone | 62.49 | 12083418 | |
| MESH:D004487 | Edema | sinapinic acid | 62.49 | 18841975 | |
| MESH:D004487 | Edema | Sodium Salicylate | 62.49 | 10653021 | |
| MESH:D004487 | Edema | Staurosporine | 62.49 | 8273558 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 62.49 | 12711302 11000095 | |
| MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 62.49 | 16716910 8273558 7812673 8113982 11698051 15177302 9599246 | |
| MESH:D004487 | Edema | Trazodone | 62.49 | 12798668 | |
| MESH:D004487 | Edema | Zymosan | 62.49 | 7907874 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 2.31 | 15322242 16714409 18230668 | |
| MESH:D004646 | Emphysema | Endosulfan | 4.95 | 7900959 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | 15-deoxy-delta(12,14)-prostaglandin J2 | 24.47 | 16844232 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | 27-hydroxycholesterol | 24.47 | 17410599 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Carbamazepine | 24.47 | 17654737 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | ciglitazone | 24.47 | 16844232 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Progesterone | 24.47 | 17692515 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Raloxifene | 24.47 | 15845917 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 24.47 | 17872969 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 24.47 | 19031437 | |
| MESH:D004714 | Endometrial Hyperplasia | Estriol | 7.19 | 16402032 | |
| MESH:D004714 | Endometrial Hyperplasia | Genistein | 7.19 | 16402032 | |
| MESH:D016889 | Endometrial Neoplasms | daidzein | 10.24 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 10.24 | 17359293 | |
| MESH:D016889 | Endometrial Neoplasms | Estradiol | 10.24 | 18566989 19148513 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Genistein | 10.24 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 10.24 | 19155303 20544844 16202921 17893378 | |
| MESH:D004715 | Endometriosis | Ibuprofen | 13.61 | 15652904 | |
| MESH:D004715 | Endometriosis | Indomethacin | 13.61 | 15652904 | |
| MESH:D004715 | Endometriosis | Mifepristone | 13.61 | 16134523 | |
| MESH:D004715 | Endometriosis | Progesterone | 13.61 | 16134523 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 13.61 | 10568697 9294722 | |
| MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 8.76 | 18037988 | |
| MESH:D004719 | Endomyocardial Fibrosis | Plant Extracts | 8.76 | 15268973 | |
| MESH:D019446 | Endotoxemia | endotoxin, Escherichia coli | 21.02 | 17637181 18509659 | |
| MESH:D019446 | Endotoxemia | Ibuprofen | 21.02 | 11545620 | |
| MESH:D019446 | Endotoxemia | Indomethacin | 21.02 | 18509659 | |
| MESH:D019446 | Endotoxemia | lipopolysaccharide, Escherichia coli 0111 B4 | 21.02 | 12954792 | |
| MESH:D019446 | Endotoxemia | Lipopolysaccharides | 21.02 | 15328337 17637181 15821434 | |
| MESH:D019446 | Endotoxemia | phenylmethylpyrazolone | 21.02 | 12954792 | |
| MESH:D004751 | Enteritis | Indomethacin | 3.17 | 10567023 17763956 16328016 | |
| MESH:D020345 | Enterocolitis, Necrotizing | marker/mechanism | 17923197 | ||
| MESH:D020345 | Enterocolitis, Necrotizing | Indomethacin | 7.22 | 17980183 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 7.22 | 17923197 | |
| MESH:D004802 | Eosinophilia | Cyclophosphamide | 8.91 | 11006010 | |
| MESH:D004802 | Eosinophilia | Indomethacin | 8.91 | 11298111 | |
| MESH:D004802 | Eosinophilia | montelukast | 8.91 | 10335014 | |
| MESH:D004802 | Eosinophilia | Toluene 2,4-Diisocyanate | 8.91 | 8156442 | |
| MESH:D004816 | Epidermal Necrolysis, Toxic | Carbamazepine | 10.63 | 16415921 19915237 20485159 16538176 18855540 | |
| MESH:D004816 | Epidermal Necrolysis, Toxic | lamotrigine | 10.63 | 20235791 | |
| MESH:D004816 | Epidermal Necrolysis, Toxic | oxcarbazepine | 10.63 | 20235791 | |
| MESH:D004831 | Epilepsies, Myoclonic | Carbamazepine | 14.10 | 17275665 | |
| MESH:D004831 | Epilepsies, Myoclonic | gabapentin | 14.10 | 3659116 | |
| MESH:D004831 | Epilepsies, Myoclonic | lamotrigine | 14.10 | 17275665 | |
| MESH:D004831 | Epilepsies, Myoclonic | zonisamide | 14.10 | 3691417 3659116 | |
| MESH:D004828 | Epilepsies, Partial | Carbamazepine | 11.56 | 15008574 16628512 17116037 | |
| MESH:D004828 | Epilepsies, Partial | Diazepam | 11.56 | 3922381 | |
| MESH:D004828 | Epilepsies, Partial | lamotrigine | 11.56 | 17116037 | |
| MESH:D004828 | Epilepsies, Partial | zonisamide | 11.56 | 15140322 11558140 3691417 | |
| MESH:D004827 | Epilepsy | Carbamazepine | 17.13 | 821787 7988514 19700373 17178248 19620853 18234410 9014606 19439326 20417680 17465707 | |
| MESH:D004827 | Epilepsy | Diazepam | 17.13 | 821787 | |
| MESH:D004827 | Epilepsy | Epinephrine | 17.13 | 821787 | |
| MESH:D004827 | Epilepsy | lamotrigine | 17.13 | 19668019 | |
| MESH:D004827 | Epilepsy | oxcarbazepine | 17.13 | 17516704 7988514 | |
| MESH:D004827 | Epilepsy | Plant Extracts | 17.13 | 19439326 19700373 | |
| MESH:D004827 | Epilepsy | topiramate | 17.13 | 19148780 | |
| MESH:D004827 | Epilepsy | zonisamide | 17.13 | 20196486 | |
| MESH:D004832 | Epilepsy, Absence | Diazepam | 3.84 | 6401628 6426943 | |
| MESH:D017029 | Epilepsy, Complex Partial | Carbamazepine | 3.81 | 7750514 | |
| MESH:D004833 | Epilepsy, Temporal Lobe | lamotrigine | 9.60 | 16499746 | |
| MESH:D004833 | Epilepsy, Temporal Lobe | topiramate | 9.60 | 16499746 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Carbamazepine | 9.45 | 15276670 3659116 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | gabapentin | 9.45 | 3659116 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | zonisamide | 9.45 | 3659116 3691417 | |
| MESH:D007172 | Erectile Dysfunction | daidzein | 8.56 | 14972507 | |
| MESH:D007172 | Erectile Dysfunction | icariin | 8.56 | 16281085 15329286 | |
| MESH:D007172 | Erectile Dysfunction | Trazodone | 8.56 | 7604472 | |
| MESH:D004890 | Erythema | Mustard Gas | 3.57 | 9357497 | |
| MESH:D004916 | Erythromelalgia | Carbamazepine | 8.69 | 19549232 | |
| MESH:D004916 | Erythromelalgia | gabapentin | 8.69 | 19549232 | |
| MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 3.51 | 16302075 | |
| MESH:D004935 | Esophageal Diseases | Capsaicin | 8.27 | 19566590 | |
| MESH:D004935 | Esophageal Diseases | Hydrochloric Acid | 8.27 | 19566590 | |
| MESH:D004938 | Esophageal Neoplasms | marker/mechanism | 15264214 | ||
| MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 10.96 | 16530937 | |
| MESH:D004938 | Esophageal Neoplasms | Dimethylnitrosamine | 10.96 | 17016578 | |
| MESH:D004938 | Esophageal Neoplasms | Ethanol | 10.96 | 16704527 | |
| MESH:D004938 | Esophageal Neoplasms | Fluorouracil | 10.96 | 17638652 16337965 16785472 15173087 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | Indomethacin | 10.96 | 11005569 | |
| MESH:D004938 | Esophageal Neoplasms | nitrosobenzylmethylamine | 10.96 | 15150132 15264214 16805852 15623463 15547721 15547733 16704527 16510608 15878914 | |
| MESH:D004938 | Esophageal Neoplasms | Plant Preparations | 10.96 | 16510608 | |
| MESH:D004938 | Esophageal Neoplasms | S,S'-1,4-phenylene-bis(1,2-ethanediyl)bis-isothiourea | 10.96 | 15150132 | |
| MESH:D004941 | Esophagitis | Hydrochloric Acid | 4.41 | 12928072 | |
| MESH:D004942 | Esophagitis, Peptic | Hydrochloric Acid | 4.41 | 20516732 11346197 14621274 | |
| MESH:D020329 | Essential Tremor | Trazodone | 8.12 | 3296121 | |
| MESH:D020329 | Essential Tremor | zonisamide | 8.12 | 17149715 18297619 | |
| MESH:D005076 | Exanthema | Carbamazepine | 7.51 | 20485159 | |
| MESH:D005076 | Exanthema | zonisamide | 7.51 | 15140322 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 1.70 | 11564622 | |
| MESH:D005128 | Eye Diseases | Toluene 2,4-Diisocyanate | 4.17 | 18447907 | |
| MESH:D005221 | Fatigue | Amphetamine | 11.69 | 19890266 | |
| MESH:D005221 | Fatigue | SU 5416 | 11.69 | 12649163 12673719 | |
| MESH:D005221 | Fatigue | zonisamide | 11.69 | 17149715 | |
| MESH:D005218 | Fat Necrosis | Thioacetamide | 4.11 | 16456712 | |
| MESH:D005234 | Fatty Liver | arsenite | 48.12 | 18296743 | |
| MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 48.12 | 61145 12631006 16239168 16045604 19224547 15959796 17595544 12795759 | |
| MESH:D005234 | Fatty Liver | Curcumin | 48.12 | 19297423 | |
| MESH:D005234 | Fatty Liver | Dietary Fats | 48.12 | 17967931 19551842 19004024 18296743 | |
| MESH:D005234 | Fatty Liver | Diethylnitrosamine | 48.12 | 21071580 20387270 | |
| MESH:D005234 | Fatty Liver | Endotoxins | 48.12 | 18641190 | |
| MESH:D005234 | Fatty Liver | Ethanol | 48.12 | 16409862 18620774 19236843 | |
| MESH:D005234 | Fatty Liver | Fructose | 48.12 | 18395287 18641190 19196556 | |
| MESH:D005234 | Fatty Liver | Iron | 48.12 | 16640825 | |
| MESH:D005234 | Fatty Liver | mangiferin | 48.12 | 15975614 | |
| MESH:D005234 | Fatty Liver | phenylmethylpyrazolone | 48.12 | 12795759 | |
| MESH:D005234 | Fatty Liver | pirinixic acid | 48.12 | 19236843 20131406 | |
| MESH:D005234 | Fatty Liver | Plant Extracts | 48.12 | 15975614 | |
| MESH:D005234 | Fatty Liver | Raloxifene | 48.12 | 17473493 | |
| MESH:D005234 | Fatty Liver | rosiglitazone | 48.12 | 19196556 | |
| MESH:D005234 | Fatty Liver | Tamoxifen | 48.12 | 14986274 19224547 | |
| MESH:D005235 | Fatty Liver, Alcoholic | Ethanol | 4.06 | 17920746 | |
| MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 2.06 | 16709447 | |
| MESH:D005264 | Femoral Fractures | zoledronic acid | 4.24 | 16234978 | |
| MESH:D005310 | Fetal Alcohol Syndrome | Ethanol | 3.71 | 16946407 10194807 15451040 15513904 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 1.93 | 11858732 | |
| MESH:D005334 | Fever | Dinoprostone | 16.98 | 16997862 11852909 | |
| MESH:D005334 | Fever | endotoxin, Escherichia coli | 16.98 | 16997862 | |
| MESH:D005334 | Fever | Ibuprofen | 16.98 | 16997862 | |
| MESH:D005334 | Fever | Indomethacin | 16.98 | 10431976 11852909 17627676 | |
| MESH:D005334 | Fever | lipopolysaccharide, Escherichia coli 0111 B4 | 16.98 | 16997862 | |
| MESH:D005334 | Fever | Lipopolysaccharides | 16.98 | 11852909 9205823 | |
| MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 2.95 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 6.24 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 6.24 | 19069698 | |
| MESH:D005354 | Fibrosarcoma | Carrageenan | 11.47 | 10962813 | |
| MESH:D005354 | Fibrosarcoma | Indomethacin | 11.47 | 10962813 | |
| MESH:D005354 | Fibrosarcoma | Methylnitrosourea | 11.47 | 11555667 | |
| MESH:D005355 | Fibrosis | arsenite | 43.40 | 18296743 | |
| MESH:D005355 | Fibrosis | baicalein | 43.40 | 19474275 | |
| MESH:D005355 | Fibrosis | baicalin | 43.40 | 19474275 | |
| MESH:D005355 | Fibrosis | Carbon Tetrachloride | 43.40 | 18705752 | |
| MESH:D005355 | Fibrosis | Curcumin | 43.40 | 18705752 | |
| MESH:D005355 | Fibrosis | Dietary Fats | 43.40 | 18296743 | |
| MESH:D005355 | Fibrosis | Emodin | 43.40 | 19474275 | |
| MESH:D005355 | Fibrosis | Fructose | 43.40 | 18504504 | |
| MESH:D005355 | Fibrosis | Hydrochloric Acid | 43.40 | 18497604 | |
| MESH:D005355 | Fibrosis | Indomethacin | 43.40 | 17994277 | |
| MESH:D005355 | Fibrosis | Quercetin | 43.40 | 19474275 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 43.40 | 20067830 | |
| MESH:D005355 | Fibrosis | Trinitrobenzenesulfonic Acid | 43.40 | 17994277 | |
| MESH:D005499 | Folliculitis | Indomethacin | 3.57 | 11298111 | |
| MESH:D005596 | Fractures, Closed | montelukast | 4.58 | 19544365 | |
| MESH:D005621 | Friedreich Ataxia | Iron | 3.87 | 16604332 16640825 | |
| MESH:D005739 | Gas Poisoning | Budesonide | 7.19 | 20016425 | |
| MESH:D005739 | Gas Poisoning | Hydrochloric Acid | 7.19 | 12378975 | |
| MESH:D005756 | Gastritis | Acetaminophen | 9.94 | 16983495 | |
| MESH:D005756 | Gastritis | Ethanol | 9.94 | 15046732 | |
| MESH:D005756 | Gastritis | Indomethacin | 9.94 | 15046732 | |
| MESH:D005764 | Gastroesophageal Reflux | Hydrochloric Acid | 3.81 | 20616304 19951613 20516732 19957777 12212954 20545468 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 3.15 | 18462866 | |
| MESH:D030342 | Genetic Diseases, Inborn | vinclozolin | 3.35 | 16973722 | |
| MESH:D005832 | Genital Diseases, Male | vinclozolin | 3.69 | 16417039 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 3.10 | 16452187 | |
| MESH:D005871 | Giant Lymph Node Hyperplasia | Thalidomide | 4.70 | 12701121 | |
| MESH:D005873 | Giardiasis | Metronidazole | 6.11 | 17385912 | |
| MESH:D005909 | Glioblastoma | Aspirin | 24.09 | 12870263 | |
| MESH:D005909 | Glioblastoma | baicalein | 24.09 | 19804834 | |
| MESH:D005909 | Glioblastoma | Capsaicin | 24.09 | 18405923 | |
| MESH:D005909 | Glioblastoma | Carmustine | 24.09 | 16187019 | |
| MESH:D005909 | Glioblastoma | Curcumin | 24.09 | 17596214 | |
| MESH:D005909 | Glioblastoma | Doxorubicin | 24.09 | 17150277 | |
| MESH:D005909 | Glioblastoma | Genistein | 24.09 | 16598420 | |
| MESH:D005909 | Glioblastoma | Indomethacin | 24.09 | 12870263 | |
| MESH:D005909 | Glioblastoma | Manganese | 24.09 | 17043766 | |
| MESH:D005909 | Glioblastoma | Quercetin | 24.09 | 19804834 | |
| MESH:D005910 | Glioma | Fluorouracil | 8.14 | 16145905 | |
| MESH:D005910 | Glioma | Indomethacin | 8.14 | 18371953 16487511 | |
| MESH:D005910 | Glioma | Methylnitrosourea | 8.14 | 9825942 | |
| MESH:D005910 | Glioma | Quercetin | 8.14 | 17643826 | |
| MESH:D005910 | Glioma | Thalidomide | 8.14 | 16327979 | |
| MESH:D018316 | Gliosarcoma | Cyclophosphamide | 3.93 | 11389073 | |
| MESH:D005911 | Gliosis | Paraquat | 3.56 | 11124998 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | Indomethacin | 5.72 | 11849393 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | pioglitazone | 5.72 | 16687628 | |
| MESH:D018149 | Glucose Intolerance | Fructose | 6.88 | 19165636 | |
| MESH:D018149 | Glucose Intolerance | sodium arsenate | 6.88 | 19446573 | |
| MESH:D044882 | Glucose Metabolism Disorders | Mangifera indica extract | 5.15 | 16273134 | |
| MESH:D006030 | Glycosuria, Renal | Mercuric Chloride | 4.35 | 2918855 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 2.98 | 10696789 | |
| MESH:D006073 | Gout | Indomethacin | 3.77 | 11248219 | |
| MESH:D006086 | Graft vs Host Disease | Cyclophosphamide | 11.43 | 15172196 16376943 11014644 | |
| MESH:D006086 | Graft vs Host Disease | Methotrexate | 11.43 | 16518429 | |
| MESH:D006086 | Graft vs Host Disease | Tacrolimus | 11.43 | 16376943 | |
| MESH:D006130 | Growth Disorders | Tacrolimus | 3.70 | 11041285 | |
| MESH:D006261 | Headache | Aspirin | 17.18 | 15240983 | |
| MESH:D006261 | Headache | Nitric Oxide | 17.18 | 11554966 11284996 | |
| MESH:D006261 | Headache | Nitroglycerin | 17.18 | 11284996 11554966 | |
| MESH:D006261 | Headache | SU 5416 | 17.18 | 12673719 12649163 | |
| MESH:D006261 | Headache | zonisamide | 17.18 | 17149715 | |
| MESH:D006258 | Head and Neck Neoplasms | Curcumin | 10.90 | 18462866 18829502 | |
| MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 10.90 | 15692506 | |
| MESH:D006258 | Head and Neck Neoplasms | Fluorouracil | 10.90 | 15162350 15102660 18337622 | |
| MESH:D006258 | Head and Neck Neoplasms | Indomethacin | 10.90 | 15482327 | |
| MESH:D006258 | Head and Neck Neoplasms | nimesulide | 10.90 | 15482327 | |
| MESH:D034381 | Hearing Loss | Gentamicins | 3.48 | 19130971 17868369 18024279 15968427 | |
| MESH:D006356 | Heartburn | Capsaicin | 8.27 | 19566590 | |
| MESH:D006356 | Heartburn | Hydrochloric Acid | 8.27 | 19566590 | |
| MESH:D006330 | Heart Defects, Congenital | Ascorbic Acid | 4.71 | 16080930 | |
| MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 4.71 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 4.71 | 11294989 10048152 | |
| MESH:D006331 | Heart Diseases | Antimony Sodium Gluconate | 13.16 | 11049798 | |
| MESH:D006331 | Heart Diseases | Doxorubicin | 13.16 | 16495754 16144979 16707910 16244372 17888722 18674790 16879835 16330681 12587719 16244371 18006777 17875725 14766674 | |
| MESH:D006331 | Heart Diseases | mangiferin | 13.16 | 12093613 | |
| MESH:D006331 | Heart Diseases | Raloxifene | 13.16 | 11110106 | |
| MESH:D006331 | Heart Diseases | Streptozocin | 13.16 | 12093613 | |
| MESH:D006331 | Heart Diseases | Urethane | 13.16 | 16046796 | |
| MESH:D006333 | Heart Failure | Dobutamine | 14.98 | 17440445 | |
| MESH:D006333 | Heart Failure | Doxorubicin | 14.98 | 17481944 | |
| MESH:D006333 | Heart Failure | Isoproterenol | 14.98 | 18097624 | |
| MESH:D006333 | Heart Failure | pirinixic acid | 14.98 | 20558911 | |
| MESH:D006333 | Heart Failure | pitavastatin | 14.98 | 15502390 | |
| MESH:D006333 | Heart Failure | Plant Extracts | 14.98 | 18097624 | |
| MESH:D006333 | Heart Failure | Selenium | 14.98 | 17162251 | |
| MESH:D006394 | Hemangiosarcoma | Doxorubicin | 2.50 | 15692506 | |
| MESH:D006432 | Hemochromatosis | Iron | 3.18 | 17255318 16574947 16604332 16640825 17236123 17053826 | |
| MESH:D006461 | Hemolysis | allyl alcohol | 4.66 | 2222504 | |
| MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 2.94 | 16366002 | |
| MESH:D006467 | Hemophilia A | Cyclophosphamide | 3.73 | 11918545 | |
| MESH:D006470 | Hemorrhage | Endosulfan | 5.57 | 7900959 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 5.57 | 11000095 | |
| MESH:D006486 | Hemosiderosis | Iron | 3.63 | 16604332 | |
| MESH:D006501 | Hepatic Encephalopathy | Ammonia | 9.80 | 20549931 12420312 16338762 | |
| MESH:D006501 | Hepatic Encephalopathy | Indomethacin | 9.80 | 15633222 | |
| MESH:D006501 | Hepatic Encephalopathy | Thioacetamide | 9.80 | 18665440 15929193 17276928 | |
| MESH:D006504 | Hepatic Veno-Occlusive Disease | Cyclophosphamide | 3.93 | 14986274 | |
| MESH:D006505 | Hepatitis | 1-Naphthylisothiocyanate | 25.51 | 18590720 | |
| MESH:D006505 | Hepatitis | allyl alcohol | 25.51 | 11394713 | |
| MESH:D006505 | Hepatitis | Carbon Tetrachloride | 25.51 | 19110552 19900420 | |
| MESH:D006505 | Hepatitis | DDT | 25.51 | 16487989 | |
| MESH:D006505 | Hepatitis | Dichlorodiphenyl Dichloroethylene | 25.51 | 16487989 | |
| MESH:D006505 | Hepatitis | Drugs, Chinese Herbal | 25.51 | 18339527 | |
| MESH:D006505 | Hepatitis | Thioacetamide | 25.51 | 16456712 | |
| MESH:D006505 | Hepatitis | Zymosan | 25.51 | 19110552 | |
| MESH:D019698 | Hepatitis C, Chronic | Indomethacin | 3.16 | 15135802 | |
| MESH:D006521 | Hepatitis, Chronic | Copper | 6.82 | 17338147 | |
| MESH:D006521 | Hepatitis, Chronic | Diclofenac | 6.82 | 14986274 | |
| MESH:D006525 | Hepatitis, Viral, Human | Iron | 3.87 | 16640825 | |
| MESH:D006527 | Hepatolenticular Degeneration | Copper | 6.36 | 17182432 19888908 16607473 17109627 17276780 | |
| MESH:D006527 | Hepatolenticular Degeneration | Iron | 6.36 | 17182432 | |
| MESH:D006529 | Hepatomegaly | DDT | 8.47 | 2387028 | |
| MESH:D006529 | Hepatomegaly | Iron | 8.47 | 16890145 | |
| MESH:D006529 | Hepatomegaly | pirinixic acid | 8.47 | 16221962 19176532 19772884 18467677 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 8.47 | 15340226 12621046 16120746 | |
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 3.48 | 17701891 | |
| MESH:D006548 | Hernia, Diaphragmatic | Ascorbic Acid | 3.29 | 16863852 16490937 | |
| MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 3.29 | 7520565 | |
| MESH:D006558 | Herpes Genitalis | Estradiol | 3.42 | 15709030 | |
| MESH:D006561 | Herpes Simplex | Etoposide | 14.38 | 10809021 | |
| MESH:D006561 | Herpes Simplex | Mangifera indica extract | 14.38 | 10715843 | |
| MESH:D006561 | Herpes Simplex | mangiferin | 14.38 | 10715843 | |
| MESH:D006561 | Herpes Simplex | Plant Extracts | 14.38 | 10715843 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 14.38 | 16876885 | |
| MESH:D015658 | HIV Infections | Iron | 3.52 | 16597321 | |
| MESH:D015658 | HIV Infections | Plant Extracts | 3.52 | 12878215 | |
| MESH:D006689 | Hodgkin Disease | Bleomycin | 8.52 | 15147373 18501091 17606976 | |
| MESH:D006689 | Hodgkin Disease | Cyclophosphamide | 8.52 | 17606976 16135485 | |
| MESH:D006689 | Hodgkin Disease | Doxorubicin | 8.52 | 17606976 15147373 18501091 | |
| MESH:D006689 | Hodgkin Disease | Etoposide | 8.52 | 17606976 16200630 18180244 15147373 16135485 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 8.52 | 12676792 | |
| MESH:D019584 | Hot Flashes | Estradiol | 11.78 | 17088409 | |
| MESH:D019584 | Hot Flashes | gabapentin | 11.78 | 14716179 | |
| MESH:D019584 | Hot Flashes | Plant Extracts | 11.78 | 16566672 14716179 17454163 | |
| MESH:D019584 | Hot Flashes | Trazodone | 11.78 | 19711746 | |
| MESH:D006869 | Hydronephrosis | Lithium Chloride | 7.74 | 19797860 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 7.74 | 15340226 16959395 16354765 8697196 18606429 | |
| MESH:D012001 | Hyperacusis | Aspirin | 4.16 | 15240983 | |
| MESH:D006930 | Hyperalgesia | 4-(nitroxy)butanoic acid 4-acetylaminophenyl ester | 30.27 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Acetaminophen | 30.27 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Capsaicin | 30.27 | 17043245 17434803 | |
| MESH:D006930 | Hyperalgesia | Dinoprostone | 30.27 | 16793879 | |
| MESH:D006930 | Hyperalgesia | Ethanol | 30.27 | 18783367 | |
| MESH:D006930 | Hyperalgesia | Indomethacin | 30.27 | 12727271 | |
| MESH:D006930 | Hyperalgesia | Prazosin | 30.27 | 12727271 | |
| MESH:D006930 | Hyperalgesia | rosiglitazone | 30.27 | 12083418 | |
| MESH:D006930 | Hyperalgesia | Trazodone | 30.27 | 12790215 | |
| MESH:D006930 | Hyperalgesia | Yohimbine | 30.27 | 12727271 | |
| MESH:D006930 | Hyperalgesia | zoledronic acid | 30.27 | 16769263 | |
| MESH:D034321 | Hyperamylasemia | Indomethacin | 4.11 | 17883296 | |
| MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 2.95 | 16899240 | |
| MESH:D006934 | Hypercalcemia | zoledronic acid | 3.58 | 19622757 18089816 | |
| MESH:D053565 | Hypercalciuria | Gentamicins | 4.13 | 17652376 | |
| MESH:D006937 | Hypercholesterolemia | 27-hydroxycholesterol | 16.98 | 17873880 | |
| MESH:D006937 | Hypercholesterolemia | Cholesterol | 16.98 | 16933029 | |
| MESH:D006937 | Hypercholesterolemia | Curcumin | 16.98 | 18704882 | |
| MESH:D006937 | Hypercholesterolemia | Dietary Fats | 16.98 | 21332399 | |
| MESH:D006937 | Hypercholesterolemia | Pravastatin | 16.98 | 17188708 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 16.98 | 17188708 | |
| MESH:D006940 | Hyperemia | marker/mechanism | 12646421 | ||
| MESH:D006940 | Hyperemia | Hydrochloric Acid | 12.25 | 12646421 | |
| MESH:D006940 | Hyperemia | Indomethacin | 12.25 | 12524144 | |
| MESH:D006940 | Hyperemia | Nitric Oxide | 12.25 | 11156591 | |
| MESH:D006943 | Hyperglycemia | kaempferol | 7.51 | 18262572 | |
| MESH:D006943 | Hyperglycemia | pirinixic acid | 7.51 | 20558911 | |
| MESH:D006943 | Hyperglycemia | Quercetin | 7.51 | 11834736 18262572 | |
| MESH:D020138 | Hyperhomocysteinemia | Carbamazepine | 10.60 | 10459572 | |
| MESH:D020138 | Hyperhomocysteinemia | Catechin | 10.60 | 17292331 | |
| MESH:D020138 | Hyperhomocysteinemia | Plant Extracts | 10.60 | 16484555 | |
| MESH:D020138 | Hyperhomocysteinemia | Superoxides | 10.60 | 12615666 | |
| MESH:D006946 | Hyperinsulinism | Fructose | 5.84 | 15752949 19008412 14757778 18563319 18360027 | |
| MESH:D006946 | Hyperinsulinism | mangiferin | 5.84 | 11315760 9881663 | |
| MESH:D006948 | Hyperkinesis | Amphetamine | 3.87 | 14960337 1977408 | |
| MESH:D006949 | Hyperlipidemias | Dietary Fats | 16.99 | 21332399 | |
| MESH:D006949 | Hyperlipidemias | Fructose | 16.99 | 15752949 | |
| MESH:D006949 | Hyperlipidemias | Indomethacin | 16.99 | 17546600 | |
| MESH:D006949 | Hyperlipidemias | mangiferin | 16.99 | 15975614 | |
| MESH:D006949 | Hyperlipidemias | Plant Extracts | 16.99 | 15268973 15975614 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 16.99 | 16873680 | |
| MESH:D006938 | Hyperlipoproteinemia Type II | Simvastatin | 3.86 | 16238680 | |
| MESH:D006965 | Hyperplasia | Carbamazepine | 3.68 | 18773962 | |
| MESH:D006967 | Hypersensitivity | fexofenadine | 9.29 | 17910814 | |
| MESH:D006967 | Hypersensitivity | Mangifera indica extract | 9.29 | 16536907 | |
| MESH:D006967 | Hypersensitivity | mangiferin | 9.29 | 16536907 | |
| MESH:D006967 | Hypersensitivity | Toluene 2,4-Diisocyanate | 9.29 | 10880147 11019492 | |
| MESH:D006973 | Hypertension | carvedilol | 12.52 | 16640825 | |
| MESH:D006973 | Hypertension | daidzein | 12.52 | 17169123 | |
| MESH:D006973 | Hypertension | Dexamethasone | 12.52 | 17042910 | |
| MESH:D006973 | Hypertension | Fructose | 12.52 | 14568997 14633139 19008412 16843071 14573337 | |
| MESH:D006973 | Hypertension | Phenylephrine | 12.52 | 12717712 8949925 | |
| MESH:D006973 | Hypertension | Quercetin | 12.52 | 18356687 | |
| MESH:D006973 | Hypertension | Raloxifene | 12.52 | 17577099 15787275 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 12.52 | 18850075 18670907 | |
| OMIM:145500 | HYPERTENSION, ESSENTIAL | marker/mechanism | |||
| MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 6.29 | 15338365 | |
| MESH:D006975 | Hypertension, Portal | Hydrochloric Acid | 6.29 | 16984587 | |
| MESH:D046110 | Hypertension, Pregnancy-Induced | Diazoxide | 5.10 | 16612254 | |
| MESH:D006976 | Hypertension, Pulmonary | cyclo(Trp-Asp-Pro-Val-Leu) | 8.66 | 16327149 | |
| MESH:D006976 | Hypertension, Pulmonary | Hydrochloric Acid | 8.66 | 19262391 | |
| MESH:D006976 | Hypertension, Pulmonary | Monocrotaline | 8.66 | 16936438 17042913 14726295 | |
| MESH:D006976 | Hypertension, Pulmonary | Nitric Oxide | 8.66 | 15838368 | |
| MESH:D015228 | Hypertriglyceridemia | Fructose | 6.55 | 19342510 19799862 | |
| MESH:D015228 | Hypertriglyceridemia | Triglycerides | 6.55 | 16979400 16238453 | |
| MESH:D006984 | Hypertrophy | Ibuprofen | 9.43 | 16672835 | |
| MESH:D006984 | Hypertrophy | Isoproterenol | 9.43 | 12791704 | |
| MESH:D006984 | Hypertrophy | Phenylephrine | 9.43 | 12791704 18502941 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | phenylmethylpyrazolone | 5.97 | 15824197 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 5.97 | 17488730 | |
| MESH:D006996 | Hypocalcemia | zoledronic acid | 4.58 | 12669777 | |
| MESH:D007003 | Hypoglycemia | Glyburide | 4.47 | 10918110 | |
| MESH:C537150 | Hypoglycemia, leucine-induced | Diazoxide | 5.62 | 6510895 | |
| MESH:D007006 | Hypogonadism | Iron | 3.12 | 16640825 | |
| MESH:C537153 | Hypomagnesemia primary | Tacrolimus | 4.57 | 11041285 | |
| MESH:D007022 | Hypotension | anandamide | 16.35 | 14504685 | |
| MESH:D007022 | Hypotension | Epinephrine | 16.35 | 6740701 | |
| MESH:D007022 | Hypotension | Hydrochloric Acid | 16.35 | 11574821 | |
| MESH:D007022 | Hypotension | Isoflurane | 16.35 | 12967683 | |
| MESH:D007022 | Hypotension | Isoproterenol | 16.35 | 6740701 | |
| MESH:D007022 | Hypotension | Tacrolimus | 16.35 | 11041285 | |
| MESH:D007024 | Hypotension, Orthostatic | Trazodone | 4.43 | 15811171 | |
| MESH:D007037 | Hypothyroidism | Iron | 3.54 | 16640825 | |
| MESH:D007077 | Ileal Diseases | Indomethacin | 12.57 | 10574470 18306037 | |
| MESH:D007077 | Ileal Diseases | irsogladine | 12.57 | 18306037 | |
| MESH:D007077 | Ileal Diseases | Rolipram | 12.57 | 18306037 | |
| MESH:D007079 | Ileitis | Indomethacin | 3.77 | 10647630 10651667 16133968 | |
| MESH:D007154 | Immune System Diseases | Cyclophosphamide | 8.15 | 16076520 | |
| MESH:D007154 | Immune System Diseases | mangiferin | 8.15 | 16076520 | |
| MESH:D007235 | Infant, Premature, Diseases | Ibuprofen | 8.89 | 16133044 | |
| MESH:D007235 | Infant, Premature, Diseases | Indomethacin | 8.89 | 16133044 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | Progesterone | 6.35 | 15869954 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 6.35 | 17600658 | |
| MESH:D007247 | Infertility, Female | Acrylamide | 3.73 | 11020651 | |
| MESH:D007248 | Infertility, Male | Acrylamide | 34.51 | 15749267 12507653 15355880 11020651 | |
| MESH:D007248 | Infertility, Male | alachlor | 34.51 | 16466525 17049205 12948887 | |
| MESH:D007248 | Infertility, Male | Cyclophosphamide | 34.51 | 16517039 7193160 | |
| MESH:D007248 | Infertility, Male | DDT | 34.51 | 17192596 17157474 | |
| MESH:D007248 | Infertility, Male | Dichlorodiphenyl Dichloroethylene | 34.51 | 12948891 17192596 | |
| MESH:D007248 | Infertility, Male | Endosulfan | 34.51 | 8588293 9432128 | |
| MESH:D007248 | Infertility, Male | fulvestrant | 34.51 | 11514358 | |
| MESH:D007248 | Infertility, Male | Methoxychlor | 34.51 | 16467254 11955947 | |
| MESH:D007248 | Infertility, Male | Methylnitrosourea | 34.51 | 7193160 | |
| MESH:D007248 | Infertility, Male | Paraquat | 34.51 | 4850670 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 34.51 | 12646999 15346721 | |
| MESH:D007248 | Infertility, Male | Sulfasalazine | 34.51 | 10689203 | |
| MESH:D007248 | Infertility, Male | Theophylline | 34.51 | 16988215 | |
| MESH:D007248 | Infertility, Male | vinclozolin | 34.51 | 16467254 | |
| MESH:D007249 | Inflammation | marker/mechanism | 11289658 | ||
| MESH:D007249 | Inflammation | 4-dimethylamino-3',4'-dimethoxychalcone | 111.00 | 11134894 | |
| MESH:D007249 | Inflammation | aloe emodin | 111.00 | 19352036 | |
| MESH:D007249 | Inflammation | Aluminum | 111.00 | 16052892 | |
| MESH:D007249 | Inflammation | Bleomycin | 111.00 | 17118201 | |
| MESH:D007249 | Inflammation | bolinaquinone | 111.00 | 12604694 | |
| MESH:D007249 | Inflammation | cacospongionolide B | 111.00 | 12721113 | |
| MESH:D007249 | Inflammation | calpain inhibitor III | 111.00 | 15275793 | |
| MESH:D007249 | Inflammation | Capsaicin | 111.00 | 16956363 | |
| MESH:D007249 | Inflammation | Carrageenan | 111.00 | 7907874 8985016 12798668 18295198 19934399 12428691 16100529 10653021 12787963 | |
| MESH:D007249 | Inflammation | Curcumin | 111.00 | 17151092 18403477 16956363 | |
| MESH:D007249 | Inflammation | Dexamethasone | 111.00 | 8960868 11099482 | |
| MESH:D007249 | Inflammation | Diclofenac | 111.00 | 16273134 | |
| MESH:D007249 | Inflammation | Dietary Fats | 111.00 | 20412841 | |
| MESH:D007249 | Inflammation | Diethylnitrosamine | 111.00 | 18785209 | |
| MESH:D007249 | Inflammation | Flavonoids | 111.00 | 17296493 | |
| MESH:D007249 | Inflammation | honokiol | 111.00 | 19539808 | |
| MESH:D007249 | Inflammation | Hydrochloric Acid | 111.00 | 11574821 | |
| MESH:D007249 | Inflammation | Ibuprofen | 111.00 | 3291741 | |
| MESH:D007249 | Inflammation | Indomethacin | 111.00 | 3291741 7812673 12568917 | |
| MESH:D007249 | Inflammation | Iodine | 111.00 | 16001271 | |
| MESH:D007249 | Inflammation | Lipopolysaccharides | 111.00 | 9205823 17255318 12878042 17963957 17237260 | |
| MESH:D007249 | Inflammation | Mangifera indica extract | 111.00 | 15222974 15177302 | |
| MESH:D007249 | Inflammation | mangiferin | 111.00 | 15222974 | |
| MESH:D007249 | Inflammation | montelukast | 111.00 | 18059327 | |
| MESH:D007249 | Inflammation | Mustard Gas | 111.00 | 11428647 17524151 9357497 9260866 16001271 8975870 11428631 11428620 11402378 | |
| MESH:D007249 | Inflammation | nimesulide | 111.00 | 11438310 | |
| MESH:D007249 | Inflammation | petrosaspongiolide m | 111.00 | 12628480 | |
| MESH:D007249 | Inflammation | pioglitazone | 111.00 | 16908763 | |
| MESH:D007249 | Inflammation | Plant Extracts | 111.00 | 19332304 16366677 12787963 15997105 | |
| MESH:D007249 | Inflammation | polyphenols | 111.00 | 16366677 | |
| MESH:D007249 | Inflammation | Progesterone | 111.00 | 15869954 | |
| MESH:D007249 | Inflammation | resveratrol | 111.00 | 16366677 | |
| MESH:D007249 | Inflammation | rosiglitazone | 111.00 | 12083418 | |
| MESH:D007249 | Inflammation | Roxithromycin | 111.00 | 17524151 | |
| MESH:D007249 | Inflammation | Silymarin | 111.00 | 17213517 | |
| MESH:D007249 | Inflammation | Tamoxifen | 111.00 | 19457130 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 111.00 | 12878042 12200463 | |
| MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 111.00 | 7562506 8273558 11698051 7812673 15177302 | |
| MESH:D007249 | Inflammation | Thalidomide | 111.00 | 16134734 | |
| MESH:D007249 | Inflammation | Trazodone | 111.00 | 12798668 | |
| MESH:D007249 | Inflammation | Zymosan | 111.00 | 8014878 11289658 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 11.35 | 18200517 18596194 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Dextran Sulfate | 11.35 | 20423518 15339030 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Leukotriene B4 | 11.35 | 11006272 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Rutin | 11.35 | 15652231 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Sulfasalazine | 11.35 | 15339030 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Trinitrobenzenesulfonic Acid | 11.35 | 18200517 | |
| MESH:D007251 | Influenza, Human | pyrrolidine dithiocarbamic acid | 13.87 | 18473937 | |
| MESH:D007251 | Influenza, Human | Quercetin | 13.87 | 16624496 | |
| MESH:D007251 | Influenza, Human | resveratrol | 13.87 | 16624496 | |
| MESH:D007251 | Influenza, Human | Selenium | 13.87 | 16624496 | |
| MESH:D007333 | Insulin Resistance | bisphenol A | 22.57 | 16393666 | |
| MESH:D007333 | Insulin Resistance | Dietary Fats | 22.57 | 11836018 18457598 | |
| MESH:D007333 | Insulin Resistance | Endotoxins | 22.57 | 20353583 | |
| MESH:D007333 | Insulin Resistance | Estradiol | 22.57 | 16627594 16393666 | |
| MESH:D007333 | Insulin Resistance | Fructose | 22.57 | 19008412 19586609 17133782 14633139 19799862 18981581 19342510 18563319 14757778 18057795 14573337 | |
| MESH:D007333 | Insulin Resistance | mangiferin | 22.57 | 11315760 | |
| MESH:D007333 | Insulin Resistance | pirinixic acid | 22.57 | 16306350 | |
| MESH:D007333 | Insulin Resistance | rosiglitazone | 22.57 | 16306350 | |
| MESH:D007333 | Insulin Resistance | Sodium Selenite | 22.57 | 14714311 | |
| MESH:D007410 | Intestinal Diseases | marker/mechanism | 11713966 | ||
| MESH:D007410 | Intestinal Diseases | Hydrochloric Acid | 32.17 | 11574821 | |
| MESH:D007410 | Intestinal Diseases | Indomethacin | 32.17 | 15831440 15610444 11686837 18236018 17329856 10210152 11713966 17994277 11855677 | |
| MESH:D007410 | Intestinal Diseases | N-(3-(aminomethyl)benzyl)acetamidine | 32.17 | 11713966 | |
| MESH:D007410 | Intestinal Diseases | Nitric Oxide | 32.17 | 10210152 11713966 11574821 | |
| MESH:D007410 | Intestinal Diseases | pimagedine | 32.17 | 11713966 | |
| MESH:D007410 | Intestinal Diseases | rebamipide | 32.17 | 11686837 | |
| MESH:D007410 | Intestinal Diseases | Superoxides | 32.17 | 10210152 | |
| MESH:D007410 | Intestinal Diseases | thiaton | 32.17 | 11855677 | |
| MESH:D007410 | Intestinal Diseases | Trinitrobenzenesulfonic Acid | 32.17 | 17994277 | |
| MESH:D007414 | Intestinal Neoplasms | Curcumin | 5.33 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Plant Extracts | 5.33 | 12351151 12584176 12628509 | |
| MESH:D002532 | Intracranial Aneurysm | phenylmethylpyrazolone | 5.96 | 19381132 | |
| MESH:D002532 | Intracranial Aneurysm | Reactive Oxygen Species | 5.96 | 19381132 | |
| MESH:D019586 | Intracranial Hypertension | Indomethacin | 3.77 | 15241188 | |
| MESH:D019189 | Iron Metabolism Disorders | Iron | 6.61 | 17163184 | |
| MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 6.61 | 17255318 | |
| MESH:D043183 | Irritable Bowel Syndrome | Zymosan | 4.25 | 17553498 | |
| MESH:D007511 | Ischemia | Mangifera indica extract | 9.70 | 16273134 | |
| MESH:D007511 | Ischemia | mangiferin | 9.70 | 16806951 | |
| MESH:D007511 | Ischemia | phenylmethylpyrazolone | 9.70 | 16301206 | |
| MESH:D002546 | Ischemic Attack, Transient | zonisamide | 5.29 | 9372210 | |
| MESH:D007569 | Jaw Abnormalities | Ethanol | 5.24 | 15513904 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 5.24 | 16580747 | |
| MESH:D007579 | Jejunal Diseases | Indomethacin | 12.57 | 18306037 16133968 10574470 | |
| MESH:D007579 | Jejunal Diseases | irsogladine | 12.57 | 18306037 | |
| MESH:D007579 | Jejunal Diseases | Rolipram | 12.57 | 18306037 | |
| MESH:D007627 | Keloid | Quercetin | 3.40 | 17086741 | |
| MESH:D007673 | Kidney Cortex Necrosis | Gentamicins | 4.13 | 18842672 | |
| MESH:D007674 | Kidney Diseases | Acetaminophen | 37.11 | 15629191 12587719 | |
| MESH:D007674 | Kidney Diseases | Cadmium | 37.11 | 16962696 16322080 16226777 | |
| MESH:D007674 | Kidney Diseases | Cadmium Chloride | 37.11 | 16962696 | |
| MESH:D007674 | Kidney Diseases | Doxorubicin | 37.11 | 16775033 15369732 15699352 | |
| MESH:D007674 | Kidney Diseases | Estradiol | 37.11 | 15618244 | |
| MESH:D007674 | Kidney Diseases | ferric nitrilotriacetate | 37.11 | 18617210 15834431 | |
| MESH:D007674 | Kidney Diseases | Gentamicins | 37.11 | 18289764 17934191 19349640 | |
| MESH:D007674 | Kidney Diseases | Indomethacin | 37.11 | 17190690 | |
| MESH:D007674 | Kidney Diseases | mangiferin | 37.11 | 12093613 | |
| MESH:D007674 | Kidney Diseases | ochratoxin A | 37.11 | 11409539 | |
| MESH:D007674 | Kidney Diseases | phenylmethylpyrazolone | 37.11 | 18085390 | |
| MESH:D007674 | Kidney Diseases | Quercetin | 37.11 | 16962696 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 37.11 | 20008137 | |
| MESH:D007674 | Kidney Diseases | Streptozocin | 37.11 | 12093613 | |
| MESH:D007674 | Kidney Diseases | Tacrolimus | 37.11 | 11041285 | |
| MESH:D007674 | Kidney Diseases | tempol | 37.11 | 17640563 | |
| MESH:D007676 | Kidney Failure, Chronic | Copper | 11.95 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 11.95 | 16707910 | |
| MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 11.95 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Selenium | 11.95 | 16518626 | |
| MESH:D007680 | Kidney Neoplasms | Estradiol | 9.10 | 15610895 | |
| MESH:D007680 | Kidney Neoplasms | ferric nitrilotriacetate | 9.10 | 18055543 9667754 | |
| MESH:D007680 | Kidney Neoplasms | Fluorouracil | 9.10 | 16985049 | |
| MESH:D007680 | Kidney Neoplasms | ochratoxin A | 9.10 | 16251485 | |
| MESH:D007680 | Kidney Neoplasms | Tamoxifen | 9.10 | 18625569 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Gentamicins | 3.80 | 11231351 | |
| MESH:D007805 | Language Development Disorders | Methotrexate | 3.60 | 9562676 | |
| MESH:D007818 | Laryngeal Diseases | Hydrochloric Acid | 4.75 | 16498863 | |
| MESH:D007826 | Laryngismus | Hydrochloric Acid | 4.75 | 11510729 | |
| MESH:D007859 | Learning Disorders | Cholesterol | 21.83 | 17134702 | |
| MESH:D007859 | Learning Disorders | Copper | 21.83 | 17134702 | |
| MESH:D007859 | Learning Disorders | DDT | 21.83 | 7589230 | |
| MESH:D007859 | Learning Disorders | Endosulfan | 21.83 | 8157075 | |
| MESH:D007859 | Learning Disorders | Ethanol | 21.83 | 15451040 | |
| MESH:D007859 | Learning Disorders | icariin | 21.83 | 19782061 | |
| MESH:D007859 | Learning Disorders | mangiferin | 21.83 | 19182383 | |
| MESH:D007889 | Leiomyoma | Curcumin | 6.18 | 18555241 | |
| MESH:D007889 | Leiomyoma | Raloxifene | 6.18 | 16973256 | |
| MESH:D007896 | Leishmaniasis | Antimony Sodium Gluconate | 5.19 | 20139272 7945751 7960131 8059918 | |
| MESH:D007896 | Leishmaniasis | Nitric Oxide | 5.19 | 17218153 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Antimony Sodium Gluconate | 8.78 | 15610669 1323630 8407083 9770149 11528583 20438389 12032913 9234779 1314873 15234329 19744259 9299828 1311351 15259478 10886148 2166429 14512915 9499605 7570843 17278657 7724530 10786029 1329273 2160914 10617787 10542306 10233236 7682386 1322070 9314461 15678803 10647737 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Gentamicins | 8.78 | 10219319 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Indomethacin | 8.78 | 11703811 12228301 10320625 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Pentoxifylline | 8.78 | 16863518 | |
| MESH:D007897 | Leishmaniasis, Mucocutaneous | Antimony Sodium Gluconate | 7.26 | 1325634 1322070 7519887 16135192 1645930 2173461 | |
| MESH:D007897 | Leishmaniasis, Mucocutaneous | Pentoxifylline | 7.26 | 11508396 | |
| MESH:D007898 | Leishmaniasis, Visceral | Antimony Sodium Gluconate | 4.49 | 15716043 10617787 1319700 10603400 12803856 9498473 15518175 11398119 9856145 1659303 11035738 7983993 1645929 12898450 7903366 16131481 12955641 18765878 15610669 11751149 7844400 1315397 17382981 15328135 7932924 1314709 8607595 9625910 1658990 1337639 11417033 10467834 10604050 16432602 1315396 11069076 7715298 17911647 8394861 11049798 12379707 9844051 9531339 10805470 12870129 10952587 15868188 15896700 17300636 12718341 9756784 7498017 8916804 1852133 10569788 16117959 9665985 20576500 2098410 10886148 | |
| MESH:D007898 | Leishmaniasis, Visceral | Thalidomide | 4.49 | 16514283 | |
| MESH:D007938 | Leukemia | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 13.03 | 12970779 | |
| MESH:D007938 | Leukemia | alachlor | 13.03 | 14769641 | |
| MESH:D007938 | Leukemia | Curcumin | 13.03 | 18462866 | |
| MESH:D007938 | Leukemia | Cyclophosphamide | 13.03 | 10602166 | |
| MESH:D007938 | Leukemia | Genistein | 13.03 | 18980019 17468513 | |
| MESH:D007938 | Leukemia | kaempferol | 13.03 | 17468513 | |
| MESH:D007938 | Leukemia | Quercetin | 13.03 | 17468513 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 3.55 | 16085563 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Cyclophosphamide | 6.86 | 17658394 17802794 17008537 18172266 18587576 17296974 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Disulfiram | 6.86 | 17026967 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Drugs, Chinese Herbal | 6.86 | 15802533 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | honokiol | 6.86 | 15802533 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 8.10 | 16106398 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Emodin | 8.10 | 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | zoledronic acid | 8.10 | 18089816 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | anthra(1,9-cd)pyrazol-6(2H)-one | 10.80 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 10.80 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | U 0126 | 10.80 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Cyclophosphamide | 6.65 | 10373061 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Indomethacin | 6.65 | 16572323 15631656 10785260 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | mangiferin | 6.65 | 15498116 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Deferoxamine | 3.69 | 20368581 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Indomethacin | 3.69 | 18360721 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | SU 5416 | 3.69 | 12649163 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Thalidomide | 3.69 | 18720364 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 2.41 | 16087638 | |
| MESH:D015458 | Leukemia, T-Cell | Curcumin | 3.23 | 16106398 | |
| MESH:D007964 | Leukocytosis | Indomethacin | 3.77 | 16537180 | |
| MESH:D007969 | Leukomalacia, Periventricular | Indomethacin | 4.11 | 17980183 | |
| MESH:D007970 | Leukopenia | Cyclophosphamide | 6.57 | 11830472 10052129 | |
| MESH:D007970 | Leukopenia | Lipopolysaccharides | 6.57 | 15821434 | |
| MESH:D020961 | Lewy Body Disease | Iron | 3.87 | 16563566 | |
| MESH:D007984 | Leydig Cell Tumor | vinclozolin | 3.15 | 16417039 | |
| MESH:D017880 | Limb Deformities, Congenital | Dichlorodiphenyl Dichloroethylene | 11.88 | 12745335 | |
| MESH:D017880 | Limb Deformities, Congenital | Disulfiram | 11.88 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Ethanol | 11.88 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Methylnitrosourea | 11.88 | 15526292 | |
| MESH:D017880 | Limb Deformities, Congenital | Thalidomide | 11.88 | 10473037 | |
| MESH:D008064 | Lipidoses | Tamoxifen | 1.94 | 17567588 15342952 | |
| MESH:D008101 | Liver Abscess, Amebic | Indomethacin | 4.11 | 11479899 | |
| MESH:D008103 | Liver Cirrhosis | arsenite | 32.87 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 32.87 | 17157831 11408273 11903743 16943688 21278145 16239168 16221502 17334410 17174718 | |
| MESH:D008103 | Liver Cirrhosis | Dietary Fats | 32.87 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 32.87 | 18522880 18407596 18665156 19638242 20032147 | |
| MESH:D008103 | Liver Cirrhosis | Drugs, Chinese Herbal | 32.87 | 17163593 | |
| MESH:D008103 | Liver Cirrhosis | Endotoxins | 32.87 | 20353583 | |
| MESH:D008103 | Liver Cirrhosis | Ethanol | 32.87 | 15289165 | |
| MESH:D008103 | Liver Cirrhosis | Hydrochloric Acid | 32.87 | 16984587 | |
| MESH:D008103 | Liver Cirrhosis | Iron | 32.87 | 16640825 | |
| MESH:D008103 | Liver Cirrhosis | Methotrexate | 32.87 | 14986274 | |
| MESH:D008103 | Liver Cirrhosis | Plant Extracts | 32.87 | 17157831 | |
| MESH:D008103 | Liver Cirrhosis | Silymarin | 32.87 | 17213517 | |
| MESH:D008103 | Liver Cirrhosis | Thalidomide | 32.87 | 17174718 16943688 | |
| MESH:D008104 | Liver Cirrhosis, Alcoholic | Ethanol | 3.52 | 18295389 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | Ursodeoxycholic Acid | 3.95 | 12468960 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | therapeutic | 18380797 | ||
| MESH:D008106 | Liver Cirrhosis, Experimental | allyl alcohol | 62.53 | 11063159 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | baicalin | 62.53 | 18187930 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | calpain inhibitor III | 62.53 | 15316131 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 62.53 | 14512876 18156304 17481882 18395095 15370692 18420326 12546737 17944888 17557913 18279442 14748882 15876570 18472094 17640975 18054572 11481614 12898905 14716496 12632514 18339082 16136751 18429990 17708605 15057751 15730626 15650968 18277467 12609069 15925388 12667390 15673190 17525996 12649538 14716833 12445418 15893842 12958196 12445421 16248980 17900296 15931870 10355542 17714472 16192424 18210741 18317297 12389079 17823541 15996030 17976157 17922224 17721639 18395914 17565644 17761835 15052691 18376398 18205269 16638106 18481824 14620537 16027843 17766677 12632512 17805973 12666154 15818738 16033810 17869086 17631135 12741479 16097048 12586293 13678700 17698563 18166357 18412020 18418968 15338365 15959796 18251166 14724832 18006644 20821823 18472332 18705752 16015684 16116963 18263696 15123356 15362042 18187930 16011737 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 62.53 | 17355460 18705752 18006644 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 62.53 | 16718785 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dimethylnitrosamine | 62.53 | 15086199 15369754 14568256 17534399 16009107 17881167 18364076 18239293 15763062 16169303 17432682 16627068 15067225 15161499 15571005 15723089 14709902 15793283 12925901 18637143 18237412 14726149 15298665 14659978 18672772 15138612 17724770 15577212 16270385 17203207 15339415 15383259 15366600 15591649 18095165 15798949 18371158 18210741 16544323 17201889 17719030 17198567 15733078 18629640 17196135 15744066 15942678 16570917 17348192 14643895 15842777 16603200 12918455 15504291 15864749 18567088 17666798 17465448 15479170 15492853 17640959 16042886 17036385 15081153 15099470 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dinoprostone | 62.53 | 15816358 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 62.53 | 16595196 16439617 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Drugs, Chinese Herbal | 62.53 | 15641146 16610055 15763062 18606216 15864749 15744066 17348192 18567088 15849816 12632512 15818738 17881167 17036385 15754396 15339415 15383259 17629604 17666798 18237412 18371158 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Emodin | 62.53 | 15288473 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | epigallocatechin gallate | 62.53 | 17481882 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 62.53 | 14716833 14659978 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Ethanol | 62.53 | 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | gadolinium chloride | 62.53 | 12666154 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 62.53 | 17823541 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Indomethacin | 62.53 | 18194892 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 62.53 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Melatonin | 62.53 | 15925388 15298665 16703270 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Methionine | 62.53 | 15158331 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | naringenin | 62.53 | 14709902 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Pentoxifylline | 62.53 | 16703270 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pioglitazone | 62.53 | 15052691 16484506 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 62.53 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Extracts | 62.53 | 15479170 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Preparations | 62.53 | 17724770 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Poly I-C | 62.53 | 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pyrrolidine dithiocarbamic acid | 62.53 | 15078482 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 62.53 | 12741479 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | rosiglitazone | 62.53 | 15980055 17347453 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | silybin | 62.53 | 16169303 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Silymarin | 62.53 | 15864749 17198567 15754394 18277467 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Sulfasalazine | 62.53 | 15633128 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 62.53 | 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 62.53 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Thalidomide | 62.53 | 15465738 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Thioacetamide | 62.53 | 12175628 16343077 14739098 16126171 12085344 18031379 15288473 11682029 12679928 15474484 16489207 17292413 18416461 17355460 12557150 15158331 18032466 15288472 16097051 15716488 15334695 15465738 18295389 15095483 12531686 15362042 10677585 18458672 17629604 18380797 18606216 16248980 11481614 15078482 16098781 17050028 17127702 18263696 15075984 15316131 18395095 11172339 16511523 18615449 12891558 | |
| MESH:D008107 | Liver Diseases | marker/mechanism | 19784758 | ||
| MESH:D008107 | Liver Diseases | 1-Naphthylisothiocyanate | 34.41 | 17184895 | |
| MESH:D008107 | Liver Diseases | Acetaminophen | 34.41 | 16610002 12969438 19784758 19460945 12587719 16611625 11587558 19014921 | |
| MESH:D008107 | Liver Diseases | Antimony Sodium Gluconate | 34.41 | 7570843 | |
| MESH:D008107 | Liver Diseases | Capsaicin | 34.41 | 16956363 | |
| MESH:D008107 | Liver Diseases | Carbon Monoxide | 34.41 | 17173083 | |
| MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 34.41 | 15830285 16246199 15720792 17285989 16964402 | |
| MESH:D008107 | Liver Diseases | Curcumin | 34.41 | 16956363 | |
| MESH:D008107 | Liver Diseases | DDT | 34.41 | 15729006 | |
| MESH:D008107 | Liver Diseases | Diclofenac | 34.41 | 16867024 14566034 | |
| MESH:D008107 | Liver Diseases | Diethylnitrosamine | 34.41 | 17034775 | |
| MESH:D008107 | Liver Diseases | Dinoprostone | 34.41 | 15816358 | |
| MESH:D008107 | Liver Diseases | Drugs, Chinese Herbal | 34.41 | 17207593 | |
| MESH:D008107 | Liver Diseases | Hemin | 34.41 | 17173083 | |
| MESH:D008107 | Liver Diseases | naringenin | 34.41 | 16945181 | |
| MESH:D008107 | Liver Diseases | nimesulide | 34.41 | 16867024 | |
| MESH:D008107 | Liver Diseases | Plant Extracts | 34.41 | 17034775 | |
| MESH:D008107 | Liver Diseases | polyphenols | 34.41 | 16698588 | |
| MESH:D008107 | Liver Diseases | Silymarin | 34.41 | 17213517 | |
| MESH:D008107 | Liver Diseases | Thioacetamide | 34.41 | 18374380 15158337 16337175 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Ethanol | 10.28 | 17207112 17347304 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Iron | 10.28 | 17207112 16737972 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Silymarin | 10.28 | 17213517 | |
| MESH:D017093 | Liver Failure | Carbon Tetrachloride | 2.62 | 15123358 | |
| MESH:D017114 | Liver Failure, Acute | Acetaminophen | 15.44 | 17185352 16871587 | |
| MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 15.44 | 16899240 14706259 | |
| MESH:D017114 | Liver Failure, Acute | Dimethylnitrosamine | 15.44 | 17457977 | |
| MESH:D017114 | Liver Failure, Acute | Thioacetamide | 15.44 | 15633222 12479984 15313186 17276928 | |
| MESH:D017114 | Liver Failure, Acute | Trazodone | 15.44 | 19857765 | |
| MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 38.20 | 21137059 20195826 | |
| MESH:D008113 | Liver Neoplasms | beta-Naphthoflavone | 38.20 | 21295105 19389873 | |
| MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 38.20 | 19294768 | |
| MESH:D008113 | Liver Neoplasms | Copper | 38.20 | 20302851 | |
| MESH:D008113 | Liver Neoplasms | DDT | 38.20 | 15975961 11948501 | |
| MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 38.20 | 19255062 9163691 12112319 20405173 19812893 19551842 19499222 19427195 15175105 18754104 20137499 10737359 12771043 21047994 20583210 19073162 20101389 18978307 18648771 2422723 19996281 20118626 19638242 19833225 21071580 20492335 18977376 19850985 21278145 16942905 19294768 2862719 19254457 20501860 20452335 18644402 19690152 21167192 19426721 19256749 19090486 15885732 19642983 20434301 | |
| MESH:D008113 | Liver Neoplasms | Dimethylnitrosamine | 38.20 | 15890375 3113478 | |
| MESH:D008113 | Liver Neoplasms | Drugs, Chinese Herbal | 38.20 | 18339527 | |
| MESH:D008113 | Liver Neoplasms | Fluorouracil | 38.20 | 16603448 17045692 15113037 18383874 | |
| MESH:D008113 | Liver Neoplasms | Glycyrrhizic Acid | 38.20 | 19426721 | |
| MESH:D008113 | Liver Neoplasms | Iron | 38.20 | 20302851 16640825 | |
| MESH:D008113 | Liver Neoplasms | pirinixic acid | 38.20 | 15890375 20007298 16377806 | |
| MESH:D008113 | Liver Neoplasms | Plant Extracts | 38.20 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | Quercetin | 38.20 | 18980244 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 38.20 | 19321006 19812893 20405173 19073162 | |
| MESH:D008113 | Liver Neoplasms | Silymarin | 38.20 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 38.20 | 16712894 15276417 | |
| MESH:D008113 | Liver Neoplasms | Tamoxifen | 38.20 | 16684651 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 38.20 | 16984957 | |
| MESH:D008113 | Liver Neoplasms | Urethane | 38.20 | 16391232 17559639 17093202 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Ascorbic Acid | 17.24 | 18544905 | |
| MESH:D008114 | Liver Neoplasms, Experimental | beta-Naphthoflavone | 17.24 | 18164116 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 17.24 | 15583823 12014681 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 17.24 | 19009564 16842330 19519916 2563599 18544905 18253720 18282651 19004024 16267830 17942915 18079962 18164116 18775883 21159647 19539802 9362446 18093689 3124819 18308698 17174075 17854601 19126423 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Dimethylnitrosamine | 17.24 | 1848544 15603536 6150874 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 17.24 | 16842330 17085340 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Organoselenium Compounds | 17.24 | 16170372 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 17.24 | 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 17.24 | 12151625 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Vanadium | 17.24 | 17174075 | |
| MESH:D008133 | Long QT Syndrome | Dobutamine | 4.82 | 19353679 | |
| MESH:D008133 | Long QT Syndrome | Trazodone | 4.82 | 18167038 | |
| MESH:D038061 | Lower Extremity Deformities, Congenital | Methylnitrosourea | 3.90 | 16080182 | |
| MESH:D008171 | Lung Diseases | 2-chloroethyl ethyl sulfide | 22.04 | 12815614 18675330 16252256 | |
| MESH:D008171 | Lung Diseases | Acetylcysteine | 22.04 | 12815614 | |
| MESH:D008171 | Lung Diseases | Aluminum | 22.04 | 16052892 | |
| MESH:D008171 | Lung Diseases | Ascorbic Acid | 22.04 | 16863852 | |
| MESH:D008171 | Lung Diseases | Dobutamine | 22.04 | 16638327 | |
| MESH:D008171 | Lung Diseases | Hydrochloric Acid | 22.04 | 16784557 | |
| MESH:D008171 | Lung Diseases | Mustard Gas | 22.04 | 18161513 18702808 | |
| MESH:D008171 | Lung Diseases | Ozone | 22.04 | 19066396 8266340 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 22.04 | 19095001 | |
| MESH:D017563 | Lung Diseases, Interstitial | Methotrexate | 6.82 | 18516814 | |
| MESH:D017563 | Lung Diseases, Interstitial | zonisamide | 6.82 | 17228818 | |
| MESH:D055370 | Lung Injury | Asbestos, Crocidolite | 23.16 | 17365036 | |
| MESH:D055370 | Lung Injury | Hydrochloric Acid | 23.16 | 17627322 18339021 15090967 15044056 20597076 18573544 15607125 21311175 18497604 16129981 19262391 11395602 21114838 19644408 | |
| MESH:D055370 | Lung Injury | Lipopolysaccharides | 23.16 | 21114838 | |
| MESH:D055370 | Lung Injury | Nitric Oxide | 23.16 | 11395602 | |
| MESH:D055370 | Lung Injury | Ozone | 23.16 | 20417186 | |
| MESH:D055370 | Lung Injury | pyrrolidine dithiocarbamic acid | 23.16 | 16129981 | |
| MESH:D055370 | Lung Injury | S-methylisothiopseudouronium | 23.16 | 18573544 | |
| MESH:D055370 | Lung Injury | Sucralfate | 23.16 | 18573544 | |
| MESH:D008175 | Lung Neoplasms | marker/mechanism | 12460898 | ||
| MESH:D008175 | Lung Neoplasms | Acetaldehyde | 51.33 | 17372256 | |
| MESH:D008175 | Lung Neoplasms | arsenite | 51.33 | 16809336 | |
| MESH:D008175 | Lung Neoplasms | Ascorbic Acid | 51.33 | 16401635 | |
| MESH:D008175 | Lung Neoplasms | Azoxymethane | 51.33 | 15824018 | |
| MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 51.33 | 18520028 18816296 6695378 18569708 20135361 17053015 20064080 20464547 20869020 | |
| MESH:D008175 | Lung Neoplasms | bexarotene | 51.33 | 17849452 | |
| MESH:D008175 | Lung Neoplasms | Bleomycin | 51.33 | 6189445 | |
| MESH:D008175 | Lung Neoplasms | Budesonide | 51.33 | 17163412 16885199 12117777 | |
| MESH:D008175 | Lung Neoplasms | ciglitazone | 51.33 | 15899809 | |
| MESH:D008175 | Lung Neoplasms | Curcumin | 51.33 | 19359593 18462866 16243823 | |
| MESH:D008175 | Lung Neoplasms | Dexamethasone | 51.33 | 15824018 11195469 | |
| MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 51.33 | 6695378 20970405 21163286 20512841 | |
| MESH:D008175 | Lung Neoplasms | Dimethylnitrosamine | 51.33 | 16061637 19555203 11884234 | |
| MESH:D008175 | Lung Neoplasms | Doxorubicin | 51.33 | 17418594 6189445 | |
| MESH:D008175 | Lung Neoplasms | Drugs, Chinese Herbal | 51.33 | 18339527 | |
| MESH:D008175 | Lung Neoplasms | Fluorouracil | 51.33 | 15246190 | |
| MESH:D008175 | Lung Neoplasms | Indomethacin | 51.33 | 16537180 11497255 11053908 | |
| MESH:D008175 | Lung Neoplasms | Iron | 51.33 | 16640825 | |
| MESH:D008175 | Lung Neoplasms | mangiferin | 51.33 | 18520028 18816296 18569708 | |
| MESH:D008175 | Lung Neoplasms | Melatonin | 51.33 | 17195641 | |
| MESH:D008175 | Lung Neoplasms | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | 51.33 | 17363558 | |
| MESH:D008175 | Lung Neoplasms | Methylene Chloride | 51.33 | 15172992 | |
| MESH:D008175 | Lung Neoplasms | Methylnitrosourea | 51.33 | 18062963 | |
| MESH:D008175 | Lung Neoplasms | Mustard Gas | 51.33 | 8781369 3148597 | |
| MESH:D008175 | Lung Neoplasms | Ozone | 51.33 | 8597069 7614698 | |
| MESH:D008175 | Lung Neoplasms | Plant Extracts | 51.33 | 20869020 | |
| MESH:D008175 | Lung Neoplasms | Quercetin | 51.33 | 16280456 | |
| MESH:D008175 | Lung Neoplasms | silybin | 51.33 | 16788158 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 51.33 | 16712894 17077188 17306315 15276417 19931552 | |
| MESH:D008175 | Lung Neoplasms | Tamoxifen | 51.33 | 18625569 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 51.33 | 11884234 19555203 | |
| MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 51.33 | 11807781 | |
| MESH:D008175 | Lung Neoplasms | Urethane | 51.33 | 16391232 11307925 15902970 12765245 11246140 11552296 6695378 11992545 16926031 15136453 15166089 10530776 12957351 7750092 10822126 11074608 11323394 11497255 16289808 11062179 12466968 16337739 10997738 12117781 11807781 16007126 16204055 17255336 11893704 16788158 11544531 17093202 14587096 17195641 10779650 | |
| MESH:D008178 | Lupus Erythematosus, Cutaneous | Fluorouracil | 3.21 | 15086387 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Carbamazepine | 3.53 | 16628512 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Melatonin | 3.53 | 16373423 | |
| MESH:D008223 | Lymphoma | Curcumin | 18.77 | 18462866 | |
| MESH:D008223 | Lymphoma | Cyclophosphamide | 18.77 | 12854902 | |
| MESH:D008223 | Lymphoma | Doxorubicin | 18.77 | 16098063 | |
| MESH:D008223 | Lymphoma | Doxycycline | 18.77 | 20133848 | |
| MESH:D008223 | Lymphoma | Etoposide | 18.77 | 12556972 12854902 | |
| MESH:D008223 | Lymphoma | Methotrexate | 18.77 | 17352296 | |
| MESH:D008223 | Lymphoma | Methylnitrosourea | 18.77 | 16257854 11418001 | |
| MESH:D008223 | Lymphoma | Nitric Oxide | 18.77 | 16166326 | |
| MESH:D016393 | Lymphoma, B-Cell | Cyclophosphamide | 12.35 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | Methylnitrosourea | 12.35 | 14633661 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 12.35 | 17088997 | |
| MESH:D016393 | Lymphoma, B-Cell | Sodium Selenite | 12.35 | 14737004 | |
| MESH:D017728 | Lymphoma, Large-Cell, Anaplastic | 17-(allylamino)-17-demethoxygeldanamycin | 5.03 | 17157164 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Cyclophosphamide | 6.65 | 11911406 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 6.65 | 17654614 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 6.65 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 10.72 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Curcumin | 10.72 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 10.72 | 15621674 | |
| MESH:D016410 | Lymphoma, T-Cell, Cutaneous | bexarotene | 3.59 | 11161223 | |
| MESH:D008231 | Lymphopenia | Antimony Sodium Gluconate | 4.82 | 9770149 | |
| MESH:D008268 | Macular Degeneration | Iron | 2.89 | 16640825 | |
| MESH:D008275 | Magnesium Deficiency | Magnesium | 4.86 | 17823441 | |
| MESH:D008288 | Malaria | marker/mechanism | |||
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 4.87 | 15688416 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 4.87 | 19428831 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | bexarotene | 34.31 | 15591091 19196722 19196723 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 34.31 | 15458769 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Drugs, Chinese Herbal | 34.31 | 14758024 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 34.31 | 16891317 11807958 17203775 11408345 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 34.31 | 14578162 12929590 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Ibuprofen | 34.31 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Iodine | 34.31 | 15922087 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Methylnitrosourea | 34.31 | 19196723 16619500 11751437 10767621 15313902 14633655 10838139 14999141 16051031 11807958 15688392 12931682 17131329 16944150 16827153 15113128 17020996 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | ochratoxin A | 34.31 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Progesterone | 34.31 | 17203775 11408345 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 34.31 | 11606380 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | rosiglitazone | 34.31 | 16827153 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 34.31 | 15318939 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 34.31 | 14580682 16827153 11731420 19196723 19196722 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 34.31 | 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | zoledronic acid | 34.31 | 17312309 | |
| MESH:D020149 | Manganese Poisoning | Estradiol | 13.24 | 19453300 | |
| MESH:D020149 | Manganese Poisoning | Manganese | 13.24 | 19453300 16551646 16568477 | |
| MESH:D020149 | Manganese Poisoning | Tamoxifen | 13.24 | 19453300 | |
| MESH:D008545 | Melanoma | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | 15.60 | 17992120 | |
| MESH:D008545 | Melanoma | Bleomycin | 15.60 | 15577320 | |
| MESH:D008545 | Melanoma | Carmustine | 15.60 | 12393984 | |
| MESH:D008545 | Melanoma | Curcumin | 15.60 | 18462866 17885582 | |
| MESH:D008545 | Melanoma | Dinitrochlorobenzene | 15.60 | 17334785 12202904 | |
| MESH:D008545 | Melanoma | Disulfiram | 15.60 | 15367699 | |
| MESH:D008545 | Melanoma | Doxorubicin | 15.60 | 16827129 | |
| MESH:D008545 | Melanoma | epigallocatechin gallate | 15.60 | 11746506 17992120 | |
| MESH:D008545 | Melanoma | Reactive Oxygen Species | 15.60 | 17992120 | |
| MESH:D008545 | Melanoma | resveratrol | 15.60 | 17992120 | |
| MESH:D008545 | Melanoma | sodium arsenite | 15.60 | 16487513 19082730 | |
| MESH:D008545 | Melanoma | Tamoxifen | 15.60 | 12393984 19393235 | |
| MESH:D008545 | Melanoma | Thalidomide | 15.60 | 16098027 12829675 17089043 | |
| MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 2.62 | 15990972 | |
| MESH:D008546 | Melanoma, Experimental | Acetaminophen | 5.72 | 19513568 | |
| MESH:D008546 | Melanoma, Experimental | Cyclophosphamide | 5.72 | 16388313 | |
| MESH:D008569 | Memory Disorders | Curcumin | 10.58 | 17263510 | |
| MESH:D008569 | Memory Disorders | Ethanol | 10.58 | 18411066 15451040 | |
| MESH:D008569 | Memory Disorders | icariin | 10.58 | 19782061 | |
| MESH:D008569 | Memory Disorders | mangiferin | 10.58 | 19182383 | |
| MESH:D007706 | Menkes Kinky Hair Syndrome | Copper | 4.30 | 17268249 17109627 | |
| MESH:D001523 | Mental Disorders | Fluvoxamine | 5.40 | 16856516 | |
| MESH:D001523 | Mental Disorders | Maprotiline | 5.40 | 16856516 | |
| MESH:D001523 | Mental Disorders | Trazodone | 5.40 | 16856516 | |
| MESH:D008607 | Mental Retardation | Carbamazepine | 2.97 | 9014606 | |
| MESH:D008654 | Mesothelioma | Asbestos, Crocidolite | 6.42 | 16966607 18303189 16166281 | |
| MESH:D008654 | Mesothelioma | Doxorubicin | 6.42 | 17638057 | |
| MESH:D008654 | Mesothelioma | Selenium | 6.42 | 15107826 | |
| MESH:D008654 | Mesothelioma | zoledronic acid | 6.42 | 16675582 | |
| MESH:D008659 | Metabolic Diseases | phenylmethylpyrazolone | 6.15 | 16301206 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 6.15 | 17112576 | |
| MESH:D024821 | Metabolic Syndrome X | Fructose | 5.39 | 19165636 17098227 17261469 18497449 16815490 | |
| MESH:D024821 | Metabolic Syndrome X | rosiglitazone | 5.39 | 17261469 | |
| MESH:D008679 | Metaplasia | Ozone | 3.50 | 10496685 | |
| MESH:D008708 | Methemoglobinemia | Nitroglycerin | 5.35 | 3537620 | |
| MESH:D008708 | Methemoglobinemia | Propanil | 5.35 | 2315934 2237922 4714336 | |
| MESH:D008850 | Microphthalmos | ochratoxin A | 4.26 | 20036863 | |
| MESH:D008881 | Migraine Disorders | Aspirin | 15.63 | 15240983 | |
| MESH:D008881 | Migraine Disorders | gabapentin | 15.63 | 18803445 18759728 | |
| MESH:D008881 | Migraine Disorders | Indomethacin | 15.63 | 11903285 | |
| MESH:D008881 | Migraine Disorders | Magnesium | 15.63 | 18803445 | |
| MESH:D008881 | Migraine Disorders | montelukast | 15.63 | 10759916 | |
| MESH:D008881 | Migraine Disorders | Nitric Oxide | 15.63 | 11701602 | |
| MESH:D008881 | Migraine Disorders | topiramate | 15.63 | 16942474 18759728 18803445 18765137 | |
| MESH:D020326 | Migraine without Aura | 6-Ketoprostaglandin F1 alpha | 17.18 | 11304026 | |
| MESH:D020326 | Migraine without Aura | Dinoprostone | 17.18 | 11304026 | |
| MESH:D020326 | Migraine without Aura | Nitric Oxide | 17.18 | 14659530 11304026 | |
| MESH:D020326 | Migraine without Aura | Nitrites | 17.18 | 11304026 | |
| MESH:D020326 | Migraine without Aura | Nitroglycerin | 17.18 | 14659530 | |
| MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 3.02 | 15792986 | |
| MESH:D018200 | Mixed Tumor, Mullerian | Raloxifene | 3.94 | 15863610 | |
| MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 9.56 | 16381670 | |
| MESH:D009062 | Mouth Neoplasms | Fluorouracil | 9.56 | 16757204 18986760 | |
| MESH:D009062 | Mouth Neoplasms | Indomethacin | 9.56 | 12636206 | |
| MESH:D009062 | Mouth Neoplasms | Plant Preparations | 9.56 | 17418620 | |
| MESH:D009069 | Movement Disorders | Manganese | 6.81 | 16551646 | |
| MESH:D009069 | Movement Disorders | Trazodone | 6.81 | 4066620 | |
| MESH:D052016 | Mucositis | Doxorubicin | 7.30 | 17415656 | |
| MESH:D052016 | Mucositis | Methotrexate | 7.30 | 17488658 | |
| MESH:D009101 | Multiple Myeloma | alachlor | 20.64 | 14769641 | |
| MESH:D009101 | Multiple Myeloma | Capsaicin | 20.64 | 17505005 | |
| MESH:D009101 | Multiple Myeloma | Curcumin | 20.64 | 19372569 | |
| MESH:D009101 | Multiple Myeloma | Dexamethasone | 20.64 | 15744524 15867202 16118317 | |
| MESH:D009101 | Multiple Myeloma | Raloxifene | 20.64 | 16497877 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 20.64 | 16267019 16490592 17164350 17049120 17935668 14749477 | |
| MESH:D009101 | Multiple Myeloma | Thalidomide | 20.64 | 15920492 19112201 15744524 17168659 19372569 19112817 15867202 15939924 15741222 16445831 | |
| MESH:D009101 | Multiple Myeloma | zoledronic acid | 20.64 | 16996129 18089719 19621390 | |
| MESH:D009101 | Multiple Myeloma | zonisamide | 20.64 | 11868602 | |
| MESH:D009102 | Multiple Organ Failure | Zymosan | 3.72 | 15241586 15834315 12130978 17724436 10479408 15259001 10890648 12879239 18160304 15213630 | |
| MESH:D020528 | Multiple Sclerosis, Chronic Progressive | Aluminum | 9.20 | 17086897 | |
| MESH:D020528 | Multiple Sclerosis, Chronic Progressive | Iron | 9.20 | 17086897 | |
| MESH:D020529 | Multiple Sclerosis, Relapsing-Remitting | Aluminum | 4.77 | 17086897 | |
| MESH:D009128 | Muscle Spasticity | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 4.52 | 17220914 | |
| MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 12.12 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | epigallocatechin gallate | 12.12 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 12.12 | 17962980 | |
| MESH:D009135 | Muscular Diseases | pirinixic acid | 1.98 | 16239165 | |
| MESH:D009137 | Muscular Dystrophy, Animal | Gentamicins | 4.67 | 18694830 | |
| MESH:D009139 | Musculoskeletal Abnormalities | sodium arsenate | 3.39 | 18186108 | |
| MESH:D009145 | Mushroom Poisoning | Silymarin | 5.33 | 17213517 | |
| MESH:D009175 | Mycoplasma Infections | Thiopental | 5.03 | 10773494 | |
| MESH:D009181 | Mycoses | Iron | 3.87 | 16640825 | |
| MESH:D009182 | Mycosis Fungoides | Trioxsalen | 5.43 | 16259964 | |
| MESH:D015878 | Mydriasis | Tropicamide | 5.74 | 16308726 | |
| MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 8.16 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Pentoxifylline | 8.16 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | SU 5416 | 8.16 | 12649163 | |
| MESH:D009190 | Myelodysplastic Syndromes | Thalidomide | 8.16 | 18720364 | |
| MESH:D009203 | Myocardial Infarction | marker/mechanism | 11489778 10090345 | ||
| MESH:D009203 | Myocardial Infarction | Aspirin | 25.53 | 12692751 | |
| MESH:D009203 | Myocardial Infarction | Doxorubicin | 25.53 | 15857846 19429709 | |
| MESH:D009203 | Myocardial Infarction | Genistein | 25.53 | 17141266 | |
| MESH:D009203 | Myocardial Infarction | Hydrochloric Acid | 25.53 | 18534312 | |
| MESH:D009203 | Myocardial Infarction | Isoproterenol | 25.53 | 17052832 15740881 19595682 16584858 16538859 19172585 16697266 | |
| MESH:D009203 | Myocardial Infarction | mangiferin | 25.53 | 19172585 17052832 16584858 16538859 16697266 | |
| MESH:D009203 | Myocardial Infarction | Nitroglycerin | 25.53 | 14729435 | |
| MESH:D009203 | Myocardial Infarction | pirinixic acid | 25.53 | 19151258 | |
| MESH:D009203 | Myocardial Infarction | Pravastatin | 25.53 | 17188708 | |
| MESH:D009203 | Myocardial Infarction | Quercetin | 25.53 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 25.53 | 16456233 16317513 17015251 17188708 17125593 16525036 | |
| MESH:D009203 | Myocardial Infarction | S-methylisothiopseudouronium | 25.53 | 10090345 | |
| MESH:D017202 | Myocardial Ischemia | Dobutamine | 10.69 | 12447174 | |
| MESH:D017202 | Myocardial Ischemia | Iron | 10.69 | 16604332 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 10.69 | 17015251 17125593 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 10.69 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | marker/mechanism | 19207477 | ||
| MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 12.48 | 16810080 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 12.48 | 17141266 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Iron | 12.48 | 16604332 | |
| MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 12.48 | 16411023 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 12.48 | 19207477 | |
| MESH:D017682 | Myocardial Stunning | marker/mechanism | 11927517 | ||
| MESH:D009205 | Myocarditis | Particulate Matter | 7.21 | 12563109 | |
| MESH:D009205 | Myocarditis | resveratrol | 7.21 | 17322642 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | zonisamide | 4.61 | 9477142 | |
| MESH:D009216 | Myopia | Atropine | 3.82 | 12601066 | |
| MESH:D009224 | Myotonia Congenita | Carbamazepine | 3.90 | 20399394 | |
| MESH:D009232 | Myxoma | Raloxifene | 3.94 | 16343187 | |
| MESH:D009325 | Nausea | Aspirin | 7.13 | 15240983 | |
| MESH:D009325 | Nausea | zonisamide | 7.13 | 16855456 | |
| MESH:D009336 | Necrosis | Melatonin | 3.92 | 12195237 | |
| MESH:D009361 | Neoplasm Invasiveness | bis(4-hydroxycinnamoyl)methane | 12.53 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | Curcumin | 12.53 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | demethoxycurcumin | 12.53 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | Disulfiram | 12.53 | 18047805 | |
| MESH:D009362 | Neoplasm Metastasis | Acetylcysteine | 14.59 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 14.59 | 9029167 3581430 | |
| MESH:D009362 | Neoplasm Metastasis | Disulfiram | 14.59 | 15367699 | |
| MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 14.59 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Indomethacin | 14.59 | 11053908 16537180 11239499 | |
| MESH:D009362 | Neoplasm Metastasis | Pentoxifylline | 14.59 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 14.59 | 19393235 | |
| MESH:D009362 | Neoplasm Metastasis | zoledronic acid | 14.59 | 17312309 19139120 15867366 | |
| MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 1.78 | 19410462 | |
| MESH:D009369 | Neoplasms | Benzo(a)pyrene | 23.05 | 11141357 | |
| MESH:D009369 | Neoplasms | Cyclophosphamide | 23.05 | 18854779 | |
| MESH:D009369 | Neoplasms | DDT | 23.05 | 8820588 | |
| MESH:D009369 | Neoplasms | dimethoxycurcumin | 23.05 | 17317839 | |
| MESH:D009369 | Neoplasms | Disulfiram | 23.05 | 17079463 | |
| MESH:D009369 | Neoplasms | Fluorouracil | 23.05 | 16928823 18239605 18600527 | |
| MESH:D009369 | Neoplasms | Methylnitrosourea | 23.05 | 15533788 | |
| MESH:D009369 | Neoplasms | naringenin | 23.05 | 15185748 | |
| MESH:D009369 | Neoplasms | Nicotine | 23.05 | 16365874 | |
| MESH:D009369 | Neoplasms | pirinixic acid | 23.05 | 17405874 | |
| MESH:D009369 | Neoplasms | Quercetin | 23.05 | 15185748 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 23.05 | 11559025 | |
| MESH:D009369 | Neoplasms | SU 5416 | 23.05 | 17264769 | |
| MESH:D009369 | Neoplasms | Urethane | 23.05 | 15625555 | |
| MESH:D009374 | Neoplasms, Experimental | Indomethacin | 16.04 | 15625704 10663608 | |
| MESH:D009374 | Neoplasms, Experimental | Methylnitrosourea | 16.04 | 12696579 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 16.04 | 8985016 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 16.04 | 20056578 | |
| MESH:D009374 | Neoplasms, Experimental | Toluene 2,4-Diisocyanate | 16.04 | 1670384 | |
| MESH:D009374 | Neoplasms, Experimental | Urethane | 16.04 | 15582191 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | bexarotene | 9.23 | 19196722 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 9.23 | 12497104 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 9.23 | 19200415 19189210 19196722 | |
| MESH:D009389 | Neovascularization, Pathologic | arsenite | 15.53 | 15738583 | |
| MESH:D009389 | Neovascularization, Pathologic | Copper | 15.53 | 17308104 | |
| MESH:D009389 | Neovascularization, Pathologic | Disulfiram | 15.53 | 15367699 | |
| MESH:D009389 | Neovascularization, Pathologic | Estradiol | 15.53 | 17289903 | |
| MESH:D009389 | Neovascularization, Pathologic | Nicotine | 15.53 | 16365874 | |
| MESH:D009395 | Nephritis, Interstitial | Ibuprofen | 3.43 | 6375363 | |
| MESH:D009401 | Nephrosis | Doxorubicin | 3.21 | 16899518 16636307 | |
| MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 5.05 | 15640375 16889571 | |
| MESH:D009404 | Nephrotic Syndrome | Iron | 5.05 | 17178036 | |
| MESH:D009410 | Nerve Degeneration | Acrylamide | 18.90 | 12387366 12387367 11264303 | |
| MESH:D009410 | Nerve Degeneration | Ibuprofen | 18.90 | 10961664 | |
| MESH:D009410 | Nerve Degeneration | Manganese | 18.90 | 16551646 | |
| MESH:D009410 | Nerve Degeneration | mangiferin | 18.90 | 17433543 | |
| MESH:D009410 | Nerve Degeneration | N-(1-methylethyl)-1,1,2-trimethylpropylamine | 18.90 | 17356569 | |
| MESH:D009410 | Nerve Degeneration | Paraquat | 18.90 | 16893418 | |
| MESH:D009410 | Nerve Degeneration | Rotenone | 18.90 | 15790535 18619942 17356569 | |
| MESH:D009422 | Nervous System Diseases | Acrylamide | 3.60 | 12164553 12507653 | |
| MESH:D009421 | Nervous System Malformations | bisphenol A | 19.13 | 16427766 11399458 | |
| MESH:D009421 | Nervous System Malformations | Carbamazepine | 19.13 | 16990009 | |
| MESH:D009421 | Nervous System Malformations | Estradiol | 19.13 | 16427766 11399458 | |
| MESH:D009421 | Nervous System Malformations | Genistein | 19.13 | 16427766 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 19.13 | 14600291 | |
| MESH:D009421 | Nervous System Malformations | Thalidomide | 19.13 | 16859833 | |
| MESH:D009423 | Nervous System Neoplasms | Curcumin | 4.02 | 18462866 | |
| MESH:D009436 | Neural Tube Defects | Acetylcysteine | 7.33 | 19446573 | |
| MESH:D009436 | Neural Tube Defects | ochratoxin A | 7.33 | 20036863 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenate | 7.33 | 19446573 11749123 18186108 10525206 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 7.33 | 12854658 | |
| MESH:D009442 | Neurilemmoma | Methylnitrosourea | 3.91 | 11555667 | |
| MESH:D019954 | Neurobehavioral Manifestations | Plant Extracts | 3.63 | 17168769 | |
| MESH:D009447 | Neuroblastoma | Cyclophosphamide | 3.57 | 8761367 15176712 16115947 | |
| MESH:D009447 | Neuroblastoma | Doxorubicin | 3.57 | 15555623 | |
| MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 22.28 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | Amphetamine | 22.28 | 15183010 | |
| MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 22.28 | 20387270 | |
| MESH:D019636 | Neurodegenerative Diseases | Indomethacin | 22.28 | 12349958 | |
| MESH:D019636 | Neurodegenerative Diseases | Iron | 22.28 | 17296847 16604332 | |
| MESH:D019636 | Neurodegenerative Diseases | Oxidopamine | 22.28 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 22.28 | 17652729 | |
| MESH:D019636 | Neurodegenerative Diseases | Tacrolimus | 22.28 | 15081597 | |
| MESH:D017599 | Neuroectodermal Tumors | Cyclophosphamide | 3.33 | 8761367 12837982 | |
| MESH:D020078 | Neurogenic Inflammation | Capsaicin | 9.31 | 17961222 | |
| MESH:D020078 | Neurogenic Inflammation | Quercetin | 9.31 | 17929310 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 9.31 | 17929310 | |
| MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 3.51 | 20387270 | |
| MESH:D020258 | Neurotoxicity Syndromes | 3-xylene | 8.72 | 7820390 8907413 | |
| MESH:D020258 | Neurotoxicity Syndromes | Disulfiram | 8.72 | 11005259 | |
| MESH:D020258 | Neurotoxicity Syndromes | Fluorouracil | 8.72 | 16436463 | |
| MESH:D020258 | Neurotoxicity Syndromes | Glyburide | 8.72 | 16725203 | |
| MESH:D009503 | Neutropenia | Cyclophosphamide | 7.25 | 8291058 | |
| MESH:D009503 | Neutropenia | Leukotriene B4 | 7.25 | 8305713 | |
| MESH:D009503 | Neutropenia | Mustard Gas | 7.25 | 16761898 7688884 | |
| MESH:D052556 | Niemann-Pick Disease, Type C | Cholesterol | 4.16 | 9802331 20557099 | |
| MESH:C541083 | Non-alcoholic Fatty Liver Disease | Endotoxins | 4.43 | 20353583 | |
| MESH:D009669 | Nose Neoplasms | alachlor | 3.35 | 16178123 15580706 14563481 11127290 16698726 | |
| MESH:D009765 | Obesity | 2-chloroethyl ethyl sulfide | 13.94 | 16289378 | |
| MESH:D009765 | Obesity | Ascorbic Acid | 13.94 | 17217161 | |
| MESH:D009765 | Obesity | Capsaicin | 13.94 | 19056576 | |
| MESH:D009765 | Obesity | Curcumin | 13.94 | 19297423 | |
| MESH:D009765 | Obesity | Dietary Fats | 13.94 | 21332399 18457598 17217161 19632207 20518802 20132043 16723640 11836018 18674790 | |
| MESH:D009765 | Obesity | Fructose | 13.94 | 18585860 17707055 | |
| MESH:D009765 | Obesity | pirinixic acid | 13.94 | 20558911 | |
| MESH:D009765 | Obesity | Plant Extracts | 13.94 | 19056576 20132043 | |
| MESH:D009765 | Obesity | rimonabant | 13.94 | 19046740 20518802 18773755 | |
| MESH:D007752 | Obstetric Labor, Premature | Indomethacin | 3.57 | 6374098 | |
| MESH:D009784 | Occupational Diseases | Hydrochloric Acid | 5.12 | 12378975 | |
| MESH:D009784 | Occupational Diseases | Toluene 2,4-Diisocyanate | 5.12 | 6091946 18394133 6091945 3040596 12585506 8156442 11077013 | |
| MESH:D009845 | Oligospermia | Cyclophosphamide | 3.17 | 16517039 | |
| MESH:D053578 | Opsoclonus-Myoclonus Syndrome | Trazodone | 4.87 | 1318289 | |
| MESH:D010003 | Osteoarthritis | Aspirin | 13.66 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Diclofenac | 13.66 | 18287210 | |
| MESH:D010003 | Osteoarthritis | Doxycycline | 13.66 | 17267227 | |
| MESH:D010003 | Osteoarthritis | Ibuprofen | 13.66 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Indomethacin | 13.66 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Iron | 13.66 | 16640825 | |
| MESH:D010005 | Osteoarthropathy, Secondary Hypertrophic | Dinoprostone | 4.87 | 18500342 | |
| MESH:D010014 | Osteolysis | zoledronic acid | 3.80 | 15867366 | |
| MESH:D010018 | Osteomalacia | Carbamazepine | 3.90 | 17016548 | |
| MESH:D010024 | Osteoporosis | Curcumin | 14.98 | 18719352 | |
| MESH:D010024 | Osteoporosis | Genistein | 14.98 | 19401787 | |
| MESH:D010024 | Osteoporosis | icariin | 14.98 | 18236786 19747809 | |
| MESH:D010024 | Osteoporosis | Iron | 14.98 | 16648989 16640825 | |
| MESH:D010024 | Osteoporosis | kaempferol | 14.98 | 16756079 | |
| MESH:D010024 | Osteoporosis | Raloxifene | 14.98 | 17882678 19059307 15775268 | |
| MESH:D010024 | Osteoporosis | zoledronic acid | 14.98 | 17882678 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Drugs, Chinese Herbal | 15.94 | 16548355 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 15.94 | 16169203 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 15.94 | 19495926 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Raloxifene | 15.94 | 15758505 15579764 17893378 17823083 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 15.94 | 17513867 | |
| MESH:D012516 | Osteosarcoma | Disulfiram | 5.74 | 18047805 | |
| MESH:D012516 | Osteosarcoma | Doxorubicin | 5.74 | 15930896 | |
| MESH:D010049 | Ovarian Diseases | bisphenol A | 3.40 | 11985600 | |
| MESH:D010051 | Ovarian Neoplasms | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 23.89 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | Curcumin | 23.89 | 18462866 19020741 | |
| MESH:D010051 | Ovarian Neoplasms | Disulfiram | 23.89 | 17026967 | |
| MESH:D010051 | Ovarian Neoplasms | Estradiol | 23.89 | 19401270 | |
| MESH:D010051 | Ovarian Neoplasms | Genistein | 23.89 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Luteolin | 23.89 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Mifepristone | 23.89 | 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | Progesterone | 23.89 | 17393432 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | Quercetin | 23.89 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 23.89 | 17306315 15276417 | |
| MESH:D010051 | Ovarian Neoplasms | Thalidomide | 23.89 | 16288038 | |
| MESH:D010051 | Ovarian Neoplasms | U 0126 | 23.89 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | Urethane | 23.89 | 16391232 | |
| MESH:D010146 | Pain | 4-(nitroxy)butanoic acid 4-acetylaminophenyl ester | 44.93 | 16870215 | |
| MESH:D010146 | Pain | Acetaminophen | 44.93 | 16870215 | |
| MESH:D010146 | Pain | Aspirin | 44.93 | 6363464 6995502 | |
| MESH:D010146 | Pain | Capsaicin | 44.93 | 18987195 17084039 17434803 16996476 17043245 19081190 | |
| MESH:D010146 | Pain | Carbamazepine | 44.93 | 15215642 | |
| MESH:D010146 | Pain | Cyclophosphamide | 44.93 | 12161096 18093676 | |
| MESH:D010146 | Pain | Diclofenac | 44.93 | 13679232 | |
| MESH:D010146 | Pain | Ibuprofen | 44.93 | 3291741 | |
| MESH:D010146 | Pain | Indomethacin | 44.93 | 17440234 3291741 13679232 17627676 | |
| MESH:D010146 | Pain | Mangifera indica extract | 44.93 | 15177302 16273134 | |
| MESH:D010146 | Pain | montelukast | 44.93 | 15935457 | |
| MESH:D010146 | Pain | Morphine | 44.93 | 20225289 6776300 18699797 15215642 15275824 16273134 | |
| MESH:D010146 | Pain | nimesulide | 44.93 | 11438310 | |
| MESH:D010146 | Pain | Pinacidil | 44.93 | 13679232 | |
| MESH:D010146 | Pain | rimonabant | 44.93 | 18987195 | |
| MESH:D010146 | Pain | Trazodone | 44.93 | 12798668 12790215 | |
| MESH:D010146 | Pain | zoledronic acid | 44.93 | 16475674 | |
| MESH:D010146 | Pain | zonisamide | 44.93 | 17666864 16217643 15140322 | |
| MESH:D010149 | Pain, Postoperative | Ibuprofen | 6.23 | 16678543 | |
| MESH:D010149 | Pain, Postoperative | Indomethacin | 6.23 | 18702446 12538197 | |
| MESH:D010190 | Pancreatic Neoplasms | Curcumin | 20.41 | 19196508 19401701 17440100 | |
| MESH:D010190 | Pancreatic Neoplasms | Cyclophosphamide | 20.41 | 11332152 | |
| MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 20.41 | 16540662 | |
| MESH:D010190 | Pancreatic Neoplasms | Ethanol | 20.41 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Etoposide | 20.41 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Fluorouracil | 20.41 | 19003803 16929163 15113037 16500647 | |
| MESH:D010190 | Pancreatic Neoplasms | Ibuprofen | 20.41 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Methylnitrosourea | 20.41 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Quercetin | 20.41 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Reactive Oxygen Species | 20.41 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 20.41 | 15976015 | |
| MESH:D010195 | Pancreatitis | Antimony Sodium Gluconate | 10.92 | 7519887 | |
| MESH:D010195 | Pancreatitis | Indomethacin | 10.92 | 15028970 17883296 | |
| MESH:D010195 | Pancreatitis | Metronidazole | 10.92 | 10484002 | |
| MESH:D010195 | Pancreatitis | phenylmethylpyrazolone | 10.92 | 20035747 | |
| MESH:D010195 | Pancreatitis | Trinitrobenzenesulfonic Acid | 10.92 | 17698068 | |
| MESH:D010212 | Papilloma | Hydrogen Peroxide | 9.88 | 12065085 | |
| MESH:D010212 | Papilloma | Iron | 9.88 | 12065085 | |
| MESH:D010212 | Papilloma | Plant Extracts | 9.88 | 16517061 15173996 | |
| MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 9.88 | 8330346 12065085 18922899 18404319 | |
| MESH:D010257 | Paraneoplastic Syndromes | Indomethacin | 4.11 | 16537180 | |
| MESH:D010267 | Parapsoriasis | Carbamazepine | 4.14 | 16538176 | |
| MESH:D020447 | Parasomnias | Iron | 4.41 | 17352947 | |
| MESH:D010291 | Paresis | Thalidomide | 4.70 | 9200351 | |
| MESH:D010292 | Paresthesia | zonisamide | 5.29 | 17149715 | |
| MESH:D010300 | Parkinson Disease | Ditiocarb | 10.27 | 11445065 | |
| MESH:D010300 | Parkinson Disease | Iron | 10.27 | 16563566 16640825 | |
| MESH:D010300 | Parkinson Disease | Manganese | 10.27 | 11181820 | |
| MESH:D010300 | Parkinson Disease | mangiferin | 10.27 | 17433543 | |
| MESH:D010300 | Parkinson Disease | Paraquat | 10.27 | 15824117 15451049 12911755 11445065 11181820 11124998 16510128 16140633 | |
| MESH:D010300 | Parkinson Disease | Rotenone | 10.27 | 19114014 19232380 18191903 16412576 11535288 16140633 15451049 18619942 11445065 | |
| MESH:D010300 | Parkinson Disease | zonisamide | 10.27 | 17200492 11755227 19594199 13677302 20196486 | |
| MESH:D010302 | Parkinson Disease, Secondary | Oxidopamine | 9.89 | 15893579 11771942 | |
| MESH:D010302 | Parkinson Disease, Secondary | Paraquat | 9.89 | 16190885 | |
| MESH:D010302 | Parkinson Disease, Secondary | Trazodone | 9.89 | 3378227 | |
| MESH:D020734 | Parkinsonian Disorders | Diazoxide | 20.84 | 15927086 15795934 | |
| MESH:D020734 | Parkinsonian Disorders | Indomethacin | 20.84 | 12349958 | |
| MESH:D020734 | Parkinsonian Disorders | Manganese | 20.84 | 16140633 | |
| MESH:D020734 | Parkinsonian Disorders | Melatonin | 20.84 | 15574749 | |
| MESH:D020734 | Parkinsonian Disorders | N-(1-methylethyl)-1,1,2-trimethylpropylamine | 20.84 | 15927086 15795934 | |
| MESH:D020734 | Parkinsonian Disorders | Rotenone | 20.84 | 15795934 18197244 15574749 15927086 | |
| MESH:D020734 | Parkinsonian Disorders | Tropicamide | 20.84 | 17594079 | |
| OMIM:167400 | PAROXYSMAL EXTREME PAIN DISORDER | Carbamazepine | 4.34 | 17145499 17679678 | |
| MESH:D051302 | Paroxysmal Hemicrania | Indomethacin | 4.11 | 11903285 | |
| MESH:D010382 | Peliosis Hepatis | 1-Naphthylisothiocyanate | 8.49 | 20133375 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 8.49 | 12520081 | |
| MESH:D010391 | Pemphigoid, Bullous | Doxycycline | 4.97 | 11026799 | |
| MESH:D010437 | Peptic Ulcer | Indomethacin | 3.57 | 11148446 | |
| MESH:D010438 | Peptic Ulcer Hemorrhage | Aspirin | 3.96 | 11156591 | |
| MESH:D010518 | Periodontitis | 8-chlorocarbochromen | 16.62 | 16572308 | |
| MESH:D010518 | Periodontitis | Antimony Sodium Gluconate | 16.62 | 1325634 | |
| MESH:D010518 | Periodontitis | Indomethacin | 16.62 | 17225004 | |
| MESH:D010518 | Periodontitis | mangiferin | 16.62 | 19026997 | |
| MESH:D010523 | Peripheral Nervous System Diseases | 4-methylcatechol | 6.13 | 18219259 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Acrylamide | 6.13 | 11510240 | |
| MESH:D016491 | Peripheral Vascular Diseases | Cadmium | 3.80 | 15687053 | |
| MESH:D010538 | Peritonitis | Isoflurane | 11.74 | 17414419 | |
| MESH:D010538 | Peritonitis | Melatonin | 11.74 | 15707874 | |
| MESH:D010538 | Peritonitis | Ozone | 11.74 | 16369182 | |
| MESH:D010538 | Peritonitis | Zymosan | 11.74 | 19088179 17371808 19641140 11985352 17826846 18760300 18557954 14761945 15259001 18977430 15979727 | |
| MESH:D020795 | Photophobia | Aspirin | 4.16 | 15240983 | |
| MESH:D003557 | Phyllodes Tumor | Doxorubicin | 3.55 | 17983394 | |
| MESH:D010900 | Pituitary Diseases | Iron | 4.07 | 16604332 | |
| MESH:D010911 | Pituitary Neoplasms | Urethane | 3.86 | 16391232 | |
| MESH:D010954 | Plasmacytoma | pristane | 9.25 | 15087411 | |
| MESH:D010954 | Plasmacytoma | Selenium | 9.25 | 15087411 | |
| OMIM:248310 | PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL | marker/mechanism | |||
| MESH:D010995 | Pleural Diseases | Asbestos, Crocidolite | 3.34 | 10923243 | |
| MESH:D010997 | Pleural Neoplasms | Doxorubicin | 3.55 | 17638057 | |
| MESH:D010998 | Pleurisy | Carrageenan | 5.15 | 19934399 | |
| MESH:D011014 | Pneumonia | 1,5-anhydrofructose | 18.61 | 19559007 | |
| MESH:D011014 | Pneumonia | Bleomycin | 18.61 | 18024389 17071938 16317386 | |
| MESH:D011014 | Pneumonia | Lipopolysaccharides | 18.61 | 12224865 11605937 | |
| MESH:D011014 | Pneumonia | Ozone | 18.61 | 18007984 18381685 18929643 | |
| MESH:D011014 | Pneumonia | Paraquat | 18.61 | 12504350 | |
| MESH:D011015 | Pneumonia, Aspiration | marker/mechanism | 15607125 | ||
| MESH:D011015 | Pneumonia, Aspiration | Hydrochloric Acid | 14.76 | 18497604 15970105 15607125 18573544 | |
| MESH:D011015 | Pneumonia, Aspiration | Nitric Oxide | 14.76 | 18573544 | |
| MESH:D011015 | Pneumonia, Aspiration | S-methylisothiopseudouronium | 14.76 | 18573544 | |
| MESH:D011015 | Pneumonia, Aspiration | Sucralfate | 14.76 | 18573544 | |
| MESH:D011041 | Poisoning | Atropine | 6.32 | 17849254 18072136 | |
| MESH:D011041 | Poisoning | Iron | 6.32 | 16604332 | |
| MESH:D011041 | Poisoning | Mustard Gas | 6.32 | 15727166 | |
| MESH:D011085 | Polycystic Ovary Syndrome | Simvastatin | 3.90 | 17105841 | |
| MESH:D011141 | Polyuria | Lithium Chloride | 4.42 | 19692487 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Iron | 5.97 | 16640825 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 5.97 | 18163543 | |
| MESH:D011230 | Precancerous Conditions | Azoxymethane | 7.48 | 14668109 12458338 19056647 | |
| MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 7.48 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Quercetin | 7.48 | 19056647 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Cyclophosphamide | 5.87 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 5.87 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Thalidomide | 5.87 | 17031469 | |
| MESH:D011225 | Pre-Eclampsia | Iron | 3.10 | 16640825 | |
| MESH:D011248 | Pregnancy Complications | Carbamazepine | 3.62 | 9014606 | |
| MESH:D047928 | Premature Birth | Indomethacin | 3.57 | 17000239 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 14.30 | 10548101 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Carbamazepine | 14.30 | 9014606 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 14.30 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 14.30 | 11399792 11118676 11222880 11896295 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | vinclozolin | 14.30 | 19015723 18042343 18220299 | |
| MESH:D011469 | Prostatic Diseases | vinclozolin | 3.35 | 18220299 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 5.65 | 20887781 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 5.65 | 20887781 | |
| MESH:D011471 | Prostatic Neoplasms | Apigenin | 14.35 | 17132221 | |
| MESH:D011471 | Prostatic Neoplasms | baicalin | 14.35 | 15714805 | |
| MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 14.35 | 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | bisphenol A | 14.35 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Cadmium | 14.35 | 17075824 | |
| MESH:D011471 | Prostatic Neoplasms | Copper | 14.35 | 17079463 17308104 | |
| MESH:D011471 | Prostatic Neoplasms | Curcumin | 14.35 | 18226269 18769126 11398177 12497104 18156803 10851300 15129424 | |
| MESH:D011471 | Prostatic Neoplasms | Cyclophosphamide | 14.35 | 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | DDT | 14.35 | 12584743 | |
| MESH:D011471 | Prostatic Neoplasms | Disulfiram | 14.35 | 19789329 | |
| MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 14.35 | 16888761 16729912 15749863 15897917 16868541 18437689 | |
| MESH:D011471 | Prostatic Neoplasms | Estradiol | 14.35 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Etoposide | 14.35 | 17172428 | |
| MESH:D011471 | Prostatic Neoplasms | fisetin | 14.35 | 18922931 | |
| MESH:D011471 | Prostatic Neoplasms | Fluorouracil | 14.35 | 19082440 18626508 | |
| MESH:D011471 | Prostatic Neoplasms | Genistein | 14.35 | 16925846 15378649 15256057 | |
| MESH:D011471 | Prostatic Neoplasms | Hyaluronic Acid | 14.35 | 16864594 | |
| MESH:D011471 | Prostatic Neoplasms | Ibuprofen | 14.35 | 17409433 | |
| MESH:D011471 | Prostatic Neoplasms | Methylnitrosourea | 14.35 | 15682402 12376480 | |
| MESH:D011471 | Prostatic Neoplasms | Plant Extracts | 14.35 | 17804756 14666653 | |
| MESH:D011471 | Prostatic Neoplasms | pyrrolidine dithiocarbamic acid | 14.35 | 16139439 | |
| MESH:D011471 | Prostatic Neoplasms | Quercetin | 14.35 | 17292933 14715546 | |
| MESH:D011471 | Prostatic Neoplasms | Raloxifene | 14.35 | 16220300 15731164 16536755 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 14.35 | 17718901 17675339 16731767 17636462 17804756 15767336 | |
| MESH:D011471 | Prostatic Neoplasms | S-allylcysteine | 14.35 | 17155983 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 14.35 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | Sodium Selenite | 14.35 | 18760546 | |
| MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 14.35 | 15067354 | |
| MESH:D011471 | Prostatic Neoplasms | Thalidomide | 14.35 | 16729912 | |
| MESH:D011471 | Prostatic Neoplasms | zoledronic acid | 14.35 | 12438248 19103299 | |
| MESH:D011472 | Prostatitis | vinclozolin | 3.35 | 18629315 | |
| MESH:D011507 | Proteinuria | Gentamicins | 10.14 | 15033597 | |
| MESH:D011507 | Proteinuria | Ibuprofen | 10.14 | 6375363 | |
| MESH:D011507 | Proteinuria | Indomethacin | 10.14 | 11849393 | |
| MESH:D011507 | Proteinuria | pioglitazone | 10.14 | 16687628 | |
| MESH:D011528 | Protozoan Infections | Iron | 4.41 | 16640825 | |
| MESH:D011536 | Prurigo | Thalidomide | 4.70 | 12755975 | |
| MESH:D011537 | Pruritus | fexofenadine | 5.26 | 17133778 | |
| MESH:D011537 | Pruritus | Mustard Gas | 5.26 | 18058305 | |
| MESH:D019310 | Pseudolymphoma | Carbamazepine | 4.00 | 9591791 12752131 | |
| MESH:D011565 | Psoriasis | marker/mechanism | 20953189 | ||
| MESH:D011565 | Psoriasis | Leukotriene B4 | 4.77 | 11006272 | |
| MESH:D011565 | Psoriasis | Methotrexate | 4.77 | 17410198 | |
| MESH:D011565 | Psoriasis | Trioxsalen | 4.77 | 16259964 | |
| MESH:D011629 | Puberty, Precocious | bisphenol A | 3.21 | 10548101 | |
| MESH:D011649 | Pulmonary Alveolar Proteinosis | 27-hydroxycholesterol | 4.79 | 15466366 | |
| MESH:D001261 | Pulmonary Atelectasis | Hydrochloric Acid | 4.41 | 20597076 | |
| MESH:D029424 | Pulmonary Disease, Chronic Obstructive | Theophylline | 3.81 | 18983928 | |
| MESH:D011654 | Pulmonary Edema | Bleomycin | 12.99 | 15808516 | |
| MESH:D011654 | Pulmonary Edema | Hydrochloric Acid | 12.99 | 15090967 | |
| MESH:D011654 | Pulmonary Edema | Isoproterenol | 12.99 | 10903255 | |
| MESH:D011654 | Pulmonary Edema | Thiourea | 12.99 | 10849556 | |
| MESH:D011656 | Pulmonary Emphysema | Curcumin | 3.07 | 19168576 | |
| MESH:D011657 | Pulmonary Eosinophilia | Ascorbic Acid | 12.36 | 14606601 | |
| MESH:D011657 | Pulmonary Eosinophilia | Toluene 2,4-Diisocyanate | 12.36 | 14606601 | |
| MESH:D011657 | Pulmonary Eosinophilia | Trazodone | 12.36 | 8520792 | |
| MESH:D011658 | Pulmonary Fibrosis | Asbestos, Crocidolite | 14.05 | 17322281 17975199 17365031 15814490 | |
| MESH:D011658 | Pulmonary Fibrosis | Bleomycin | 14.05 | 15322207 16115399 17177178 18162602 17434272 12624602 17241526 16314464 14609568 18008008 21435439 12574379 11554783 15541506 | |
| MESH:D011658 | Pulmonary Fibrosis | Cyclophosphamide | 14.05 | 16636934 | |
| MESH:D011658 | Pulmonary Fibrosis | Drugs, Chinese Herbal | 14.05 | 16987627 | |
| MESH:D011658 | Pulmonary Fibrosis | Mustard Gas | 14.05 | 17720292 17894541 17620002 17266442 10334151 | |
| MESH:D011658 | Pulmonary Fibrosis | Paraquat | 14.05 | 17997886 16324872 | |
| MESH:D011658 | Pulmonary Fibrosis | Particulate Matter | 14.05 | 12475806 | |
| MESH:D011658 | Pulmonary Fibrosis | S-allylcysteine | 14.05 | 16614485 | |
| MESH:D011693 | Purpura | Raloxifene | 3.94 | 15770314 | |
| MESH:D011833 | Radiation Injuries, Experimental | mangiferin | 4.80 | 15830843 | |
| MESH:D012003 | Rectal Fistula | Drugs, Chinese Herbal | 4.36 | 15043669 | |
| MESH:D012004 | Rectal Neoplasms | Fluorouracil | 2.60 | 18286688 16160472 15538739 18722050 | |
| MESH:D000608 | Renal Aminoacidurias | Mercuric Chloride | 4.51 | 2918855 | |
| MESH:D051437 | Renal Insufficiency | Doxorubicin | 8.50 | 17922066 | |
| MESH:D051437 | Renal Insufficiency | Gentamicins | 8.50 | 15728788 17132701 | |
| MESH:D051437 | Renal Insufficiency | Methotrexate | 8.50 | 17352296 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 3.97 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | Capsaicin | 17.28 | 19211983 18460982 | |
| MESH:D015427 | Reperfusion Injury | Diazoxide | 17.28 | 12409977 | |
| MESH:D015427 | Reperfusion Injury | Leukotriene C4 | 17.28 | 12967936 | |
| MESH:D015427 | Reperfusion Injury | Morphine | 17.28 | 19211983 | |
| MESH:D015427 | Reperfusion Injury | phenylmethylpyrazolone | 17.28 | 14654979 15948865 15086910 15629865 16753835 16041266 | |
| MESH:D015427 | Reperfusion Injury | pirinixic acid | 17.28 | 19058328 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 17.28 | 16317513 16314181 15827377 17520802 17058453 | |
| MESH:D015427 | Reperfusion Injury | Superoxides | 17.28 | 18460982 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | 2-chloroethyl ethyl sulfide | 20.05 | 16292752 12210543 18257742 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Acetylcysteine | 20.05 | 12210543 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 20.05 | 18379247 10666014 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 20.05 | 11700416 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Hydrochloric Acid | 20.05 | 16784557 18549715 16129981 18339021 17627322 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Paraquat | 20.05 | 11700416 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | pyrrolidine dithiocarbamic acid | 20.05 | 16129981 | |
| MESH:D012130 | Respiratory Hypersensitivity | Acetylcholine | 6.52 | 9413022 | |
| MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 6.52 | 10835634 | |
| MESH:D012130 | Respiratory Hypersensitivity | Toluene 2,4-Diisocyanate | 6.52 | 7692837 20219652 16940033 | |
| MESH:D012131 | Respiratory Insufficiency | Trazodone | 4.27 | 8520792 | |
| MESH:D012133 | Respiratory Paralysis | Hydrochloric Acid | 4.75 | 11510729 | |
| MESH:D012135 | Respiratory Sounds | alachlor | 5.02 | 11874814 | |
| MESH:D012135 | Respiratory Sounds | Paraquat | 5.02 | 11874814 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.30 | 18990726 | |
| MESH:D012140 | Respiratory Tract Diseases | Hydrochloric Acid | 5.99 | 20516732 | |
| MESH:D012140 | Respiratory Tract Diseases | Toluene 2,4-Diisocyanate | 5.99 | 18447907 | |
| MESH:D012148 | Restless Legs Syndrome | Iron | 3.22 | 16930377 | |
| MESH:D012162 | Retinal Degeneration | Methylnitrosourea | 4.86 | 18155124 18172121 | |
| MESH:D012162 | Retinal Degeneration | Paraquat | 4.86 | 16458197 | |
| MESH:D012173 | Retinitis | Gentamicins | 4.67 | 18644591 | |
| MESH:D012174 | Retinitis Pigmentosa | Ascorbic Acid | 2.68 | 16849425 | |
| MESH:D012175 | Retinoblastoma | Methylnitrosourea | 3.91 | 11555667 | |
| MESH:D012220 | Rhinitis | Acetaldehyde | 9.07 | 17050345 | |
| MESH:D012220 | Rhinitis | Aspirin | 9.07 | 12372130 | |
| MESH:D012220 | Rhinitis | montelukast | 9.07 | 20332717 | |
| MESH:D012220 | Rhinitis | Toluene 2,4-Diisocyanate | 9.07 | 19050374 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Drugs, Chinese Herbal | 6.50 | 15015336 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Toluene 2,4-Diisocyanate | 6.50 | 15015336 12617775 | |
| MESH:D006255 | Rhinitis, Allergic, Seasonal | Toluene 2,4-Diisocyanate | 3.92 | 19075512 | |
| MESH:D012468 | Salivary Gland Neoplasms | Progesterone | 2.05 | 18045962 | |
| MESH:D012509 | Sarcoma | Curcumin | 4.81 | 18462866 | |
| MESH:D012509 | Sarcoma | Doxorubicin | 4.81 | 15625365 18313854 16767912 17203757 15675481 17710206 | |
| MESH:D012512 | Sarcoma, Ewing's | Dactinomycin | 12.42 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 12.42 | 16326096 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Etoposide | 12.42 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | zoledronic acid | 12.42 | 16121404 | |
| MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 3.22 | 17846226 | |
| MESH:D012554 | Schistosomiasis japonica | Quercetin | 3.94 | 16862918 | |
| MESH:D012555 | Schistosomiasis mansoni | therapeutic | 9673227 | ||
| MESH:D012555 | Schistosomiasis mansoni | Nitric Oxide | 3.93 | 9673227 | |
| MESH:D012559 | Schizophrenia | Copper | 3.00 | 16842975 | |
| MESH:D012559 | Schizophrenia | Methionine | 3.00 | 15737665 | |
| MESH:D012559 | Schizophrenia | Trazodone | 3.00 | 7868106 | |
| MESH:D019873 | Schnitzler Syndrome | Thalidomide | 4.35 | 16096327 | |
| MESH:D012595 | Scleroderma, Systemic | Cyclophosphamide | 3.33 | 16636934 | |
| MESH:D012640 | Seizures | 3-xylene | 23.93 | 6431079 8907413 | |
| MESH:D012640 | Seizures | Atropine | 23.93 | 17157343 11218047 12660363 | |
| MESH:D012640 | Seizures | Carbamazepine | 23.93 | 9844417 16876388 16180713 16938433 9046859 19414003 15946322 | |
| MESH:D012640 | Seizures | Diazepam | 23.93 | 10087439 9754883 15946322 | |
| MESH:D012640 | Seizures | Endosulfan | 23.93 | 7539098 10698677 | |
| MESH:D012640 | Seizures | Ethanol | 23.93 | 9754883 | |
| MESH:D012640 | Seizures | ferric chloride | 23.93 | 12941455 | |
| MESH:D012640 | Seizures | gabapentin | 23.93 | 10454489 | |
| MESH:D012640 | Seizures | Kainic Acid | 23.93 | 16336964 17827730 14637104 19414003 10686065 18657176 1641125 19186208 15686955 | |
| MESH:D012640 | Seizures | lamotrigine | 23.93 | 9844417 16499746 | |
| MESH:D012640 | Seizures | Nicotine | 23.93 | 17873105 | |
| MESH:D012640 | Seizures | topiramate | 23.93 | 16499746 | |
| MESH:D012640 | Seizures | zonisamide | 23.93 | 18455367 11044598 11755227 10029267 11518630 15946322 9046859 9806000 16938433 16180713 9844417 16876388 12941455 11879338 11442880 | |
| MESH:D018805 | Sepsis | Curcumin | 7.72 | 18389075 | |
| MESH:D018805 | Sepsis | Isoflurane | 7.72 | 17414419 | |
| MESH:D018805 | Sepsis | Zymosan | 7.72 | 11441115 | |
| MESH:D020230 | Serotonin Syndrome | Trazodone | 4.54 | 7854515 8704074 9050436 | |
| OMIM:608579 | SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO | lamotrigine | 5.03 | 19668019 20485159 | |
| MESH:D012772 | Shock, Septic | 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetra-hydroisoquinoline | 17.22 | 11961057 | |
| MESH:D012772 | Shock, Septic | endotoxin, Escherichia coli | 17.22 | 18063050 | |
| MESH:D012772 | Shock, Septic | lipoteichoic acid | 17.22 | 19573522 | |
| MESH:D012772 | Shock, Septic | Mangifera indica extract | 17.22 | 15177305 | |
| MESH:D012772 | Shock, Septic | mangiferin | 17.22 | 15177305 | |
| MESH:D012852 | Sinusitis | Ampicillin | 6.75 | 7327846 | |
| MESH:D012852 | Sinusitis | Phenylephrine | 6.75 | 7327846 | |
| MESH:D012851 | Sinus Thrombosis, Intracranial | Aspirin | 3.71 | 12269725 | |
| MESH:D012871 | Skin Diseases | Ascorbic Acid | 2.88 | 18709164 | |
| MESH:D012871 | Skin Diseases | Mustard Gas | 2.88 | 16961503 12880345 15451306 | |
| MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 24.18 | 19755658 10029692 | |
| MESH:D012878 | Skin Neoplasms | Doxorubicin | 24.18 | 15692506 | |
| MESH:D012878 | Skin Neoplasms | gingerol | 24.18 | 19481070 | |
| MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 24.18 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Iron | 24.18 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Plant Extracts | 24.18 | 16517061 15173996 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 24.18 | 15837718 8985016 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 24.18 | 18572023 19524636 | |
| MESH:D012878 | Skin Neoplasms | tert-Butylhydroperoxide | 24.18 | 8532709 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 24.18 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 24.18 | 11807781 8330346 8985016 12065085 18404319 | |
| MESH:D012878 | Skin Neoplasms | Urethane | 24.18 | 11807781 | |
| MESH:D020181 | Sleep Apnea, Obstructive | montelukast | 4.58 | 19118273 | |
| MESH:D012892 | Sleep Deprivation | Trazodone | 4.67 | 19798453 | |
| MESH:D012893 | Sleep Disorders | Carbamazepine | 13.00 | 19414003 | |
| MESH:D012893 | Sleep Disorders | Kainic Acid | 13.00 | 19414003 | |
| MESH:D012893 | Sleep Disorders | Melatonin | 13.00 | 18182647 16897403 16919138 | |
| MESH:D012893 | Sleep Disorders | Trazodone | 13.00 | 19395429 | |
| MESH:D020178 | Sleep Disorders, Circadian Rhythm | Melatonin | 5.02 | 18078449 19452292 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Melatonin | 5.69 | 18078449 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Trazodone | 5.69 | 15062207 17225163 15341891 | |
| MESH:D019082 | Smith-Lemli-Opitz Syndrome | 27-hydroxycholesterol | 4.45 | 11254748 | |
| MESH:D012912 | Sneezing | Toluene 2,4-Diisocyanate | 3.92 | 19050374 19075512 | |
| MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 3.02 | 16767912 17203757 15625365 | |
| MESH:D013035 | Spasm | thiaton | 6.30 | 11855677 | |
| OMIM:270800 | SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE | 27-hydroxycholesterol | 4.79 | 19812052 | |
| MESH:D013088 | Spermatocele | Tamoxifen | 2.70 | 16709447 | |
| OMIM:102530 | SPERMATOGENIC FAILURE 6 | Cyclophosphamide | 3.93 | 16517039 | |
| MESH:D013119 | Spinal Cord Injuries | montelukast | 9.68 | 18059327 | |
| MESH:D013119 | Spinal Cord Injuries | Progesterone | 9.68 | 15862959 16503802 | |
| MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 9.68 | 19457130 | |
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 2.45 | 12854658 | |
| MESH:D013158 | Splenic Diseases | Dimethylnitrosamine | 3.67 | 12587719 | |
| MESH:D013163 | Splenomegaly | Antimony Sodium Gluconate | 4.68 | 9665985 | |
| MESH:D013226 | Status Epilepticus | zonisamide | 4.61 | 12833885 | |
| MESH:D019956 | Stereotypic Movement Disorder | Amphetamine | 4.81 | 1977408 | |
| MESH:D013262 | Stevens-Johnson Syndrome | Carbamazepine | 14.11 | 19694795 15057820 19915237 20485159 16538176 18855540 16415921 | |
| MESH:D013262 | Stevens-Johnson Syndrome | lamotrigine | 14.11 | 20235791 | |
| MESH:D013262 | Stevens-Johnson Syndrome | oxcarbazepine | 14.11 | 20235791 | |
| MESH:D013262 | Stevens-Johnson Syndrome | zonisamide | 14.11 | 12239465 | |
| MESH:D013272 | Stomach Diseases | Dexamethasone | 11.75 | 15472012 | |
| MESH:D013272 | Stomach Diseases | Indomethacin | 11.75 | 18545984 15038085 17638125 16280098 18209964 15472012 16113693 17207306 10192188 10215738 16184426 17160473 10486359 | |
| MESH:D013272 | Stomach Diseases | rebamipide | 11.75 | 16184426 | |
| MESH:D013272 | Stomach Diseases | Rolipram | 11.75 | 15038085 | |
| MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 6.99 | 20155912 2093021 | |
| MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 6.99 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Dimethylnitrosamine | 6.99 | 16033868 | |
| MESH:D013274 | Stomach Neoplasms | Drugs, Chinese Herbal | 6.99 | 18339527 | |
| MESH:D013274 | Stomach Neoplasms | Ethanol | 6.99 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Fluorouracil | 6.99 | 16424979 17172411 17522103 19015929 18396642 15786421 16951190 18567086 19084572 17498489 | |
| MESH:D013274 | Stomach Neoplasms | Indomethacin | 6.99 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Methylnitrosourea | 6.99 | 16257854 15930296 18593901 | |
| MESH:D013274 | Stomach Neoplasms | nitrosobenzylmethylamine | 6.99 | 17575124 12958204 | |
| MESH:D013274 | Stomach Neoplasms | rebamipide | 6.99 | 15993841 | |
| MESH:D013276 | Stomach Ulcer | marker/mechanism | 15138204 12481160 | ||
| MESH:D013276 | Stomach Ulcer | 16,16-Dimethylprostaglandin E2 | 71.33 | 11595431 | |
| MESH:D013276 | Stomach Ulcer | Acetylcysteine | 71.33 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | allylpyrocatechol | 71.33 | 18431645 | |
| MESH:D013276 | Stomach Ulcer | Ascorbic Acid | 71.33 | 18726076 | |
| MESH:D013276 | Stomach Ulcer | Atropine | 71.33 | 11595415 | |
| MESH:D013276 | Stomach Ulcer | bis(4-hydroxycinnamoyl)methane | 71.33 | 19188055 | |
| MESH:D013276 | Stomach Ulcer | Curcumin | 71.33 | 16631530 19188055 | |
| MESH:D013276 | Stomach Ulcer | Dexamethasone | 71.33 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Ethanol | 71.33 | 11906479 16755016 17189318 17918041 9562338 9211565 | |
| MESH:D013276 | Stomach Ulcer | Hydrochloric Acid | 71.33 | 17189318 15309881 16755016 | |
| MESH:D013276 | Stomach Ulcer | Indomethacin | 71.33 | 11906479 12500499 17627676 15104355 18726076 14567935 17135157 18181030 16755016 18193104 17895592 12498302 12787963 12467913 17977527 11595431 10423059 18087811 17654042 11523592 17918041 12077510 16169175 16934674 1323529 16397915 18431645 16252198 17657623 11729361 18543354 18237397 10878458 11595415 10750652 15138204 16631530 18209962 16150113 18299717 15255614 11145282 | |
| MESH:D013276 | Stomach Ulcer | Mangifera indica extract | 71.33 | 19305363 | |
| MESH:D013276 | Stomach Ulcer | mangiferin | 71.33 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | Melatonin | 71.33 | 16150113 12500499 11523592 | |
| MESH:D013276 | Stomach Ulcer | montelukast | 71.33 | 17895592 | |
| MESH:D013276 | Stomach Ulcer | Nitric Oxide | 71.33 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | pimagedine | 71.33 | 18209962 | |
| MESH:D013276 | Stomach Ulcer | Plant Extracts | 71.33 | 17135157 18237397 18193104 12787963 15255614 | |
| MESH:D013276 | Stomach Ulcer | Ranitidine | 71.33 | 18726076 17895592 18087811 17135157 16397915 | |
| MESH:D013276 | Stomach Ulcer | Rolipram | 71.33 | 14567935 | |
| MESH:D013276 | Stomach Ulcer | Sucralfate | 71.33 | 15991576 10423059 | |
| MESH:D013276 | Stomach Ulcer | sulglicotide | 71.33 | 17657623 | |
| MESH:D013276 | Stomach Ulcer | Thalidomide | 71.33 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | usnic acid | 71.33 | 16169175 | |
| MESH:D020521 | Stroke | Ascorbic Acid | 9.49 | 16517955 16403987 | |
| MESH:D020521 | Stroke | Aspirin | 9.49 | 16403987 | |
| MESH:D020521 | Stroke | Raloxifene | 9.49 | 16837676 | |
| MESH:D020521 | Stroke | Trazodone | 9.49 | 810300 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 3.03 | 16321402 | |
| MESH:D013345 | Subarachnoid Hemorrhage | Drugs, Chinese Herbal | 4.16 | 17634840 | |
| MESH:D019966 | Substance-Related Disorders | bisphenol A | 2.47 | 16684133 16045194 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Diazepam | 8.46 | 9754883 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Ethanol | 8.46 | 9754883 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Trazodone | 8.46 | 12749364 393279 | |
| MESH:D013398 | Sudden Infant Death | Iron | 3.87 | 16640825 | |
| MESH:D015173 | Supratentorial Neoplasms | Cyclophosphamide | 3.49 | 12837982 | |
| MESH:D013576 | Syndactyly | Methotrexate | 3.51 | 9562676 | |
| MESH:D013610 | Tachycardia | Nitroprusside | 4.11 | 15306635 | |
| MESH:D017180 | Tachycardia, Ventricular | Trazodone | 4.07 | 2424891 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Capsaicin | 13.50 | 17997062 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Plant Extracts | 13.50 | 17997062 | |
| MESH:D013705 | Temporomandibular Joint Disorders | polyphenols | 13.50 | 17997062 | |
| MESH:D013733 | Testicular Diseases | Acrylamide | 5.85 | 15864552 | |
| MESH:D013733 | Testicular Diseases | phenethyl isothiocyanate | 5.85 | 15864552 | |
| MESH:D013742 | Tetanus | Propofol | 4.83 | 2903605 | |
| MESH:D013921 | Thrombocytopenia | 1-Naphthylisothiocyanate | 5.27 | 20133375 | |
| MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 5.27 | 15821434 | |
| MESH:D013927 | Thrombosis | Aspirin | 5.43 | 17672075 | |
| MESH:D013927 | Thrombosis | SU 5416 | 5.43 | 12649163 | |
| MESH:D013953 | Thymus Neoplasms | Methylnitrosourea | 3.66 | 11418001 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 2.31 | 12697716 | |
| MESH:D013964 | Thyroid Neoplasms | alachlor | 8.67 | 8812207 | |
| MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 8.67 | 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 8.67 | 17909728 16010429 | |
| MESH:D013964 | Thyroid Neoplasms | Indomethacin | 8.67 | 14736730 18791128 11352223 | |
| MESH:D013964 | Thyroid Neoplasms | Methylnitrosourea | 8.67 | 3078959 7505956 | |
| MESH:D013978 | Tibial Fractures | Estradiol | 8.41 | 19048282 | |
| MESH:D013978 | Tibial Fractures | Raloxifene | 8.41 | 19048282 | |
| OMIM:188890 | TOBACCO ADDICTION, SUSCEPTIBILITY TO | Nicotine | 3.42 | 16785264 11259349 16720336 | |
| MESH:D014029 | Tobacco Use Disorder | Nicotine | 3.90 | 15735609 18041664 18305452 17979512 | |
| MESH:D014062 | Tongue Neoplasms | Fluorouracil | 5.19 | 16280240 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 5.19 | 16227395 | |
| MESH:D016171 | Torsades de Pointes | Dobutamine | 3.82 | 19353679 | |
| MESH:D014202 | Tremor | Atropine | 6.72 | 17594079 | |
| MESH:D014202 | Tremor | Tropicamide | 6.72 | 19467297 17594079 | |
| MESH:D014235 | Trichinellosis | Mangifera indica extract | 9.49 | 14669257 | |
| MESH:D014235 | Trichinellosis | mangiferin | 9.49 | 14669257 | |
| MESH:D014376 | Tuberculosis | Iron | 2.92 | 16597321 | |
| MESH:D014456 | Ulcer | Indomethacin | 3.32 | 10574470 17380554 | |
| MESH:D020194 | Unverricht-Lundborg Syndrome | zonisamide | 4.61 | 11814737 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2-Naphthylamine | 15.96 | 11144890 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 15.96 | 17053015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 15.96 | 18593936 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cyclophosphamide | 15.96 | 14692829 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 15.96 | 17653716 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Plant Preparations | 15.96 | 11251952 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 15.96 | 16720314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Raloxifene | 15.96 | 17572228 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 15.96 | 16452187 17306315 11723127 16712894 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 15.96 | 8653321 17572228 16712894 | |
| MESH:D014552 | Urinary Tract Infections | marker/mechanism | 9011564 | ||
| MESH:D014565 | Urogenital Neoplasms | Curcumin | 3.68 | 18462866 | |
| MESH:D014570 | Urologic Diseases | DDT | 7.44 | 16487989 | |
| MESH:D014570 | Urologic Diseases | Dichlorodiphenyl Dichloroethylene | 7.44 | 16487989 | |
| MESH:D014581 | Urticaria | Acetaminophen | 9.20 | 10982225 | |
| MESH:D014581 | Urticaria | Aspirin | 9.20 | 20485159 10982225 | |
| MESH:D014581 | Urticaria | montelukast | 9.20 | 10982225 | |
| MESH:D014581 | Urticaria | nimesulide | 9.20 | 10982225 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fluorouracil | 7.62 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 7.62 | 17473185 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 7.62 | 11813266 | |
| MESH:D014591 | Uterine Diseases | bisphenol A | 3.40 | 14652134 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 2.67 | 17044934 | |
| MESH:D014605 | Uveitis | Dexamethasone | 11.47 | 1336536 | |
| MESH:D014605 | Uveitis | Endotoxins | 11.47 | 1336536 | |
| MESH:D014605 | Uveitis | Zymosan | 11.47 | 11006244 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 6.91 | 17056641 | |
| MESH:D014652 | Vascular Diseases | Thalidomide | 6.91 | 15741222 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 2.98 | 12125929 | |
| MESH:D019043 | Vascular Neoplasms | Urethane | 4.31 | 10620525 | |
| MESH:D020301 | Vasospasm, Intracranial | Ibuprofen | 3.63 | 19057314 | |
| MESH:D014689 | Venous Insufficiency | coumarin | 4.17 | 12708602 | |
| MESH:D054556 | Venous Thromboembolism | Raloxifene | 3.60 | 16837676 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 16.01 | 17678736 17638931 17334414 16364871 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Isoproterenol | 16.01 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Plant Extracts | 16.01 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 16.01 | 17488730 | |
| MESH:D018487 | Ventricular Dysfunction, Left | rimonabant | 16.01 | 17678736 | |
| MESH:D018879 | Ventricular Premature Complexes | Trazodone | 5.21 | 2424891 | |
| MESH:D020257 | Ventricular Remodeling | Isoproterenol | 7.64 | 18097624 | |
| MESH:D020257 | Ventricular Remodeling | Plant Extracts | 7.64 | 18097624 | |
| MESH:D015837 | Vestibular Diseases | Gentamicins | 3.99 | 18776599 | |
| MESH:D014820 | Vitiligo | Trioxsalen | 4.96 | 16259964 | |
| MESH:D014839 | Vomiting | Indomethacin | 6.72 | 11897121 | |
| MESH:D014839 | Vomiting | zonisamide | 6.72 | 17157078 | |
| MESH:D014846 | Vulvar Neoplasms | Raloxifene | 3.94 | 16343187 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 2.64 | 15886252 | |
| MESH:D015430 | Weight Gain | Dietary Fats | 2.34 | 16723640 | |
| MESH:D015431 | Weight Loss | Bleomycin | 7.75 | 12624602 | |
| MESH:D015431 | Weight Loss | rimonabant | 7.75 | 20107430 | |
| MESH:D014947 | Wounds and Injuries | Drugs, Chinese Herbal | 6.56 | 16313111 | |
| MESH:D014947 | Wounds and Injuries | Estrogens | 6.56 | 11172683 | |
| MESH:D014947 | Wounds and Injuries | Plant Extracts | 6.56 | 20213670 19894650 |
| Pathway ID | Pathway Name |
|---|---|
| KEGG:05146 | Amoebiasis |
| KEGG:00330 | Arginine and proline metabolism |
| KEGG:04020 | Calcium signaling pathway |
| KEGG:05142 | Chagas disease (American trypanosomiasis) |
| REACT:604 | Hemostasis |
| KEGG:05140 | Leishmaniasis |
| KEGG:01100 | Metabolic pathways |
| KEGG:05200 | Pathways in cancer |
| KEGG:04146 | Peroxisome |
| KEGG:05222 | Small cell lung cancer |
| KEGG:05145 | Toxoplasmosis |
| KEGG:05152 | Tuberculosis |
| No data |
| Releated disease ID | Related disease Name |
|---|---|
| PA443319 | Alzheimer Disease |
| PA444859 | Malaria |
| Releated drug ID | Related drug Name |
|---|---|
| PA449412 | doxorubicin |
| PA448478 | l-arginine |
| PA164747225 | l-citrulline |
| PA450635 | nitric oxide |
| PA164712308 | Ace Inhibitors, Plain |
| PA450272 | lovastatin |
| PA452347 | glucocorticoids |
| Drugbank ID | Action | Drug Name | Description |
|---|---|---|---|
| DB00125 | - | L-Arginine | Dietary supplement;Micronutrient;Conditionally Essential Amino Acids |
| DB00155 | - | L-Citrulline | Dietary supplement;Micronutrient;Non-Essential Amino Acids |
| DB01110 | antagonist | Miconazole | Antifungal Agents |
| DB01234 | negative modulator | Tresaderm Dermatologic Solution | Anti-inflammatory Agents;Adrenergic Agents;Antiemetics;Antineoplastic Agents, Hormonal;Glucocorticoids |
| DB01686 | - | N,N-dimethylarginine | Enzyme Inhibitors |
| DB01835 | - | 4r-Fluoro-N6-Ethanimidoyl-L-Lysine | |
| DB01997 | - | 3-Bromo-7-Nitroindazole | |
| DB02044 | - | N-(3-(Aminomethyl)Benzyl)Acetamidine | Enzyme Inhibitors |
| DB02207 | - | 7-Nitroindazole | Anti-anxiety Agents;Anticonvulsants;Analgesics;Enzyme Inhibitors;Neuroprotective Agents |
| DB02234 | - | Ethylisothiourea | Vasoconstrictor Agents;Hypnotics and Sedatives;Enzyme Inhibitors |
| DB02462 | - | Thiocoumarin | |
| DB02533 | inhibitor | Aminoguanidine | Enzyme Inhibitors |
| DB02539 | - | S-Ethylisothiourea | Vasoconstrictor Agents;Hypnotics and Sedatives;Enzyme Inhibitors |
| DB02644 | - | N-Omega-Propyl-L-Arginine | |
| DB02692 | - | (6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin | |
| DB03014 | - | Heme | |
| DB03100 | - | 6-Nitroindazole | |
| DB03122 | - | B-Octylglucoside | Detergents |
| DB03144 | - | N-Omega-Hydroxy-L-Arginine | |
| DB03271 | - | 7,8-Dihydro-L-Biopterin | |
| DB03366 | - | Imidazole | Enzyme Inhibitors |
| DB03449 | - | N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine | |
| DB03953 | - | L-Thiocitrulline | |
| DB04400 | - | 7,8-dihydrobiopterin | |
| DB04534 | - | 5-Nitroindazole | |
| DB06879 | - | 5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE | |
| DB06916 | - | N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE | |
| DB07002 | - | 4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile | |
| DB07003 | - | (2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine | |
| DB07007 | - | (3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine | |
| DB07008 | - | 4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE | |
| DB07011 | - | (3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE | |
| DB07029 | - | 4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE | |
| DB07306 | - | ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE | |
| DB07318 | - | N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE | |
| DB07388 | - | ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE | |
| DB07389 | - | N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE | |
| DB07405 | - | 1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE | |
| DB08214 | - | 4-(1H-IMIDAZOL-1-YL)PHENOL | |
| DB08750 | - | 1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE |
| No data |
| No data |
| No data |